Content uploaded by Michael Bevington
Author content
All content in this area was uploaded by Michael Bevington on Jan 14, 2022
Content may be subject to copyright.
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
ELECTROMAGNETIC SENSITIVITY
ELECTROMAGNETIC HYPERSENSITIVITY
(ALSO KNOWN AS
ASTHENIC SYNDROME,
EMF INTOLERANCE SYNDROME,
IDIOPATHIC ENVIRONMENTAL INTOLERANCE - EMF,
MICROWAVE SYNDROME,
RADIO WAVE SICKNESS)
_
A SUMMARY
_
Michael Bevington
NEW EDITION
CAPABILITY BOOKS
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
Electromagnetic Hypersensitivity is categorised as a multisymptomatic ‘el-allergy’ in the Nordic
classification of 2000 (R.68.8). Its symptoms are ‘certainly real’ and it can be a ‘disabling
condition’ (W.H.O., 2005). It was first recorded in the mid 20
th
-century as an occupational
illness, but it has now spread into the general population through environmental exposure
from increasing levels of electro-magnetic fields and radiation. This covers current
research on this syndrome, covering EM Sensitivity and EM Hypersensitivity. It includes tables
of symptoms, EMF sources and exposure guidelines, along with references to scientific studies.
This New Edition adds updates, international doctors’ protocols, aspects of quantum biology,
evidence for sensitivity in animals and plants, case studies, disability issues and human rights.
Following sensitisation, Michael Bevington, a trustee of the charity ElectroSensitivity UK, found
few doctors with the range of knowledge to give full help. This aims to meet that
need and to help the growing number of people who have become sensitised to EMFs and EMR.
!"
"#
$ " "
# % & " '
"#Summary
""#
(" )) New Edition "
)#"""
"" !# % " #
"""*"
)+,*-+.,#/"
! $ 0 " *1+-),
2 3 4 *-+-, " 5
!" " " #
!&!""*67+6.,""
!'*88,#
Comments on the first edition:
“A terrific primer explaining this condition - a summary of the science developed for physicians”
- Dr J. Mercola
“We encourage all to share the ES primer with their doctors, families, schools and government officials"
- Camilla Rees, co-author Public Health SOS: The Shadow Side of the Wireless Revolution
Copies (print ₤15 including postage and packing in the UK; pdf £10; any profits go to ES-UK)
are available from:
9:;2;&+9:<=0->>#
$"#?)-).#())-#
?).68@6-176.##+'#A
© M.J. Bevington, New edition 2013.
(First published 2010; reprinted 2010, 2011)
Capability Books, MK18 5EH, UK
ISBN: 17.++.7)7++)
Printed by Catford Print Centre, London, SE6 2PN. Cover: Gordon Flavell
!'B'"!#
"!'!!#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-
ELECTROMAGNETIC SENSITIVITY AND
ELECTROMAGNETIC HYPERSENSITIVITY
A SUMMARY
NEW EDITION
CONTENTSpage
Foreword: for GPs 4
Introduction: letter by NHS doctor 5
1 Overview 7
2 Symptoms 8
3 Sources of electromagnetic exposure and symptom risk 9
4 Classification and diagnosis 10
5 Treatment 11
6 Epidemiology, prevalence and subjective provocation studies 12
7 Prognosis and developmental stages 13
8 Sub-thermal and direct or indirect biological mechanisms 14
9 Disease associations, susceptibility and sensitisation 15
10 History and nomenclature 16
11 International guidelines and sensitivity thresholds 17
12 BioInitiative Report, ICEMS, IEMFC, EU etc. 18
APPENDEX 1 Updates to mid 201219
A. Practical developments to 2012 20
(i) Regulatory, general; (ii) Regulatory, EHS
B. Non-thermal effects 23
(i) General non-thermal effects; (ii) Base stations, Mobile phones, Wi-Fi,
Wireless Smart Meters, Microwaves, ELF, CFLs; (iii) Photobiology;
(iv) General adverse non-thermal effects; (v) Positive non-thermal effects
C. Medical evidence for EHS 27
(i) Sensitivity/Intolerance illnesses; (ii) Medical markers for EHS;
(iii) Magnetoreception, the ANS and Aurora Disturbance Sensitivity
D. EHS treatment: Diagnostic and Therapeutic Protocols 29
(i) Centre for Electromagnetic Safety: Diagnostic & Therapeutic Protocols;
(ii) Austrian Medical Ass.: Guidelines; (iii) Other tests: Dr Havas, TOVA, PTH
E. 1. Inflammation, 2. Negative ions, 3. Schumann Resonance,
4. Earthing, 5. Body Voltage 33
F. 1. Information Bio-Systems, 2. Quantum Biology, 3. Qu. Signalling 37
G. Electromagnetic sensitivity: 1. Animals, 2. Plants 43
H. Tables: Exposure Levels, Biological and Heating Limits 47
I. Common sources of EM Fields and Radiation 49
J. Shielding, Protection and Measurements 50
K. Case Studies 51
L. Functional Impairment, Disability Issues and Human Rights 52
M. Key Dates: Scientific Discoveries and Regulation 54
APPENDIX 2 Acronyms and Glossary55
References 56-112
The references provided are not exhaustive; they are intended to illustrate some of the areas of research into the
health effects of electromagnetic radiation. Some references are repeated for ease of use.
The PMID reference number allows easy access to the abstract on the PMID website.
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6
FOREWORD
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY:
PRACTICAL AND COST IMPLICATIONS
FOR
GENERAL PRACTIONERS AND
THE NATIONAL HEALTH SERVICE
A. Benefits of prompt ES and EHS diagnosis (R.68.8: Electromagnetic
Hypersensitivity Idiopathic Environmental Intolerance – EMF)
1 Number and frequency of patient visits
0"!!"
4C3#
""#
!!2A0(20!"##
2 Tests
5#"#!2$%!
#9A!"#
3 Referrals
%"!"
""!"#
B. Benefits of prompt protection or shielding for ES and EHS patients
1 Delay and increasing symptomatology
%"""
2$"'!
5""""!"!
52$#4C#
2 Cost effective protection
=!!
!#!
0D/3
!
<"""!#
C. Benefits of appropriate advice
1 Avoiding ES and EHS
!!
'2(#
2 Improvement in related aspects of health care
"""2$&!
&!"'"
!"2$&
!"!!#2
!"2("
3"""#
.)E!2&#
D. Recognition of effects of EHS
EHS as a functional disability
"!D!"!3*=/,
"+!"+"#
%90$"C
!))7!#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8
INTRODUCTION
LETTER BY NHS DOCTOR
(?2;;2$04C02
F)
Open letter to GP and other Medical Colleagues
Dear Colleague,
Electrosensitivity / Electromagnetic Sensitivity
This is probably being passed to you by one of your patients, for informational purposes.
Thank you for spending a few moments to read it. I write as a medical colleague, trained at
Guy’s Hospital, and a Somerset GP since 1989. I have served on our Somerset Local Medical
Committee, and currently am a GP Patient Safety Lead at NHS Somerset, a GP Appraiser and
teacher of medical students. My particular interest is Health and Emotional Well Being,
including Physician Health.
Electrosensitivity is an invisible, but very real problem for many people, and manifests in many
ways. It is caused by the interaction of artificial electromagnetic fields with biological systems,
both from field effects from cables and appliances, and from transmission effects from
transmitting technology. Mechanisms are thought to include calcium efflux from cells,
interference with the blood-brain barrier, general sympathetic upregulation, and interference
with free radical pair recombination amongst others.
A number of my patients have symptoms and illnesses which have been caused by exposure to
electromagnetic fields, and which have been relieved by avoidance of the same fields.
Examples are a 22-year-old whose headaches and tiredness were abolished and sleep pattern
improved after moving her mobile phone on charge away from the bed, removing the mobile
from her body space by day, and switching off other electrics; a 78-year-old whose headaches
so concerned me that blood tests, an MRI and neurology opinion were sought (both normal) –
his symptoms disappeared after switching off his home Wi-Fi hub router and cordless phone; a
64-year-old very fit man who had noticed 4 months of decreased vitality and increased
irritability – both reversed after changing the wireless router to a wired one; a 40-year-old and
a 60-year-old whose headaches disappeared (one) and migraines substantially reduced (the
other) after removing cordless phones from the bedroom. Another adult has had tingling of
face and muzzle area, and loss of ability to speak and think fluently when near a Wi-Fi router,
whilst a child had a prolonged feverish illness for several weeks after a viral illness, which
coincidentally completely resolved when transmitting Wi-Fi, baby alarm and cordless phones
were removed from the house (ie failure to recover normally and rapidly from a viral illness).
Diagnosis in all of these cases is mainly on history, supported in some by the use of an
Electrosmog Detector.
Other symptoms that more sensitized people can develop include headaches, fatigue, poor
sleep patterns, altered sensation and tingling, irritation and rashes, earaches and
unsteadiness, confusion and difficulty in memory, aches and numbness, mood swings,
faintness, tremors and restless legs, and other sensitivities.
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@
I have observed all the above in patients that I have seen, and suspect that the problem is far
more widespread than is recognized. Please note, the above are all short term effects – the
jury will be out for some time on long term effects, though we already know the correlation
between EM fields and childhood leukaemia, whilst there is increasing evidence linking
dementia with EM Fields. During the Cold War microwaves were used as offensive tools to
cause ill health.
Because of my interest, I have become a trustee of the charity ES-UK (www.es-uk.info). This
has given me the opportunity to meet many people whose lives have become a misery
because of the severity of their problems, and who have had to take all sorts of measures to
avoid exposure to EM fields. I am convinced that this is very real, but under-recognized
problem. Regulatory and safety levels and information provided by the Health Protection
Agency and ICNIRP may be lagging the developments in research and the harms occurring.
Meanwhile the Council of Europe has recommended caution in the roll-out of transmitting
technologies (Wi-Fi etc), especially in schools and the World Health Organisation’s
International Agency for Research into Cancer has reclassed transmitting technologies as a
Class 2b possible carcinogen (instead of having no potential for harm). The UK Government
and industry are committed to the rollout of Smart Meters and Wi-Fi coverage without
appreciating the increasing number of people affected.
There is now a considerable amount of good scientific research on the matter world-wide, and
the area deserves urgent investigation – however, research always lags the appearance of the
problem in susceptible individuals – so we should all heed the precautionary principle advised
by Sir William Stewart of the Stewart Inquiry.
We are seeing a developing picture – possibly the patient who has asked you to read this is
one of the “canaries” in the coal mine (Canaries were used to detect carbon monoxide, dioxide
and methane, as they were affected before the miners were). The incidence is not certain, but
some reports show 3-5% moderately affected, less than 1% severely – but possibly 20%
slightly affected. I myself am moderately affected.
Treatment is problematic – but essentially includes avoidance of EM fields as much as possible,
as well as nutritional support, and antihistamines for rashes and irritation. It will certainly be a
developing field to help the many people affected.
It took a long time for adverse effects to be noted from tobacco, from lead in petrol, and from
asbestos – and the relevant industries were not exactly helpful in admitting the possibility of
any problems. Expect to see lots of lobbying that rubbishes the helpful factual information such
as on the many websites on this subject – even though Michael Bevington’s book alone has
hundreds of references.
Please take your patient seriously – you may be the first doctor in your area to diagnose and
support in this new field of illness – and you may have other patients who are helped – by you!
Thank you for reading this,
With good wishes,
Andrew Tresidder
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7
1 OVERVIEW
This document seeks to summarise aspects of current knowledge and research on human
sensitivity to electromagnetic radiation. This issue is important both for those who suffer from
sensitisation and for any wider implications as regards the rest of society.
• 17)!
"'electromagnetic
hypersensitivity*,#9'"
&"#!
#!"#
• %-+8E
"
#!electromagnetic sensitivity#
• syndrome'G"H
!1-#!"$=
'2
%%I2(
2!#
• %))8World Health Organisation+
J""+GH#=
/"G"!!"
!H#
-
• Electromagnetic Sensitivity Electromagnetic
Hypersensitivity EMF Neurosis #"!
"#""
##
• Adverse health effectsfrom non-thermal electromagnetic radiation
!16#""
!C'32'K
=(!'"#;1.)
!+!
""!"#
Current developments
A Diagnosis (section 4)
"!"!!""
'#!"02)))
!2#))1
(2K5!"#
6
5&!$("7)+.)2J
!5"#
8
! "
"5"#
B Medical treatment and protocols (section 5)
'"
""'&#
@
7
.
1
?*,+*,"
"+
2(+!'""#
C"!"(4$9#
C Reduction in exposure (section 11)
*,*,'!
"!""&#
18)"!"#/
9:9"'
!"&&#;%$
))7"&!"#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.
2. SYMPTOMS
2!K
#
)
-
6
8
@
7
.
1
)
-
6
8
@
7
.
1
-)
-
-
--
-6
-8
-@
-7
-.
-1
6)
6
6
6-
66
68
Auditory
!
Cardiovascular
&
!"
A!
!
!
!
Cognitive
"
"
'
*
,
'
A"+
Dermatological
!D3
"
'
"
"
!
"
'
'
'""
"A'
Emotional
"
&'
"
"
!
"A!
"
Gastrointestinal
"!
Genito-urinary
A
A!
"
Musculoskeletal
A!A
A'"
?
!
?
'AA
!AA
"A!'A
'A
AA
A?
A"A
'
?
A A
"
"
"
'"
Neurological
JJ
D+'
!
!
Ophthalmologic
AD3
"
AD"3"
!
"
Other physiological
!
!
!
A
A"A
Respiratory
!
"A
Sensitisation
"
"
NOTES ON SYMPTOMS
• Accumulation.0&'"
&"&#
6@
• Delay.!&
67
6.
#!"!#
• Diurnal state."3!#
3"""#
• Duration.%"#"
!#+2$&#
• Frequencies. "5!
*#"#=(!!!,#
• Intensity." ?
&!-#
• Ionising similarities.&+"
*+",*",#
• Severe reactions.J
'&!&"#
• Variety. %A!'
J#!#
61
#
K!*L)J,#
8)
8
8
8-
86
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1
3. SOURCES OF ELECTROMAGNETIC EXPOSURE AND SYMPTOM RISK
'#
88
8@
87
8.
($(&5'?
!0#
81
@)
2(&"#
@
Higher Risk
depending on proximity and
length of exposure
Lower Risk
depending on proximity and
length of exposure
Risk for sensitised
depending on the sensitised
frequencies and other factors
Personal
!
Household
!
'
0
!'
0$K
"
=(
Neighbourhood
!L6))
!
=(
=(
Area
Occupational
"
A'
'
*
"5,
'
$(
AKA
'
"'
=(
Personal
;
Household
!!"
""
"+"!!
blocks of flats:
"!
Neighbourhood
!M6))
"!30
"!3!
"!3=(
"!3
!
"!
=(
Area
=(
=2>
L:
KL:
!
Travel
Personal
""
+
"2$
&2$'
Household
"
'!
"
'
!
"
"
+"
K
'
+"
"
Neighbourhood
!!
"
"
5
"!
"
Area
"
• Body movement""#
@
• Chemical !""2(#
@-
• Dental amalgam artificial metal joints #
• ‘Electrosmog’!2$#%&"#
@6
@8
• ‘Hotspots’ #
• Power cables5
@@
"*,#
@7
• Rain'#
• Rain "B
@.
@1
#
• Signal strength !"#
7)
7
7
7-
• Twisted cables "#
76
• Week-ends!"""#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)
4. CLASSIFICATION AND DIAGNOSIS
CLASSIFICATION OF EHS
Nordic Council of Ministers*))),?%0+)#$@.#.?G"HG+
"H#
78
*%0+)#N@.#.
,#+#
WHO*))8,?J!"+#"
%%?%%+2(#
7@
DIAGNOSIS OF ES AND EHS
A. Association of symptoms with exposure to EMFs, ?
1. The patient’s association&2(
2. An observer’s association3&2(
3. The absence of any other diagnosis, !"?
(a)acute onset diagnosis: &"#
(b) chronic exposure diagnosis: !
&"5!#
B. Physiological measurements
Spontaneous hand movements&(2"K5#
77
C. Pathological markers
1. Environmental bioregulation of the autonomic nervous system
!!"52("
&+&""#%-"&
"!B&0)))O=APQ)#@KA#
*,Heart rate variability and bandwidth*!04$+'
*((,!",#?$K
5#"$K+&"!"K#
*!,Microcirculation*<""!,#$?
!K"!"#
*,Active electrical skin potentials*,
!'"#*#<!:J"=4##'#,
2. Pulsed echo-doppler brain scan:!B
blood stress proteins Burinary melatonin *8)E,#
G2(%H?*,"
!!B*!,-
"!!
!""#*C;($0,
3. Polyparametric. -2(*8)J$($(,
'2(&404
!""
"!+#*0"2))1,
4. Lymphocyte chemical sensitivity. !"
"*!J!&!"
',!2(&#&
!!
2(�""CAC!
""#*F20<!)).#,
5. Neurochemical marker antibody evaluation "#
7.
6. Skin conductance "'#
71
7. Photo-dermatology. '""'"
+""""#
*$!'C"3<#,
D. Subjective testing
1. Applied kinesiology with EMFs as an allergen
:""
.)
2("#
2. Subjective provocation to specific frequencies of EMFs
25!+!
2(5#
.
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
5. TREATMENT
""#
2$#
.
A. Principles: parasympathetic restoration after sympathetic arousal
.-
.6
.8
.@
.7
#Triple intervention ?,"2$+!
!,"""!"
+""
&,!"!#"#+&
#
..
C"2(*=%9,#
.1
#Autonomic Response Testing*$,!!+!'""
""'*:",#
1)
1
1
-#Symptomatic therapy:""
*(2;0#$,#
B. Established techniques
1. Preliminary procedure: detection and assessment of radiation exposure
'"#
2. Avoidance of radiation exposure
2$"#
*, Newly sensitised patients2$@'#
*!, Mains electricity!"*#:",#
*, Changes in lifestyle#"#"!0
=(#9!' !!"#
1-
*, Moving house&!=(
0!"!#2(+!
!9"2(#
3. Protection with shielding (RF and MW frequencies)
"$(2="&
#%!!"<(5#
*, Shielding the body""!#
!"2$'!#
*!, Shielding the home&+!
""�
""!"#
4. Protection or healing with EMR, subsonic longitudinal waves or subtle energy
'"?
*, !""!3&""2$!B
*!, "GH+5'!'B
*, "2$!+5!!#
!"!!
#
16
18
1@
17
2$+"!"#
1.
11
5. Supplements to strengthen the immune system and chelation
";#&!
))
!"#
)
0""#
)
#$2C0
J""*))1,"!
""&#
)-
6. Applied kinesiology, homeopathy, complementary therapies and plants
!'"B
!"#
#
)6
$'#
)8
7. Salutogenic group therapy and cognitive behavioural therapy
"+""&#
)@
0"
!!""
)7
!2(
B!!"'#
).
%!""'
!!!2(#2!'#
)1
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6. EPIDEMIOLOGY, PREVALENCE AND SUBJECTIVE PROVOCATION STUDIES
EPIDEMIOLOGICAL STUDIES
"2$GH#
*, Subconscious sensitivity
%2$ GH2$!#2$
9K!!!'"!#
*!, Conscious sensitivity: symptoms not recognised as linked with EMR
0+#"##-)E
L)#)@KA18E)#+)#@KA*/!'))8,#
"!"#
*, Conscious sensitivity: symptoms linked with EMR#
2$#
*, Conscious hyper-sensitivity: disabling symptoms linked with EMR#
!"GH""#
PREVALENCE OF EHS:"-+8E"#
)
=/
*))8,?G
!###+""#
&)ER
!"4'9:
(#H/""-E-8E8)E#
PREVALENCE OF DOCTORS ACCEPTING ES:%))11+8.E44CD
2(3
))@4CD "R!3
86E#
-
2")S#-T#
SUBJECTIVE PROVOCATION STUDIES
!
6
8
@
!
#
7
2"#""#
.
1. Definition."2(
""#%
5"#
1
G5!'2(#H
)
2. Practicality.*,"!
#"&*))7,
&
#*!,%!#
*,"<($(#
*,&!"
#
!"!#
-
6
3. Methodology.&#
4. Statistics. *,))))"#&
*))7,66+#
8
*!,%&!@)E
+&8)E!"
B!.)E#=D37)E!
.)E"""#
5. Hypothetical deductions.&*))7,'
'2(#
@
6. Pathological markers.C! !
'"#2"
G""!"H.1
7
'
"
.
!
#
1
2""'#
7. Genetic markers. 4'!"'
'B"!#
8. Testing procedures and analysis.%2$!"5
+""!
#%2()E2(&
""#
9. Psychological factors#"
"2(#.+81E4!
2("3#!"#
-)
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-
7. PROGNOSIS AND DEVELOPMENTAL STAGES
General sensitivity and “hyper” sensitivity to electromagnetic radiation
1. Natural Sensitivity.!"
"#%"!
""''#"
#
2. Limited Sensitivity.%!"!
&+"#!
G"+H#
2$&#
!""!
+*,#%!
&#
3. Hyper Sensitivity.2$""
&"
GH#G"H
&2$"""
!"""2$&
"&#&""
"""#
!!"'2$&
!&#
-
-
--
DEVELOPMENTAL STAGES OF EHS
;J
-6
.7.$C*M-,
$(A2=2$!"#
-8
-@
1. Initial Phase (3 sub phases) first 1-3 years
!+?
1 A Activation / excitement.Pronounced sympathicotonia (hypertonia).
!4
*18-,"<*18,<*1@7,#
1 B Positive stimulation. Increased sympathicotonic reaction.
C+"
*<18,#"*18-,#
1 C Adaptive / balancing phase.Less sympathicotonic deflection.
!"
""&
#"*18-,#
2. Weak pathologic development. Pre-morbid or early phase of a chronic disease.
-+8'!A"""
!"
#
3. Strong pathologic development. Exhaustion syndrome.
C"""
#
"&"#M8#
GH!!!!-
"#"
!GH
#%"#
#
-7
Factors increasing the likelihood of electro-sensitivity *;J,
• Age:""""#
• Electrolyte/mineral balance:'&#
• Individual state of health:"#
• Some foods and medications:#"##
2$?#"##
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6
8. SUB-THERMAL AND DIRECT OR INDIRECT BIOLOGICAL MECHANISMS
-.
-1
6)
0
6
6
6-
66
68
&
6@
67
6.
61
8)
8
8
8-
86
88
8@
87
8.
81
@)
@
@
!
@-
@6
@8
!""
@@
@7
@.
@1
7)
!"
7
!+!!
7
7-
76
78
7@
77
7.
71
.)
!
.
!
.
.-
.6
.8
.@
.7
..
.1
1)
1
1
1-
16
18
1@
17
1.
11
))
)
)
)-
!
)6
)8
)@
)7
).
)1
)
-
6
8
@
7
.
1
!
)
-
6
8
"
@
7
.
1
!
-)
-
-
&
--
-6
-8
-@
-7
-.
-1
6)
6
6
6-
'
66
68
6@
"
67
6.
61
8)
8
8
8-
86
88
8@
87
8.
81
@)
@
@
@-
@6
@8
@@
@7
@.
@1
7)
7
7
7-
76
78
7@
77
7.
71
.)
.
.
.-
.6
"A(A2(
.8
.@
.7
..
.1
1)
1
1
1-
16
18
1@
17
1.
11
-))
-)
"&
-)
-)-
-)6
-)8
-)@
""
-)7
-).
"&
-)1
-)
!&"
-
-
--
-6
-8
-@
-7
-.
-1
(C
-)
-
-
--
-6
-8
-@
-7
-.
-1
--)
!
--
--
---
--6
--8
--@
--7
--.
--1
-6)
-6
-6
-6-
-66
-68
-6@
-67
-6.
-61
-8)
!
-8
-8
-8-
-86
-88
-8@
-87
"
-8.
-81
-@)
-@
-@
-@-
-@6
-@8
-@@
-@7
-@.
-@1
-7)
-7
-7
-7-
-76
-78
-7@
-77
-7.
-71
-.)
-.
-.
-.-
-.6
-.8
-.@
-.7
-..
-.1
-1)
-1
-1
-1-
-16
-18
-1@
-17
-1.
-11
6))
6)
6)
6)-
6)6
A&
6)8
6)@
6)7
6).
'
6)1
6)
6
6
6-
66
68
6@
67
"
6.
61
6)
6
6
&
6-
66
68
6@
67
6.
J
61
6-)
6-
6-
6--
6-6
6-8
6-@
6-7
6-.
6-1
66)
66
66
66-
666
668
66@
667
66.
661
68)
68
68
68-
686
688
68@
687
68.
681
6@)
6@
&"
6@
6@-
6@6
6@8
6@@
6@7
6@.
6@1
67)
67
67
67-
676
#2(
678
67@
677
67.
671
6.)
6.
6.
6.-
6.6
6.8
6.@
6.7
"
6..
6.1
61)
61
61
"
61-
616
618
61@
"
617
61.
611
8))
8)
8)
8)-
!
8)6
8)8
8)@
8)7
"
8).
8)1
8)
8
8
8-
86
>++
88
8@
87
!'"%0$5
8.
81
8)
&"#2("""#
8
U9"*17,?G5" ""!"
"++&!!!
"#H
8
8-
U93$0*1.@,!+#
86
U9#C"#%$C=/*11-,?G!!&!"!"
2$($"#H
88
UC#;*))8,?G!!5+
+5!+#R&
!#H+5#
8@
87
U!+?!"2C'3#
8.
81
8-)
8-
8-
Examples of sub-thermal effects of microwaves on cells *;))8,
8--
Objects Effects Reference
"& <+<1.
$!-8 !&*/0, ;#1..
! " <"117
2 KJ#111
8-;C+!'+J" ;#))8
, E. coli ;#)))
!
!!+!
!*;;;,
#)))
20+ &+"+'# )))
7A-.2C: <JJ'#))
! 5*+, V!#))
Studies showing genetic effects, classified by results and sponsorship *;))8,
Effect No Effect
Independent Industry-sponsored Independent Industry-sponsored studies
3!*),B
W(*)),B
4*)-,B
2*1@!,B
2*)-,B
C*),B
'*),
4*11,B
%'*17,B
C*1.,B
*),
2
*)!)-,
*17,B
;*),B
(J*17,B
4*)),B
<*),B
2*),B
2*17,B
2*11,B
''*),B
K &
*)!)-,B
X*)-,
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8
9. DISEASE ASSOCIATIONS, SUSCEPTIBILITY AND SENSITISATION
Co-morbidity in patients with EHS
Common Occasional/possible
&!
8-6
8-8
8-@
8-7
8-.
8-1
"
86)
A$("
86
86
86-
866
868
86@
867
*",
86.
861
88)
"
88
'
88
88-
886
888
"
88@
"
887
88.
"
881
8@)
8@
8@
8@-
"
8@6
8@8
8@@
3!
8@7
Associations between disease (other than EHS) and EMFs
Extremely Low Frequency
(ELF)
30-300 Hz
household wiring,
power lines,
transformers
Radio Frequency
(RF)
4 kHz-300 MHz
CFLs, radio, AM and VHF, TV,
voltage transients (‘dirty
electricity’), dLAN plugs
Microwave Frequency
(MF)
0.3-300 GHz
DECT cordless phones,
mobile phones and masts,
WiFi, WiMAX
G!"H=/?%$0))
8@.
G!"H=/?%$0)
<
8@1
87)
87
87
87-
876
J3
878
87@
877
87.
'
871
8.)
8.
8.
8.-
8.6
8.8
8.@
8.7
8..
!
8.1
81)
!
81
81
81-
816
818
81@
#
817
81.
811
#
@))
@)
@)
@)-
"
@)6
@)8
@)@
@)7
@).
@)1
@)
@
@
!
@-
'
@6
@8
@@
@7
@.
@1
"
@)
@
@
@-
C'3
@6
@8
@@
!
@7
@.
*!,?
+"'3
@1
@-)
@-
@-
'
@--
@-6
@-8
@-@
@-7
"!
@-.
@-1
@6)
'
@6
@6
@6-
@66
@68
"
@6@
@67
@6.
@61
2
@8)
@8
@8
!!
@8-
!
@86
@88
@8@
@87
@8.
@81
@@)
@@
@@
@@-
@@6
@@8
@@@
@@7
@@.
@@1
@7)
@7
@7
!
@7-
"
@76
@78
@7@
@77
@7.
@71
'
@.)
@.
@.
@.-
@.6
@.8
@.@
@.7
@..
@.1
"
@1)
@1
@1
""
)@
@1-
Maternal and paternal exposure and teratogenic diseases or outcomes in offspring
!
@16
'
@18
@1@
!
@17
@1.
@11
7))
!
7)
7)
7)-
SUSCEPTIBILITY TO EHS
A. Age?"" +"#
B. Ethnicity?""0#
C. Gender?5!"#
7)6
D. Knowledge?'"! #
7)8
E. Socio-economic status?+#
7)@
SENSITISATION 2(A2$!"#
7)7
A. Environmental factors:*,'""2(A2$B*,""
!!B*,""
&B*,B*,?
#"#4
2B
7).
7)1
*,?!!#
7)
B. Epigenetic factors:"#2
+""#"!8E
!'''2(#
7
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@
10. HISTORY AND NOMENCLATURE
".@.#
7
!"!+
16#
7-
"16.
76
"1@#
78
7@
77
'<("'171#
7.
"))8G"H!=
/"!Radio Wave Sickness41-#
71
%
C1@6Microwave Syndrome
7)
Microwave Sickness17-#
7
%$1@6!
syndromes, Neurological Asthenia, Autonomic Vascular, Cardiac
7
JNeuro-vegetative Asthenic Syndrome))#
7-
%17
9!-#
76
Cardiac Pain Syndrome17-
78
Diplomats’ Disease17@#
7@
Visual
Display Unit Illness 177
77
1.#
7.
Electrical Sensitivities1.@
71
Electrical Hypersensitivity1.1#
7-)
Electromagnetic Hypersensitivity""
!4J0/"1160
117
7-
"#
"G"H11#
7-
%11.4J2('""Non-specific Health Symptoms
7--
!=/
))6C"''Electromagnetic Hypersensitivity
7-6
Idiopathic Environmental Intolerance with attribution to
EMF*IEI-EMF,#
7-8
%"*,
Asthenic Syndrome*/#4"0"))1,EMF
Intolerance Syndrome (SICEM) *C;$0))1,
7-@
Hyper Frequency
Syndrome
7-7
Membrane Sensitivity Syndrome*0=%)).,Microwave
Disease
7-.
Microwave Sickness
7-1
Microwave Syndrome
76)
Radiofrequency (RF)
Sickness
76
Rapid Aging Syndrome*2"))1,#
%1-)!'
16)#"
17)#%1.)!
=()))#'"-)
#1.1B9:"!"))-#
"!))#0$"
0'))7."90
$"C!#%))19!
"!#%))8=/GH
!!"!#
76
%11)! ""
76-
766
2A0(
768
!))1
(2"K5"#
76@
#%1889"'
16KA18.9$!"@#)KA#
767
%0%$C
""6KA)))))11.#%171FG
N'"
"S"+&T"!
S+&TH
76.
9018#+1.!
!G+H#
761
%))7;%$!"
)#)#@KA))#%1189C
&#%11@99:"
!#%"'#
78)
78
78
9"";%!"%0%$C
"#(=(
!"
)#@KA'#("!!
8"=(!+!#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7
11. INTERNATIONAL GUIDELINES AND SENSITIVITY THRESHOLDS
;";"4"*;!"2%Y
;!"Z['"!%;1.7+1!)&,6"?
78-
• Nil Concern +""B
• Slight Concern +"B
• Severe Concern - !BB
!"!B
• Extreme Concern - "#
International Guidelines: - !"*,?
786
788
78@
;%*))7,
787
$0%$C
78.
+"'*@#",?%0%$C*11.,781
7@)
7@
FREQU-
ENCY
FIELD
LEVEL OF CONCERN (Building Biology)
NATURE
GUIDELINES
NIL
SLIGHT
SEVERE
EXTREME
EHS
BIOLOGICAL
(non-EHS)
(chronic)
HEATING
& SHOCK
(6 mins)
*nanoTesla) (1 nT = 0.001 microTesla = 0.01 milliGauss = 0.000 001 milliTesla)
Extremely
Low
Frequency
50-60 Hz
AC
Magnet-
ic Fields
flux
intensity
nT nT nT nT nT nT nT nT
L) )+)) ))+8)) M8)) L)#))) )+) ;%?
))B
93='"
430?-)B
?8B
7@
;9?)
0#3#?)
%0%$C
C?
)))))
S8)))))
T
(Volts/metre)
ELF, AC
50-60 Hz
Electric
Fields
V/m V/m V/m V/m V/m V/m V/m V/m
Field
strength
ground
potential
L +8 8+8) M8) L)#))) )+)#8 9+0"
AC?)B
;9?)#8B
%0%$CC?
8)))
S))))
T
potential
free
L
)#-
)#-+#8 #8+) M)
K!A=(=2>(Volts/metre: peak) (microwatt/square metre: average)
Radio
Frequency
300 kHz-
300 MHz
Microwave
0.3-300
GHz
For complex
frequency
spectra RMS
MF is too
low.
7@-
Electric
Fields
V/m V/m V/m V/m V/m V/m V/m V/m
L)#
))@
)#))@+
)#)@
)#)@+)#@ M)#@ L
)#))))
)+
)#)8
;%?
)#@
)#B
J!"?
)#)@
)#)
%0%$CC?
6*1))
2J,
@*#68
4J,
Power
density
µW/m²
µW/m² µW/m² µΜw/m² µW/m²
µW/m²
µW/m² µW/m²
L
)#
)#+) )+))) M))) L
)#)))))
)+)# ;%?
)))
))B
J!"?
)
%0%$CC?
)))))))B
8
(?
8)))))))
Conductivity5?L'J)EM'J))E#)A8)J
!!)#))A))'JB(#
7@6
7@8
Cumulative health effects*!,M6@)"M)))#(2(
"&""#
7@@
Induced body voltage?!L.)K*,"LO=AP#
7@7
0)KA))KA!#
7@.
7@1
;"
K!)))))K*!!,)))*,#)#7KA!
&'KA#
77)
0?K
*+,
#
77
! (""'M78)K#
Public health safety limits !'#0
"5#
77
77-
776
778
77@
777
77.
SAR *!$B!&
771
,?!"")#)=A'"
7.)
7.
7.
)#))))I)#))=A'"#
7.-
=(!\#)=A'"!)#I#@=(
)#)8I)#*#),;*,)#8)#)#=+$#
7.6
7.8
&#
7.@
"?#)=A'"*")",#)#))=A'"]+-);A
)#)-KA#
Thresholds, MW reactions: motor?&B
7.7
cognitive?#
7..
Thresholds, sensitivity: EF?)#)8KA#
7.1
MF?8
71)
8*6))'K,)#6*",#
71
Auditory (variable):-F#6+7)2J)#*2$%,
71
8)))O=A
*Q-KA,
71-
716
)FA
#
718
MF transients?M))@)J#
71@
C'#
717
Thresholds. spontaneous reflex, ?2()A
71.
$(
711
#
Voltage transients!
.))
.)
!L)4#
.)
.)-
Windows?#"#2(!"?-)+8.)*&,#
.)6
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.
12. BIO-INITIATIVE REPORT,
INTERNATIONAL COMMITTEE ON ELECTROMAGNETIC SAFETY,
EUROPEAN UNION,
GOVERNORS’ DECLARATIONS OF EHS AWARENESS MONTH,
RESOLUTIONS AND APPEALS BY DOCTORS AND PSYCHOLOGISTS
BIOINITIATIVE REPORT
*))7,!6"!"
%0%$C311."#
.)8
INTERNATIONAL COMMITTEE ON ELECTROMAGNETIC SAFETY*ICEMS)
C"$*))1!-8,
.)@
;$*))@!-,
.)7
0$*))!@,
.).
INTERNATIONAL EMF COLLABORATIVE
$!!6)6
*))1,#
.)1
EUROPEAN UNION
The EU Parliament*
))1,!
"!"!5
"!"!%0%$C11.
""#
.)
The European Environment Agency*))7,+
2(&#
.
GOVERNORS’ DECLARATIONS OF EHS AWARENESS MONTH
"00(2
2"-@""20
*))1,#
RESOLUTIONS AND APPEALS BY DOCTORS AND PSYCHOLOGISTS
"^+;+/!!*))7!-@)8)",
.
:J*))7."8@,
.-
<*))7),
.6
D=&3*))@!@,
.8
;!"*))8!78,
.@
0!"*))8!1@,
.7
(!*))8!86,
..
!*))8!.,
.1
'*))8,
.)
*))8!@6,
.
%3*))8,
.
<*))8!-,
.-
/!"*))8!-,
.6
C'*))8,
.8
'*))8!-.,
.@
2*))6,
.7
(!"*))!8)),
..
J!"*)))!1!,
.1
K*11.!@,#
.-)
ORGANISATIONS
*("/,?$(
D!3*))1,#
.-
9K%GH*))1,#
.-
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1
APPENDIX 1 UPDATE to mid 2012
page
A. Practical Developments to 2012
(i) Regulatory, general 20
(ii) Regulatory, EHS 21
B. Non-thermal effects
(i) General non-thermal effects 23
(ii) Specific technologies: 24
Base stations, Mobile phones, Wi-Fi,
Wireless Smart Meters, Microwaves,
ELF, CFLs
(iii) Photobiology 24
(iv) General adverse non-thermal effects 25
(v) Positive non-thermal effects 26
C. Medical evidence for EHS
(i) Sensitivity/Intolerance illnesses 27
(ii) Medical markers for EHS 27
(iii) Magnetoreception, the ANS and 28
Aurora Disturbance Sensitivity
D. EHS treatment
(i) Centre for Electromagnetic Safety: 29
Diagnostic & Therapeutic Protocols
(ii) Austrian Medical Association: Guidelines 31
(iii) Other tests: Dr Havas, TOVA, PTH 32
E. 1. Inflammation 33
2. Negative and Positive Ions 33
3. Schumann Resonance 34
4. Earthing 35
5. Body Voltage 35
F. 1. Information Bio-systems 38
2. Quantum Biology 38
3. Quantum Signalling 41
G. 1. Electromagnetic sensitivity in Animals 43
2. Electromagnetic sensitivity in Plants 45
H. Tables of Exposure Levels 47
Tables of Thresholds
Tables of Biological and Heating Safety Limits
I. Common sources of EM Fields and Radiation 49
J. Shielding, Protection and Measurements 50
K. Case Studies 51
L. Functional Impairment, Disability Issues 52
and Human Rights
M. Key Dates: Scientific Discoveries and Regulation 54
APPENDIX 2 Acronyms and Glossary 55
References 56-111
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)
A. PRACTICAL DEVELOPMENTS to 2012
(i) Regulatory, general
# =/"3%$05"
Class 2B possible carcinogenic )
.--
'<())#
.-6
!!+K=+(#%
!!0!!"#
.-8
# Wireless Smart Meters were made voluntary!!!
9:")!9#
.-@
.-7
-# ! C! Council of Europe )
""#
.-.
ban on all mobiles and Wi-Fi in schools#
.-1
6# (bans advertising mobile phones"!
"@3!
#
.6)
8# "health warnings on all mobile phones#!
"!!'!%
2)#
.6
@# Seletun Scientific Statement)!
biological safety limits%0%$C3!"
#
.6
.6-
7# (24/7 radiation from masts AC4:)
;20.0001 W/m2 for sensitive areas*
"",0.01 W/m2 elsewhere"
0!0%%3%0%$C31#=A#
.66
.# Criticism of ICNIRP’s obsolete 6-minute field and power-density heating limits
"#2"+
!9:"3C
+#"
=/0"5
9!'#
.68
.6@
.67
.6.
.61
, %0%$C3"""
not to prevent biological effects long-term, low-level
exposure children, pregnant women or ill people#5
0&&#
.8)
.8
!, different individualreactions2(#
.8
.8-
, )++3!!@)E!3!
!!10 times more radiation3#
.86
, !industry funding!#
.88
.8@
.87
.8.
.81
.@)
.@
.@
.@-
, "%0%$C"atomic weapons industry
&J&#
.@6
1# Criticism of ICNIRP’s obsolete 6-minute SAR heating limits#
$*!$,+"+#
, %87+"!"!
"$)#)=A'"#
!, Current SAR 6-minute heating limits)#6=A'"!two animal
auditory experiments1.)..6"-)+@)
&\6#)=A'""
0")+
8)#).=A'"!&#
.@8
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
, The lowest SAR forbiological adverse effects)#))))=A'"#
.@@
()#)))6+)#))).=A'"#
.@7
.@.
.@1
.7)
%
)#)))6=A'"!!
)#))))6=A'"&)#))))).=A'"!&#
, ICNIRP heating limits are inadequate!+84J
)+))2J4J#
.7
.7
, %0%$C"%$Catomic weapons industry
'"+"#
.7-
)# Legal judgements.
*, %)%3" "K$
"0elevated incidences of leukaemia"
#
.76
.78
.7@
.77
.7.
*!, %))1"0;%cordless phones cause
cancer".)E"!5
.71
..)
"))6#C!#
*, %))7'0$(radiation injury
below thermal exposurelevel#
..
*, "7
2))69:refused a transmitter
"likely effects on the health
cumulative exposure&"#
..
(ii) Regulatory, Electromagnetic Hyper-sensitivity
# Classification of environmental illnesses'20
+!by the World Health Organisation)
&%0)8#!#
20"J(4<&!"3
2)%0#"J
D+"3!02)))%%+2(!=/
%0))8!#
..-
# Disability allowances!"+!
""!"0*),(*),#
..6
-# Radio-free White Zones!"!!%
()!"#%9
$/!=K"#
+J+!
!"##
6# EU Parliament))1881"2!G
&recognizepersons that suffer from electro-
hypersensitivityas being disabled"5
5H#
..8
..@
8# !Parliamentary Assembly of the Council of Europe )G
""H
?*.##6,GGH"
"
"+!
'#H
..7
@# American Academy of Environmental Medicine )
G"*2(,!
!!&2(5#H%'
G""""!H#
...
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7# ))harmed or
sensitised thousands of ordinary people
#
.# %)9:wireless smart meters voluntary!
"5!
"00"'&
+&"#
..1
1# (reduced male fertilityG&
removing cellphones"#H
.1)
)# electro-sensitivity symptoms to Wi-Fi
0))#
# reduction in the quality of life
"#
*,"+!4<*),""
#
.1
!
"""
!!"!""!"J
#
*!,:WF3F*),
!!'#
.1
5
#%9
0$"C!))79:35
))#
*,!"*),""
+5!
'+
+#
.1-
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-
B. NON-THERMAL EFFECTS
(i) General non-thermal effects
# Non-thermal long-term and low-level biological effects!
0
.16
'
.18
#
.1@
.17
+2((#
+"+#
.1.
9$+18.9
$01.@#=/3%$0
+<(;!"))
$()#%)9:"3C
+%0%$C
@+"#
# ;"non-ionizing radiation ionizing#
.11
*,+J"2(non-linearnotdose-response dependent.
*!, +J"2(GHfrequencyintensity#
(chemicals+&!
"#
1))
(EMFs5GH!"
#
1)
1)
1)-
"+&#"#
"!3=+(!+#"#!
!+!!C"#
-# “diseases of civilization”
"!'"
"")
#
1)6
1)8
1)@
#
1)7
(ii) Specific technologies at non-thermal levels
# Base station and phone masts: &!
'"!
"#
1).
1)1
1)
"+
#%87+))"!"
!"$)#)=A'"!$
")#6=A'"&)#).=A'"!
&*!#*,#1#)+,#
1
# Mobile phones!+
"""+"
1
#
1-
16
18
1@
"+'!#
17
1.
11
-# Wi-Fi laptops: ""#
1)
1
1
1-
16
18
(&&"!"+
#
1@
$#
17
=+(!!#
1.
6# Wireless Smart Meters: ""!
#
11
1-)
1-
1-
1--
1-6
1-8
8# <microwaves*)#-+-))4J,!J
&"!"!'#
1-@
1-7
1-.
1-1
@# ELF power frequencies'!
16)
16
16
16-
'
166
'
168
&
16@
167
"#
16.
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6
7# "" Compact Fluorescent Lights (CFLs)
!0(<!!!!"
0(<?*,EM radiation !*!,EM radiation
"*,!ultraviolet*9K,5#
(a) Very Low and Low frequency EM radiation from ballasts (1-100 MHz)
!0(<2(8+7)'J<(""induced levels
)#.6+.#@A
"<!!*)#8A
,!!#
3'J#8+7)'J
L)#KAL)#)A"#
28)0(<electric fields!%0%$C3
.7KA8-6KA)B!-))%0%$C#
161
18)
0(<'5\6)2J#!
""!"#'#
18
("grounded planeat the feet"'
Achilles tendons!kneesS
!2$T"brainspine#
Without grounding at the feet
"
'-7.)A
)"
'"!#=
"!""
"'#
Mitigation"(!!"
"!"&""#
18
(b) Low frequency voltage transients from CFLs on the wiring
0(<"*D3,"#!!+
"!"
!#
0(<!filters!'#
18-
(c) UV blue light from CFLs; ipRGC and melatonin
0(<""visible invisible UV#
186
188
18@
9K"
$4"0*$40,#!
"$40
"'\6.)#
187
18.
181
1@)
<"!""
#0(<@8)):6)&!suppressing melatonin!\6)E
-))):B1)&#
1@
1@
"
#;""&
*))))&,#
1@-
1@6
1@8
(iii) Photobiology
1. UVA, UVB
(a) UVA *-)+6)), UVB *1)+-),!immunosuppressive#
1@@
9K!'9K;#
1@7
9K"KX
&+'&
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8
J9K)+8#
1@.
1@1
17)
Pulsed UV"!1)E#
17
(b)Reduced UVB radiation vitamin D deficiency'autoimmune
diseases2!#K!"
"#"#203
'#
17
17-
176
178
17@
2. Infrared
(a) Near-infrared A radiation*7@)+66),damage''9KMA-
""'B@8E#
9K"#
177
(b) Photo-biomodulation with near infrared@7)"!therapeutic
"2"
"#%'"""!
2
+"&#
17.
(c) Low-level laser light therapybi-phasic response#Reactive Oygen
Species!"""
&"#
171
(d) Cryptochrome"2(""
'5++#
1.)
0&+.-)@7)"
"!!&#
1.
(iv) General adverse non-thermal effects
# Pregnant women?*,!?"
1.
1.-
*,"?"'
1.6
!
1.8
#
# ADHD-like affects&#
1.@
1.7
1..
1.1
11)
Autism!'
2(
11
11
11-
#
116
!
!+*0,#
118
11@
117
"'"
11.
111
)))
!#
))
-# Male fertility"!"#
))
))-
))6
))8
C
&-!"#
))@
6# Precocious puberty'&#
))7
8# Visual reaction times!!#
)).
@# 2& microwave hearing, #
))1
))
)
)
)-
7# Mercury in dental amalgam fillings!2$%&#
)6
!)8)KA@)J#
)8
.# Sensitisation#
)@
1# 2adaptive response+"2$"
)7
).
)1
))
)
)
!?6@.!
"!6*C#"6EB#8E,#
)-
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@
)# Hypothyroidism:&<(!!*
))@,reduces thyroid hormones,"&
"!#
)6
)8
)@
)7
# Increased adrenalin
#
).
C&
cortisol&"
!
)1
<(#
)-)
# Immunological effects J#
)-
)-
)--
)-6
-#
Oxidative stress2&
)-8
)-@
)-7
)-.
)-1
"0(
)6)
)6
#
)6
)6-
!&
""
""#
)66
6# Stress <(&;4-#
)68
#684J2$C&#
)6@
8# Brain glucose metabolism!!&#
)67
)6.
@# 2" bone teeth mineralization#
)61
)8)
)8
)8
Bone marrow
stem cells)#88)J"""%$
#
)8-
7# Genetic epigenetic2("
9242
7#
)86
)88
)8@
+'_+
!'2(!!"#
)87
Primary cells can
show responses#
)8.
.# 9K9M)DNA damage#
)81
""+
!'#.4J"$/#
)@)
1# Parotid gland cancer#
)@
)# Skin electromagnetic characteristics!
'J"#
)@
# (demyelination2
)@-
2
)@6
#
)@8
<(&+!#
)@@
# Right-handed elliptically polarized radiation!"+
J#
)@7
(v) Positive non-thermal effects
# Regenerative medicine non-thermal pulsed EMF#
)@.
)@1
<(+2(7J%0$
!'#
)7)
)7
$2('
'$A(
"#
)7
)7-
)76
8)J2(
#
)78
;+2"$"2"#
)7@
)77
%C$*%C$,&
00"#
)7.
# %Electro Magnetic Information Transfer*2%,
"!"#
)71
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7
C. MEDICAL EVIDENCE FOR EHS
(i) Sensitivity / Intolerance illnesses
# idiopathic "+"!=
/""""
"+*!,#
))!'electromagnetic-sensitivity can be
independent of conscious perception'2(#(
'""
&#
).)
).
ShieldingRF emissions#
).
# "+Sensitivity-Related Illnesses
(SRI)#+$ ""!
+&!&&#"+
&&"20
.)E#
).-
'
"!!+#
).6
).8
-# Toxicant-induced loss of tolerance(TILT)!"
"""#&+!
"$%#
).@
6# Kindling"!+
+#/""'
"&#%
&#
).7
8# Genetic markers""+
+"#4
'$%200(!"#
)..
).1
)1)
(ii) Medical markers for EHS
2+"
2(A2$&#
# & review study of EHS!4W<*),
!+'
)1
&"#
)1
)1-
# 0" heart-rate variability!
)16
blood
pressure#
)18
)1@
-# 05behavioural effects are related to field
transitions or gradients"!
&#
)17
6# Cortisol levels42!#
)1.
8# Involuntary hand movements"!
K"""
)11
&#
))
@# Symptoms of electro-sensitivity at non-thermal exposures, !
!!
#
)
+!+'
!"#
)
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.
(iii) Magnetoreception, the ANS and Aurora Disturbance Sensitivity
# Magnetoreception!!
"!#
)-
)6
""
"!#
)8
# Non-linear analysis!5
"'2(*4
@)J)#+#),4+""#
latency !differ individually#
)@
)7
).
-# $*)#,"""
!plasma membrane#
)1
&5#
6# /A magnetic fields" brain electrical activity#
)
='
"right hemisphere
-
)#
7J
6
6+87+.J#
8
8# Geomagnetic storms))+-))*\E32(\-))))
5\@))))","L
#0"
))+-))'?
@
!
7
!
.
A
1
)
*"
""M))
,%+)-+6)
-
"&'J#
6
@# 4"melatonin#
8
@
/"&
!)E.E-.E8+-86)68#/)E
)8)J#
7
Mechanisms
!
.
1
-)
#
-
#
-
7# %‘Aurora Disturbance Sensitive People’$K+
"""C"""#
--
.# """10-15% of the population
\))#4$(5*<(,$K)#)6+
)#8J"5*(,$K)#8+)#6J
#
• /""
sympathetic response<((#
• "parasympathetic response(
<(#<(A(""#
-6
-8
1# `4&"
))#
-@
%non-local perturbation3
5#
-7
"V
'
-.
!!
-1
"
5#
6)
Sensing a presence +=
""A)#8+)#
6
)# 0"2(gene expression
"
6
+8#
6-
+DNA breaks
116<(2(8)J#
66
68
6@
67
6.
61
8)
# 2(2$%!! "
nystagmusvertigo!'"!
"""<J!2(
"!#
8
8
8-
86
88
8@
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1
D. EHS TREATMENT
(i) Centre for Electromagnetic Safety: Diagnostic and Therapeutic Protocol
“Health and EMF Exposure: Protocol for Diagnostics and Therapy” !/4"*)),
* 0 " $B $!"
"+%J"$<!(2;0B+
$0%$C?$0+%J"$C,
))!0178+))1$1@8+))1#
87
0
# C Draft of
the Standard of the Federal Medical Biophysical Centre of the Russian Federation#
"?
, !2(&!&
occupational general #
!, %individual EMF sensitivity#
, Several criteria"2(#
, %""""2(
&#
, %"high EMF sensitivity“EMF Neurosis”#
, %"#
1. Diagnostic Protocol
a) aims:
• ! !32(&B
• "#
b) all 4 diagnostic criteria are necessary:
• 2(&B
• 3B • &B
• "#
c) 3 groups of people:
*, "2(&B
*, "2(B
*, 2(*'!2(,#
d) scope:
!"+2(&#
e) disease status:
• !2(B
• &!2(B
• &2(&#
f) Diagnosis52(&
"B
g) Individual radio-sensitivity!+
B
h) Normal EMF conditions""+
B
i) "occupationalgeneral&B
j) "B
k) "chronicacute,2(&#
2. Protocol structure
a) General examination:
, 3
, !
, !"
b) Assessment of individual sensitivity to EMF at varying frequencies:
, !2("B
, +"?+"+
B
, 2(&'B
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-)
, &B
, conclusion?!+,,#
c) Clinical examination:
, +"B
, "?B
, !!B
, +"B
, "
, &5!#
3. Individual sensitivity
, ++2(individual characteristics#
!, %!2(
poly-parametrical*?5J&,#
, At least 2 methods!+#
, %2(
#
, -'2(?
, "5*8)J,
, +5
, ++5#
, 2(2("#
", !C178
!C<!116#
, 0!#
, +"?
# %+!+
!#
# C"+"&+
+#
-# 0"+40
"4#
6# "!&2(!+
2(!#
,0+?
, =&2(!"#
, #
, 0"#
, 2("+#
, "2(
2(&!2(
&#
, !?
•
• +"
• #
4. Therapy
?
, "
!,
, "2(#
, !B
, B
, G""H?"2(
"""B
", ?
, ?-'B
, +"?-+@'#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-
D. EHS TREATMENT contd.
(ii) Austrian Medical Association
Guidelines for the diagnosis and treatment of EMF-related health problems and illnesses (EMF
syndrome), by the Austrian Medical Association, EMF Working Group, 2012.
1158
# History of health problems and EMF exposure: 5?
,
!, !"
, 2(&#
# Examination and findings
" 2( '" " "
""#"+"
#
, !"B
, 2(&B
-, "#
0?
!"? !
"?
6+!"*!"+,
6+04
6+!$K*",#
<!?
"*@+
/,
*-,
;*!A"A";,
""
?*6,*,!*1?2,#
-# Measurement of EMF exposure:
2( 2( & *" =+(
" ! K "+"
!,!!&"#
2 !
C4;";"?42;+)).?
?AA#!!"#AA"A))."#
Recommended threshold levels (bedroom or desk/sitting area)
Normal limit Significant concern
AC magnetic fields L)*Q)#4, M6))*Q64,
AC electric fields L)#-KA M)KA
RF radiation La=A M)))a=A
6# Prevention or reduction of EMF exposure
C 2( &#
!'#
C?
• B#
• =+(B#
• !#
• "5#
• 2!'&#
• #
• $+!"#
• (2&!#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-
8# Diagnosis
• "2("!!
"!!2(
&"#
• "2(&
"#
• /!&!#
• X8.#6*&,%
0*%0+),#
@# Treatment:
Primary: #C2(&#
Additional treatments, depending on the individual case:
#"
*&!,B
-#
*+&+
,B
6#!
#
The main EMF effect seems to be the reduction of oxidative and nitrosative regulation capacity.
This explains changing EMF sensitivity and the large number of EMF symptoms. As with other
multi-system disorders, it helps to minimize adverse peroxynitrite effects.
(iii) Other tests and observations:
Dr Havas: "?
• !
• *
W"0-6,
81
• *!
!",#
Provocation testing?=+(0
!*!B&!!,#
• !"&
• !&)&
• "!"-)&#
Test of variables of attention*/K,?
""#
@)
@
@
Parathyroid hormone*C,!"#
<!"C-))"'
#2('!#
@-@6@8
@@
MCS:mast cell disorder""! 20#
@7
20!"
"""imbic hypermetabolism#
@.
@1
$*0-Z0@Z,20#
7)
Other treatments: *+,"&#
7
Difference between EHS ES EMFIS:
*,EHS*,geneticcondition#"#"!
!"*!,acquiredheavy metal poisoning
*,""!Electrosensitivity*,EMF Intolerance
Syndrome*2(%,5"prolonged EM exposure#
;2(%!"#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
--
E. INFLAMMATION, NEGATIVE AND POSITIVE IONS, SCHUMANN RESONANCE,
EARTHING, BODY VOLTAGE
1. INFLAMMATION ?
(a) positively charged free radicals
(b) an excess of reactive oxygen species, "
"!
(c) chronic diseases"!
"
7
(d) cortisol'
7-
(e) environmental stress"!!
"#
76
78
(f) earthing or grounding the body !3
"""#
Inflammation and oxidative stress
inflammation normal / healing
polarity "
electrons "
stress
(sources)
&
#"#2(& "
free radicals
(positive,
missing an electron)
&&"*$/,
&"*$/,
&*0,
&
!
'!" '!
health state chronic, immune diseases:
!
C'3J3
""2
"''
D
!
*!?2A0(!",
"
cortisol
2. NEGATIVE AND POSITIVE IONS, AIRBORNE
(a) Negative ions !"#
7@
"
parasympathetic nervous system&"
&#
*,"improve?
• cognitive skills
77
• metabolism,
7.
• Seasonal Affective Disorder
71
.)
.
.
• computers.
.-
*,"reduce?
• cancertumor growth &'
.6
• bacteria
.8
.@
.7
• J
..
• TB infection*@)E7)E9K",#
.1
*, "Jtwo reactive oxygen
species,&"&"""!"
"&
C'3#!!$/"#
1)
1
1
*, " asthma
1-
16
!
18
#
1@
"!!8)JB)J#
*, ("!#
17
1.
(c) Concentrations of negative (anion) and positive ions (cation):
(i) High concentrationsnegative ions?!
*)))+6)))"#A
-
,"*M))))"#A
-
,#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-6
"!<waterfalls"
#"#
11
))
Low concentrations"?5
0$*L))"#A
-
,#
(ii) % positive ions*8#A
-
,
6#@"*-8#A
-
,#(
+
)
#C
!#
)
9!
""#N"-)))+
6)))"
-
B?-))+6))
-
.)+))
-
#
(iii) "vital#
)-
3. SCHUMANN RESONANCE
(a) Global Electrical Circuit3"
"+"+""""
"Schumann resonance*$,!#$
$(sferics100 lightning strikes per second+
")#8+#)+-)'J!7+6)J#
!5+"#=3
\61))".@)))
7#6@7#.-J'
-#.1#78#7-#7-168JB1.)$\J#
\)#8J#'
)@9!'+#
$"()#+#KA2(\)#))#
)6
*,Global warming""$#$
+$#
)8
)@
*,<""$2""#
)7
).
*,2+electromagnetic pollution'!$#
*,$"sea"#
(b) Human bio-effects:
*,negative charge!""!#
negative ionsearthingS#-8T#
)1
*,Higher levels$positive health#
*,Solar flares"
!#2(
)#1#-#GAurora DisturbanceHS#.T#
)
*,Blood pressure lower"$#
*,"
"reduces human circadian effects#
-
6
*,<'2(!"melatonin#
8
*,%)Jhuman weather sensitivityB)J
&"#
@
*,7+6)J"$human brainwaves
!5"""entrainment!
!+4.#.+-#J#
7
(c) Sensitivity threshold for human bio-effects:
*,;"entrainment!$
<()#+)J)#;"\
$!!
"!)
!!&!"$#
.
2()#1#-B
!)#6!""8)#
*,$!""individual sensitivity#
1
*,$!!'! man-made EM pollution, #
)
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-8
4. EARTHING
Earthing or groundingthe body,
&"
!"!'
*!,#
-
Beneficial effects"#
*,reduced delayed-onset muscle soreness!)E"'B
6
8
@
*!,nocturnal reduction&!
"!&+"#%
!""#
7
*,neuromodulation!V"424C#
.
1
%
&!#
*,skin conductancerespiratory rateblood oxygenation variance
""!""pulse rateperfusion index
"6)#""#
-)
*,therapist"+#
-
Methods of earthing+!"!
#
-
*#,
5. BODY VOLTAGE
;"#%!!#
--
(a)Ovulation3*!""
,+6)K6Z.)K+)
K&6#&
'6+6.#
-6
-8
-@
-7
-.
(b) Cancer. """"
#"#!""
"#$""""#
-1
6)
6
0!!!""
#
6
0."#
6-
(c)Usual cellular functioning20-25 milliVolts7.35 pH.0
!)K)K#(""
#58)K!
"#0"#
""""#
(d) Diurnal variation in EMFs: 6+7&
'@+'6+'"""
!#/#
%/!!
F2+7Z.K+-)Z-8K#
66
(e)!conductive'
"#
(f)Body voltage sleeping?"-#-KB")#))7K#3
)J'""8+@#))#
(g) Phospholipids!'
'!#$""7)
!!&
#0'"#
(h) Oxygen!#<&"'#
0"&"#&"
"#="&"!!
!#;"
&"!#
(i) pH (power of hydrogen)"#
• '7+6"!"
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-@
• 7+"!"#
pH testing?
• healthy urine or saliva pH!7#-."B!
B&#
• 9!"!@#8""'#
• @#6+@#.!"7#8"#
• '!8#8#
pH of blood#")#8
#"!#
Cellular voltage: health effects related to pH, body voltage, food, environment
health disease normal healing
state '
pH (1 number
= x 10)
+@ 7#-8@b
*"7#)+7#68,
.+6
pH voltage
(60 mV per pH
change)
@QZ@)K*Z)#)@K,
8QZ)K*Z)#K,
6QZ.)K*Z)#.K,
+)K
*+)#)K,b
.Q+@)K*+)#)@K,
1Q+)K*+)#K,
)Q+.)K*+)#.K,
body voltage L+)K*ZK, +)+8K M+8)K
polarity "*,
foods &?
""
0bb
"?
"!'
#W'#
life-style &
environment 2(##
?
"
cellular oxygen
&" "&"
tissue " "
* See table below for children, young adults and athletes, and ill health.
** Oxidant (electron receptor) therapies include (a) high dose vitamin C, stimulating hydrogen peroxide, (b) UV blood
irradiation therapy.
pH and cellular body voltages: typical health effects
acidic-
alkaline
cellular body
voltage
person
health effects
pH milliVolt
Volt
M7#8 M+-)K M+)#)K !"
7#8 +-)K +)#)-K
"
7#6 +8K +)#)8K
7#-- +)K +)#))K ?
7#8 +8K +)#)8K
7#7 +)K +)#)K '
7#). +8K +)#))8K "
M7#). M+8K M+)#))8K &"
@#8 Z-)K Z)#)-K
""
Short-term bio-effects of grounding
parameter at grounding during 40 minutes’
grounding
after grounding
skin conductance
respiratory rate
respiratory rate variance
blood oxygenation variance "
pulse rate variance ?-)+6) "
perfusion index variance ?-)+6) "
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-7
F INFORMATION BIO-SYSTEMS, QUANTUM BIOLOGY QUANTUM SIGNALLING
1. INFORMATION BIO-SYSTEMS
(a)Systems biology !"
""!#
"!#
68
6@
67
6.
61
(b)Electromagnetic information bio-systems
*,"
*,#"#+""
*,""
*,&"!++2$#
8)
8
8
8-
(c)mechanisms of interreaction+"!'"K=
!!"9K$""!
!""" #
Information
bio-system Wave-particle Range Energy Categories
1 active information
scalar energy, subtle
energy quantum nonlocal,
entangled wide low plants,
animals
2 DNA singalling,
photonic electro-magnetic solitons,
photons, biophotons quantum EM dynamic,
quantum mechanical wide,
medium low,
medium plants,
animals
3 perineural phonons, electrons,
protons quantum mechanical medium medium plants,
animals
4 neuro-endocrine solitons, ions quantum electro-chemical narrow high animals
2. QUANTUM BIOLOGY
;+5A
5A#""J
86
88
8@
87
8.
?
*, photosynthesis
81
@)
@
@
*, avian animal navigation
@-
5
@6
*, intra-cellular signalling*-?`"",
*, quantum coherence
@8
@@
@7
@.
@1
*, quantum tunneling#"#
7)
7
7
*, quantum Zeno effect
7-
*, quantumentanglement
76
78
*, spintronics?!+"
!+""'#
7@
77
7.
Quantum biology and quantum mechanics: wave-particle duality of EMR
Aspect Detail Date
A
electron (ion, electric negative/positive charge, Lenard spray effect) 1834 Faraday, Arrhenius
magnetic field splits spectral field (el. spin,photon emission) 1896, Zeeman
as discrete particles 1897/1904, Thomson
as wave-form, deduced from Schrodinger equation c.1930 Clifford, Schrod.
all matter wave-like proposed; proved (electron diffraction) 1924 de Broglie; 1927
uncertainty principle measuring position disturbs momentum 1927 Heisenberg
Schrodinger’s equation quantum state (wavefunction) changes with time 1926 Schrodinger
photoelectric effect high-frequency blue light makes metal emit electrons 1901 Tesla
energy of emitted electrons depends on the light frequency 1902 Lenard
exciton (photosynthesis) =quasiparticle, electron in semiconductor as in free space 1931 Frenkel
electron spin resonance =electron paramagnetic resonance, radical pair mechanism 1944 Zavoisky
B
quantised EMF for
light (wave-particle), named photon 1900 Planck, 1926 Lewis
energy of light quanta
based on their frequency E=hf (energy=Planck’s constant, h, x frequency of light )
proposed; proved 1905 Einstein;
1915 Millikan
C
quantum tunelling possibility of a wave/particle going through classical barrier 1927 Hund, 1957
D
quantum Zeno effect an unstable particle observed continuously will never decay 1954 Turing
E
electromagnetic potential
fundamental (not field) proposed 1949 Ehrenberg, Siday
proved: EM field affects an electron wave, no EMF 1959 Aharonov, Bohm
F
non-locality/entanglement non-locality/entanglement, an information potential 1975 Bohm, Hiley
G
spintronics electron’s quantum mechanical spin: up/down spin filter 1985
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-.
Vibrations !"
"5
71
!!"
!"#
.)
.
.
.-
.6
.8
.@
.7
..
A. QUANTUM BIOLOGICAL EFFECTS
• Fertilization"!""
#""+''
""!#
.11)11
• Healing , epigenetic effects embryo development
""#
1-
16
18
1@
17
1.
11
-))
-)
-)
-)-
-)6
-)8
"!+'")+)-)+6)J#
-)@
• Electron loss "oxidation !
*#"#&",#&'K0#
-)7
-).
-)1
• Electrotaxis galvanotaxis0!-)
""L)#@KAM)#@KA#
-)
-
!
'metastasis#
-
--
-6
• Chemotaxis+""phospholipids#
-8
-@
-7
-.
""#
-1
• lack of coherent radiationcancer#
-)
-
-
• Electrokinesis: 0#6KA*J,#
--
• Electrophoresis '
!"!#
-6
-8
-@
• Iontophoresis #
-7
-.
-1
• Phonophoresissonoporation+-2J)+=A
<(
L))'J!#%&
#
--)
--
--
---
--6
--8
• 2 emotions#
--@
--7
--.
• Photons"
--1
!'#
-6)
-6
-6
-6-
-66
• Solitons and phonons: +
+"
'#
-68
-6@
-67
-6.
-61
-8)
-8
-8
• Soliton ))8"
!"+"#C
&"!J#
-8-
-86
-88
-8@
-87
-8.
• Ions +#<+"!+
+J+"!#
-81
-@)
B. ELECTRONS
(a, b) " ‘quantised’ ‘wave-particle duality’
!3quantum potential 2$"
!!!#
5electronslight quanta photons
!!"3uncertainty principle"3"#
2$mass!#
%Zeeman effect"3
!&"5
"*",#electron spin resonance
2$%!""#
(c) Quantum tunnelling5"""
!
-@
-@
-@-
-@6
-@8
-@@
`9%2$% '
-@7
-@.
-@1
-7)
-7
#
-7
-7-
-76
-78
-7@
-77
-7.
(d) %quantum Zeno effect!!#
(e) <""""3electromagnetic potentials
!""""2(#
2+!"++?"
""#2
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
-1
B2(!!+#
!+;#
(f) `non-locality or ‘entanglement’#!
#!
!#5
"
!#
-71
-.)
-.
-.
-.-
-.6
-.8
-.@
-.7
-..
-.1
C;+&
"#!&?*,*,
!"*,"#
-1)
-1
-1
-1-
`consciousness#
Human intention!
*%%,#%"&#&
"#
!!"
""#25
!#
-16
-18
-1@
-17
-1.
-11
6))
""!?*,
"+!*,""+!#
!!#""+!!
#"#
6)
6)
(g) Spintronics35"#
'"cccc#+"!
GHGH""#
C. PHOTONS
(a) %1))C'""
packets"#
%1)8!"quantised#
%1@5Dphotons3#
(b) C55wave-particle duality
!!"#
(c) Cmassless"#
(d)C"!force-carrier"#
(e)polarised!
#+"!#
(f)Chirality!"!++"
"""""!!+#
6)-
D. SCALAR AND SUBTLE ENERGY
(a) ""55#
(b)!"& four established forces?
"'+""#
*,!+!'*, "! "#
(c)!"“vacuum”, negative energy,
chaotic Dirac Sea, zero-point field#5
!"!#"5
!!""
&!'!'!"#
(d);!"GH!
!!bio-effects living system#"
G!"H!!!!"
!!""#
6)6
(e)"&"!
!4
!"""&#
6)8
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6)
3. QUANTUM SIGNALLING
!3!+""
5*A,#
6)@
6)7
A. DNA QUANTUM SIGNALLING
(a) longdoublehelix &""
' +! 5 "#
6).
6)1
6)
6
!!6"!
! ! ! "
"+ " ! J ! "
#
(b)fractal antennas*,
*,+#2(
'"5#
6
6-
(c) "!+spin selective"#
%+!"#
"!"#
66
(d) Coherence resonance signal-to-noise amplification +
!'"#
"++&J#
68
6@
!""#
(e)Gene expression."&)#-+.!
!!"#68)J2(
&)#6-&"20(+7#)#+
"&!""
'"""C'3"&
C&#
67
6.
61
Epigenetic modification "'J3C'32#
6)
6
(f)!damaged!*,THz radiation*,UV light*,free radicals"
!!'#&!
#
6
6-
(g) Homeostasis&"!"&#
(h) biofield!3""5"
""&""
66
68
"!#
6@
(i)Magneticlongitudinal scalar waves!
"#
67
6.
(j)phantom leaf effect1@@8+)
#:!+""
D3""#'
""""
#&8+)E#"
""8+)#
61
6-)
(k)%DNA phantom effect 1.2"
!!"#
""!#
6-
6-
(l)""!5generateEM
waves
6--
"5#"#)
+1
)
+.
#%!
"""!!9<(2!'"#!
2"!!#
(m)92"5 !
5DNA recreation#%)2""%K
"2"#!&J)6!1.E
52"")6!
#
6-6
6-8
6-@
6-7
6-.
6-1
66)
66
66
66-
(n)2(""!nervous disorders#"#
J3C'32"""!"#
666
668
2""?
(i) Digital response:GAHB2"!!#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6
(ii) Frequency: +58))I-)))J#
(iii) Nanostructure of water as signal carrier:"2"!
) &! !!))
"""#
(iv) ELF background *,
7#.-J*!,#
(v) Temperature sensitivity:2"
M7)d0 L+.) d0! 5#
(vi) Succussion "'"2"#
(o) Water
66@
667
"'
#
66.
/ 2"
digital transmission of drugs#C""
"!2!#`9%"
2""#
661
68)
68
68
68-
686
688
68@
687
68.
2"""#
681
B. BIOPHOTONIC QUANTUM SIGNALLING
(a)%1)4'biophotons!"
"""structure of organisms#
6@)
(b)%176Cbiophoton emissions*))+.)),"#
(c)%176:Jintracellular communication!!#
(d)"!"")
1
#
Coherent!regulate many processes#"#
""&
6@
+"
6@
"
6@-
!"
#
6@6
6@8
6@@
6@7
6@.
6@1
67)
67
67
(e); illness, injurystress?
*,higher rate"$/&
67-
676
*,incoherent2#
(f) Quantum teleportation"#
678
67@
677
67.
(g)!"5
8)2JK(#1)E"D '3
)E!genetic text!&
"!2#9"
"!5
"""#5
+!fast-wave genetic information channels#
671
(h) Biophoton emission analysis:
*, Changes"!"""
"#$"?@)+.))'@-)+@7)8)+8.)#
*,Location:"?'-)))
A
B?&+!"#67)+87)""
!6)+67)A#
*,Diurnal changes:'
!"#2"#
*,;"!
gravimetric tidal acceleration"#
6.)
*,;"cortisol2('#
*,Measurement !"5#
*,UVA irradiation &+'
'&'""#
"?!*)+8,.)E
"+!9K9C
9C*8+)),
#
6.
6.
6.-
6.6
6.8
6.@
6.7
6..
6.1
61)
61
61
*,Moxibustion"-+8"c"
c!""#
61-
616
618
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6
C. CEREBRAL QUANTUM SIGNALLING
(i) Rewiring the brain!'
!"!"""
'&#
61@
617
61.
611
8))
(ii) default mode network!""'
0
8)
8)
"" '#
8)-
8)6
(iii)Abnormal(ephaptic indirect) brain signalling
2#&L)#8KAL.J!'
!+"
!'+#'*6)KA18
aKA',""*.8
-16aKA,#J"))KA.)+@))J
"#
8)8
8)@
8)7
8).
8)1
8)
8
8
8-
86
88
8@
87
8.
(iv)%neurodegenerative diseases'J3""
#
81
8)
D. PERINEURAL /$ SEMI-CONDUCTOR BIO-SYSTEM - DC, ELECTRONS, PROTONS
(i);semi-conductors5collagen fibreglial cells
" !"
'#CB'"
#"#22(
8
8
"#
8-
86
88
!18E"!@8E#
(ii)3positive"'!
negative&!'#
8@
87
(iii)%allergens'meridian acupuncture points"
"'#2+#
8.
81
8-)
8-
8-
8--
(iv)direct!"!
32(8)!24!4"!3
#%&!+
B!#
(v)%light#%'bio-photons#
(vi)9regeneration Bartificial conception#
E. NEURO-ENDOCRINE BIO-SYSTEM - AC, IONS
(i)"magnetic fields8)))"
!"!8!#+!-8
!)))
!"))))))
3"#
(ii)%speed)!"&
#8#
(iii) +!electric field!)#8K#
(iv)""*,chemical synapse"+"
*!,electrical synapse" !
""#0+!
!!#
(v)advancedB#
Quantum signalling via different media
Medium Signalling Date
1
quartz ‘mirror’ cytopathic effect, produced by UV between 2 identical cell cultures
sealed and separated by a quartz barrier (a pathology in 3 days in 2nd cell) 1979,
Kaznacheev
1534 1535
1536
DNA phantom effect (DNA sample moved from a quartz cuvette) 1984, Gariaev
1537
malformations between fish in sealed glass containers with quartz barrier 2000, Burlakov
1538
2
water ordered water can retain EMF signals 1988, Benveniste
1539
HIV DNA can generate EMR 2011, Montagnier
1540
3
ight raspberry plant developed from red laser recorded hologram of tissue fragment ‘00,Budagovski
1541
,
1542
4
ir by-stander effect: EM signalling between separate Petri dishes, but no EM filter 2011
1543
5
wave
genetic 2 genetic programs create an organism, although DNA mutations:
(i) geometric, to design body, (ii) maintenance instructions for geometric program 2000 on, Gariaev
1544
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6-
G. ELECTROMAGNETIC SENSITIVITY IN ANIMALS AND PLANTS
1. ANIMALS
*,""""*!,+
*,+*,+"*,#
(a) Magnetic sensitivity to geomagnetic fields for navigation
""!"
""#
868
86@
867
86.
861
88)
• Birds:*, Inclination compass!radical pair "
"9K8@8""#
88
88
88-
886
888
88@
C" JA !"
#
887
88.
881
<"""#+
"""++"A"#
8@)
X! !'""
*2J",!+!"#
8@
*, D(&3magnetite !'"
"'#
8@
8@-
8@6
8@8
8@@
8@7
*, $inner ear lagena""
""'"""
#
8@.
8@1
87)
• Bats "3"#
87
87
87-
876
+!J2(#
878
87@
877
87.
• mole rat’s "?
'!!#-82J6.)#
871
8.)
8.
8.
8.-
8.6
• Cattle"""+&2(#
8.8
8.@
8.7
" """#
8..
• !fishes*'',induction-based magnetoreception
"""+#
8.1
(
""""#
81)
• !"?K*+,
?)K*+,#""""
"&)K*+,#
""
K*+,#
81
81
81-
816
5#
KA+)J#
818
(7)KA#
81@
• Freshwater algae6#8+-*#+#8KA,
)+"2("))#
817
• $+7))))+3'#
81.
• Loggerhead sea tutles""!"
3!"""
"M8!L-)"#
811
@))
@)
• Sharks """#5"'
!?!#
@)
@)-
• Spiny lobsters+"#
"J!3#
@)6
@)8
• Newts!!&!"+
""M)'#
@)@
@)7
@).
• Ants"+#
"C"-"""
(AA/
"++#'
"#
@)1
@)
@
@
(b) Electro-location
Fish+"!'#
@-
"++5?
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
66
*,
*,"!"#
@6
@8
@@
@7
@.
@1
@)
5+!'#
@
@
@-
@6
brown ghost knifefish"!"
'++#
"0Z+!
!#
@8
@@
(c) Electro-communication
Skates!"#
@7
'<(
@.
+""#
@1
(d) Electro-physiology
("Obelia Amblystoma (newt), "!
"#
@-)
@-
2(
3"&#
@-
(e) Adverse effects
• Rats mice "?
<(
@--
@-6
@-8
J)#)))8=$(#
@-@
@-7
+
)#=A:"
@-.
cc#
@-1
0')#@
=A'"#
@6)
%+!'2(#
@6
@6
<(
+""#
@6-
6)J7@)6
&-)
@66
"""#
@68
@6@
• Cattle '!*,<(
@67
@6.
@61
*!,$()#))+)#7=A+@#))#);82J#
@8)
• Rabbits""2(#
@8
@8
@8-
@86
• Frogs’ eggs and tadpoles&6)#.+-#8KA
+"1)E#
@88
• % cockroaches #2J+.!#62J.+66
"72J66"'!#.8E
'!M.+)'KA*+,
&'#
@8@
@87
@8.
@81
• Snails8)J+5&!(#
@@)
• Earthworms +<(
@@
!002("#
@@
• Sea-urchin: !"#
@@-
@@6
@@8
@@@
• bird
@@7
&
@@.
#
@@1
• house sparrow"("*2J+-4J,#
@7)
• (house sparrow males"*1)).))2J,#
@7
• ("stork))6)EL))
'5"'"!#
@7
• Tree swallows"!"<(&
""63&<(#
@7-
• Bats#
@76
• Bees2(*,direct' !
"
@78
@7@
@77
@7.
@71
@.)
@.
@.
@.-
@.6
@.8
@.@
@.7
@..
@.1
*, indirect
+"$+'
="%C"
J!!00#
@1)
@1
@1
!!"7:KA)#8
8#:KA!#.:KA
@1-
@"3""!))@)J#
@16
@18
• fruit fly"59K+A!"*"L6)
,#
@1@
@17
@1.
@11
$421)).))!
!VV-)))=A
)#@+)#7KA
#7))7)
7)
2(
7)-
7)6
J#
7)8
$&)"#
7)@
• 2+ ' cats dogs#
7)7
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
68
2. PLANTS
C2"""#
7).
(a) Electro-physiology of plants
• kernels""&
!#'C-16K""mutant0-)@K#
Jhybrid vigour#
7)1
7)
• "!xylem"soil#"#
8)+))K(+"(! !#
7
• diurnal voltage variationsB
"6+6.!#
7
7-
• 2''annual'
2FAF!!2#
76
• KV2("3
#4")#I8J)#)8I)#'electrical
potential oscillations))OK#
78
• &5&"photosynthesis
7@
77
7.
71
7)
7
7
7-
!#
76
(b) Magnetoreception in plants
magnetoreception ""?
*,ferrimagnetism!"&
*,radical pair mechanism'""+
*,ion cyclotron resonance
&2(2(""&#
78
7@
• +"2("3!
!"#"#mitochondriaJ
!"!#/"J2(5#
77
• <"mitochondria#
7.
• Magneto-priming !J!aids growth,"
'&"#&"/'11
""#
71
7-)
7-
7-
7--
• ='2(inhibits growthseedlings"
"#2'2(
0Z+#
7-6
7-8
<(2("
!!#
7-@
2('"
B"!#
7-7
• 0'J"&2())
))"!#
7-.
7-1
76)
76
• 2(enlarges distorts#
76
• <(7@Jgrowth8M8)'
&))+7))"#6&"#."
)#.#-B'))+-))#
76-
766
• 2""8)J8+7)#@+)#
768
• 0'rotation"""!
'"#
76@
• foliar spiral direction ""
?$<#
767
76.
761
• Magnetotactic! "32(2(M)#84B
"!+!B"
higher redox potential#%""
"&"3"#
78)
78
78
(c) Electrical stimulation of movements
• <#electrical signalling"
#-+#8K"#
78-
786
788
78@
• 3''"electrochemical oscillators
!"#
787
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6@
(d) Electro-signalling and plant neurobiology
- electrical signalling#
(i) Fast signalsaction potentials?"A"
"!"&"0
Z
:
Z
0
e
!&+!#
78.
781
7@)
7@
7@
7@-
+ Heatchanges"-+8A"
7@6
*,!+!J!:Z+&
*!,"+J!"0/
'#0+"#
7@8
+ Phototropic ?!68)@7)7-)
)#-@)K#
7@@
7@7
7@.
(ii) Slow signalsvariation potentials++J!"
'#
7@1
77)
+ Pesticides8A)#@!
#
77
77
(iii) Long-distance system potential!
Z
+C#""
8+)A##%&#"#0*Z,:*Z,
*Z,0*+,""!"
77-
!#
776
(iv) Calcium fluxphospholipids-"""
""#
!"""
#0""#
778
77@
777
77.
771
7.)
7.
7.
7.-
7.6
7.8
Electric signalling for plant defences
• Cdefence"calcium-mediated electrical signals#
7.@
!$/"""0Z!J
"*",#
7.7
7..
7.1
• "tomato"""
L8!"!#
71)
71
71
71-
• "avocado trees&
"!!#2 "
.+)A&""#
716
718
71@
717
71.
(e) Electrical memory and cumulative effects
.+10"!!!K
)#-6#0.+-@"0#!+"
"""
+#
711
.))
.)
(f) Adverse effects from anthropogenic EM sources
• Meristem""&"!42)84J#
.)
.)-
• <!decreased hydrogen peroxide
carbohydrates):J52(L1=88#
.)6
• &1))2J8KA)+$
environmental stress#
.)8
• ;""2(++&
retarded#
.)@
• "$(76E"@)E#
+)))2J+)1;?!'#
.)7
• $X"0)#8+#8KA
8)J-"
*$2,#
.).
• !calcium
&""#
.)1
• :!2&!#
.)
• $ respiration rates&<(2(
&"#
.
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
67
H. TABLES: EXPOSURE LEVELS, THRESHOLDS,
BIOLOGICAL LIMITS
AND
HEATING LIMITS
NB: For most toxins safety limits are usually 50 times lower than the human threshold.
b18)))KA*18KA,'
b18)))KA*18KA,'
b))="Electrosmog in the Environment*))8#86,#
1. Electric fields - milliVolts/metre
0.3 - 300 GHz, microwave (Wi-Fi, mobile phone masts and phones, cordless phones) (peak to peak)
nature
biological
response
threshold
non-
thermal,
biological
limit
Burger-
form
proposed
non-
thermal,
biological
limit
Salzburg
indoors
conscious
symptom
threshold
(some
EHS)
conscious
symptom
threshold
(30% gen.
population)
non-
thermal,
biological
limit
Bio-
Initiative
indoors
non-
thermal,
biological
limit
Bio-
Initiative
outdoors
heating
limit,
6-minute
average,
*HPA,
ICNIRP
<0.02 0.1 2 20 < 20 < 60 194 600 61,0000
Volts/metre
<0.00002 0.0001 0.002 0.02 < 0.02 < 0.06 0.19 0.6 *61
2. Electric fields - milliVolts/metre (V/m)
0.3 - 300 GHz, microwave (peak to peak)
near transmitter
nature
Some
conscious
reactions (ES)
non
-
thermal
biological limit
BioInitiative
heating limit
*HPA, ICNIRP
mV/m mV/m mV/m mV/m mV/m
61,000 (61.0 V/m)
mobile phone /
Wi-Fi router 6,000 (6.0 V/m)
Wi-Fi laptop 1,000 (1.0 V/m)
phone mast 900 (0.9 V/m)
dLAN, at 1.5m
.
40-220 (0.04-0.22
V/m)
194 (0.19 V/m)
< 20 (0.02 V/m)
0.02 (0.00002V/m)
3. Electric fields - milliVolts/metre
300 kHz – 300 MHz, radio frequency (AM, FM, UHF, VHF radio, TV) (peak to peak)
biological
response:
peripheral
nerve
stimulation
<5 miles RF/TV
transmitter:
brain tumours
non-thermal,
biological
limit
BioInitiative
Indoors
2 km from
AM:
increased
childhood
leukaemia
non-thermal,
biological
limit
BioInitiative
Outdoors
3 km from
FM, TV, UHF
masts:
x 5 child’d
cancers
AM
exposure
adult
leukemia
heating
limit,
6 min.av.,
ICNIRP
0.6 ~194 194 870-5,500 614 2,000 2,200 -
4,600 28,000
Volts/metre
0.0006 ~ 0.194 0.194 0.87-5.5 0.614 2 2.2 - 4.6 28
4. Electric fields - milliVolts/metre (V/m) and dBm (decibels related to mW), by power of transmitter (milliWatts)
some wireless smart meters, Wi-Fi routers, laptops (measured levels vary considerably)
distance
(metres)
transmitter power (milliWatts)
ZigBee HAN (10 mW; UK, EU)
(inside home smart meter) mobile phone WAN; ZigBee HAN (100mW; USA)
(area wireless smart meter) (inside home, USA)
laptop Wi-Fi router
10 mW transmitter 25 mW *100 mW transmitter
dBm mV/m (V/m) mV/m (V/m) minimum, mV/m (V/m) maximum, mV/m (V/m)
0 -30 dBm 2,000 (2 V/m) 3,000 (3 V/m) 2,000 (2 V/m) 7,000 (7 V/m)
0.5 -48 dBm 40 (0.04 V/m) 140 (0.14 V/m) 1,100 (1.1 V/m) 4,900 (4.9 V/m)
1 -51 dBm 20 (0.02 V/m) 70 (0.07 V/m) 700 (0.7 V/m) 2,800 (2.8 V/m)
2 -72 dBm 10 (0.01 V/m) 30 (0.03 V/m) 400 (0.4 V/m) 1.500 (1.5 V/m)
5 -76 dBm 4 (0.004 V/m) 10 (0.01 V/m) 100 (0.1 V/m) 700 (0.7 V/m)
10 -80 dBm 2 (0.002 V/m) 7 (0.007 V/m) 50 (0.05 V/m) 400 (0.4 V/m)
20 -90 dBm 1 (0.001 V/m) 3 (0.003 V/m) 30 (0.03 V/m) 200 (0.2 V/m)
50 2 (0.002 V/m) 10 (0.01 V/m) 100 (0.1 V/m)
100 6 (0.006 V/m) 50 (0.05 V/m)
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
6.
5. SAR heating (Specific Energy Absorption Rate) - Watts/kilogram
2.0 W/kg heating averaged for 10 grams of tissue for 6 min. for male adult: ICNIRP 1998 & EU.
(1.6 W/Kg heating averaged for 1 gram of tissue for 6 min. for male adult: USA 1997 & Australia)
biolog-ical
damage
thresh-old
biological
limit:
whole body
*long-term
Seletun
neuron
(brain cell)
death
threshold
SAR
heating
limit:
whole
body
Wi-Fi
laptop
at 1 metre
mobile
phone,
good
recept-
ion
mobile,
full power
< 3 cm to
head
SAR
heating
limit:
head
Wi-Fi
laptop
on lap,
access
point
SAR
heating
limit:
limbs
0.00002 0.00033
*0.000033 0.012
*0.001 0.08 0.05–0.11 0.1 0.12 – 1.6 2.0 2.0 4.0
microWatts/kilogram
20 330
*33 12,000
*1,000 80,000 50,000-
110,000 100,000 120,000-
1,600,000
2,000,00
0
2,000,00
0
4,000,00
0
"$!#"#0))!)#6
*##))J,8)=!"?Q)=#8E$)#)).+)#)@=A'"#
b!""+&)#))))--=A'"*--O=A'",*)),#
!"8)!'")#))))))6=A'"*)#6O=A'",#
b*"",#
)#))))))))=A
?"E.Coli*;11@,#
NB: For most toxins safety limits are usually 50 times lower than the human threshold.
6.
Power flux density
-
microWatts/m squared
(100 microW/m
2
(uW/m
2
) = 0.1 milliW/m
2
= 0.0001 W/m
2
= 0.01 microW/cm
2
= 0.00001 milliW/cm
2
)
nature
*sleep
disorder
**ES symp.
***EEG alt.
non
-
thermal biological limit
near transmitter
heating limit
uW/m
2
uW/m
2
uW/m
2
uW/m
2
UK 58,000,000
uW/m
2
ICNIRP,1800MHz 9,200,000
some mobile
phones 2,000 -
1,800,000 ICNIRP, 900 MHz 4,500,000
Bulgaria, Italy*, Paris,
Poland, Russia 100,000 Wi-Fi access
point, 0.5 m 87,000
China outdoors 60,000 iPad, airplane 30,000
Switzerland* 40,000 laptop, 0.5 m 22,000
Luxembourg 20,000 mobile phone
mast, 100 m 100-10,000
- 100,000
Seletun (or 1,700) 170
AMA, BioInitative, Kumar* 100
*20 Salzburg outdoors 2002 10
Salzburg indoors 2002;
BUND outdoors 2008 1
**< 1 Burgerform sleeping 0.01
***0.00001 mobile phones work to 0.00003
0.000001
7. Magnetic fields (including time-varying) – nanoTesla
power lines etc. (100 nT = 0.01 microTesla = 1 milliGauss = 100,000 pT)
human
sensitivity:
Aurora
Disturbance
(solar flare)
human
brain
entrain-
ment:
Schum-
ann reson-
ance
typic-
al
house
conscious
symptom
threshold
(some EHS)
non-
thermal,
biological
limit
California
Educat-ion
Dept.
proposed
non-
thermal,
biological
limit
Seletun,
Bio-
Initiative
childhood
leukemia x
3
1813
*x3.8
1814
ch. acute
lympho-
blastic
leuk. x 5
non-
thermal,
biological
limit
Italy
(parts)
CNS induced
current limit
<2 mAm
-2
,
powerlines
UK
HPA,DECC
1815
rise/fall of
0.0004 nT at
0.0013 nT
0.05 nT 2-12 rise/fall of
5 nT
at 7 nT
10 100 ≥100
>300*
200 360,000
8. Voltage transients (‘dirty electricity’) - GS units
high frequency (Graham-Stetzer units, measured with a Stetzerizer metre)
typical house
(dimmer
switch, TV,
microwave
oven)
*non-
thermal,
biological
limit
Fisher
1816
conscious
symptom
threshold
(some
EHS)
non-thermal,
biological
limit
Kazakh-stan
energy
saving
lights,
compact
flouresc-
ent lights
*MS
*cancer risk
increased by
13%
after one
year
*cancer risk
increased by
26%
after one
year
severe ill
health:
diabetes,
asthma, MS,
cancers
25-50 30 27-40 50 15-2,000 580 1,000 >2,000 >2,000
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
61
I. COMMON SOURCES OF ELECTROMAGNETIC FIELDS AND RADIATION
COMMON SOURCES OF ELECTROMAGNETIC FIELDS AND RADIATION
KEY FOR PICTURES
'0(<!!!!!=(
"
!'!<"K
+++</=+++++++++++++++++++++++FREQUENCY++++++++++++++++++++++%4+++
50 Hz 1 MHz 1 GHz
+++</4++++++++++++++++++++++WAVELENGTH+++++/$+++++++2%0$/=K+++
6,000,000 metres 300 metres 0.3 metre
K
!!'
!
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8)
J. SHIELDING, PROTECTION MEASUREMENT
NOTE: Some of these items need earthing. Reputable suppliers can give advice.
PERSONAL SHIELDING
(made from silvered netting, as used by military personnel for protection from electromagnetic
warfare; different types are available)
"!" 0"
BEDS
"
SHIELDING A ROOM OR HOUSE
0!+!#=#!*,*",
EXAMPLES OF METERS FOR MEASURING ELECTROMAGNETIC FIELDS AND RADIATION
- 6 8 @
# <(*", MEELF3030B "
# <(*", EMFields PRO Meter "
-# $(*!=+(, Electrosmog detector
6# $(*!=+(, Acoustimeter "
8# =+( WiFi Hotspot finder 8"
@# K" GrahamStetzer Microsurge Meter"
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8
K. CASE STUDIES
C!"?
*, &2B
*, "&""""B
*, !52&#
(a) Articles on individual sufferers
• ;*),G3""3?2-@"=+(
!"!"H*The Daily
Mail6
F),#C%''!=+
(! !#
?AA###'AA+7.8.A2+-@++
++"+"+"#
•
*2"),#4;
"=/"!))#
?AA#"#A"++!+'+++++A
• C"<*),G"=+(!H*The Guardian
)
F),#C%''!=+(!
!#
?AA#"##'AA)A A)A+"+++
++!
• *),G+3"+H*The Sun
F),#
23&"""'"
"#
?AA###'AA"AA6-@..7A+++++++"+++#
• #*),GX"('?'!"!"
X="#G*Badische Zeitung7
(!),#;!!"
F""!""4;'(#
?AA#!+J"#AAJ+
"++'++886..@77#
#"##?
?AA#!"#?.).)AAA!AA-@.A
•
*),G"?2""
!"H*2.
2),#F
#
?AA###'AA+-.717A=+"++0+++
""++"#
• /V;FJ2*),H=+"3=K"H*BBC News Magazine
-
!),#(&5
4;'=K"9#
?AA#!!##'AA+++6..76.
•
4F*)),G2=="$=H*Popular Science-
)),#C
"!''!#
?AA##AAA))+)A
• 2*))1,G%3"+H*The Sun.
F))1,#2F
GH&"=+( !#
?AA###'AA"AA8888-A=+++'++F++2+'#
• #*))7,G"H*The Daily Mail)
(!))7,#0&;
&!#
?AA###'AA+6-7-)A"+#
• #*))@,G="''H*London Evening Standard-
!))@,#
:("&=+(#
?AA###'AA+"+
++'+77@#
• 02*##,20!#
?AA##A))A)@A)A++++++A
• 2f&0*))7,G&K0H*G"J&H8
",C#
?AA#+'#AA)+)6+++#
(b) Books
• <!"4*)),Forced to Disconnect: Electrohypersensitive fugitives in Sweden *#F
))"?Ett vackert fängelse)).7)",
?AA#"!#"A(E)E)E)+E)E)"E)*,#
• 4+<$<F*)),Black on White*-
/!))66-",
*"?Svart på vitt - Röster och vittnesmål om elöverkänslighet,!
45117"0='<$*$<(?
$gh!'",#+"!!"
.
2)))6))
"#
?AA#!#A!A!'++!'#
(c) Videos
• G?H*"!),#
K)'"!"#
?AA#"##'A&#A+A+
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8
L. FUNCTIONAL IMPAIRMENT, DISABILITY ISSUES AND HUMAN RIGHTS
4"*,(%*,!*-,$"#
.7
..
.1
1. FUNCTIONAL IMPAIRMENT
!!#
!"!+""
A"!2#
!"#"#""#
• *)#8E,?!!
!"B
• !"*)#+)#6E,?#"#8JB
• *-+.E,?#"#0#
2. DISABILITY ISSUES
(a) Definition
!?
*,transientpermanentB
*,disability'B
*,work-related impairmentdisability!3#
*,involuntary"!!#
(b) Areas of disability!"#
*, Employment?=+(!""!0(<!!
" !9:!
, "!2&
, "'"'
'#
*, Housing?&!"
, !!!
, "!3=+(;(/0#
*, Access to public, commercial and community places?!
""""
!2=+(;(/
0!0(<?
, C!#"#!"!"
"B
, 0#"#!
B
-, 0#"#"#
*, Access to private places?!""
"!2=+
(;(/0!0(<?
, C3"!33"!3"B
,C""
"!!"!32#
*, Children??
,!=+(B
,(3=+(#
*, Elderly??
, 2B
, '"2B
-, "#
(c) Disability allowancesill-health pensions and recognition
"#"#0(9
recognisedlegally accepted!!
#9:J#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8-
(d) ES disability building regulations
%;";"4S"7T#
.)
%9;0;*
;,!!!))?
G;"J20!!
"
!3 #H
9%;"*%;,))8?
G(!
"""!+"
"5"
'!"!#H
%/?
*, "'!!J"
*, "'32(
*, "+2("!*#"#,
*, "2(&#
.
(f) Individual ES susceptibilityand disability
"9!%/))7?
G"&!!
+&"A*",#%
J!!'&"
!'
&!&#H
.
(g) Assessment of EM exposure at non-thermal levels, not ICNIRP heating levels
%"&
%0%$C3@+"low-level biological
exposure"#9!?GR
!++"!
2(&R!"#H
.-
%=/3%$0non-thermal effects2))
)2)B"+
&+!"#"#*),#
3. HUMAN RIGHTS
*,Health rights"2&?
.6
#"!#
#"#
-#"#
6#"#
8#"#
@#"#
7#"#
.#"#
1#""#
*!,General rights?93 Universal Declaration of Human Rights
"#
-?G"R#H
8?G!! R""#H
#G"5!#H
-#G"'R!'#H
8#G""5+
!"""#H
7?G"#H
*,9Rio Declaration@"#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
86
M. KEY DATES: SCIENTIFIC DISCOVERIES AND REGULATION
DATE SCIENTIFIC DISCOVERY REGULATION
1.
THERMAL (high-level, 6 minute average)
1)1
+"
168
+" ?"
188
$(I""!& 9?"
1.6
%$C*11.?C%0%$C,?"
2. NON-THERMAL (low-level, long term)
# (?*C,
71
*4,
.@8
*C,
.@.
*;,
1-
$='*,*',
16.
*$,B#"#*%",
18-
'!*2<", 18-?+
188
*4,
187
""#+#*;',
181
"*, 18.?9$?+
1@)
W"
*/",B#*<!,
1@
"*(,
1@
!#"*<,B2(*;3@-,
1@6
2*,*0J',
1@8
3&*",
17)
&*;,B#*=,
17
?*4J9, 17-?=/?J
178
;;;!*(,B*;,
171
'*=,B
*$,B*;,
1.
"*<,
1.-
*;',
1.6
""*;', 1.7?;";"?+
1.1
*="B0", 1..?0+
11
!+!*$,
11
!*,
116
!'*',B*(,B
"*4,B*,
)))?02?"W
%0)?$@.#.+"A
118
J3*!,B#*<,
11@
<*',B+<*J"', )))?J+
)))
C*F, 9:?L@$(!
))
&'2*C, =/3%$0?<(?;!"
))
!*,
*!",
?!
(!"*8)),
))-
3'#+&#*%+$,
%?+
))6
!*=,B*",
2(*$J,
?$("
))8?9?!
))8
*;,B!*))@, =/??GHG!"H
))7
"*0!!, #"?+
)).
"W*N",B*, $(
))1
*,
'*4!!,
9#?!B!
(?!
)
!*20,
0"*',
"*(,
#?+
=/3%$0?$(?;!"
9:?+
)
)?!"*K', 2#?
)?!*2, %?+
B#*("<",
%??!
/"+"C!"#
4!!C'3J3#
.8
.@
.7
..
Heat shock protein stress reactions from thermal and non-thermal radiation
source EMF, EMR frequency photonic polarised stress reaction
% C+
+ + <(4J + C+"
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
88
APPENDIX 2 ACRONYMS AND GLOSSARY
MEDICAL
ORGANISATIONS
PHYSICS /TECHNOLOGIES
ACTH
ADHD
ADP/ATP
A
!
ADSP !
ALS
AMA
ANS
ART "
BBB !!!
CFS "
CNS
DNA &!
*",
ECG +"
EEG +"
EHS"+
EM "
EMFIS "
*%02,
EMHS "+
EMS"
ES"
ES +
GP "
GRF "'
HbA "!
HFS"5
HMC
HRV !
HSP '
IEI
ipRGC
""
MCS
ME "
MEG ""
MRI *,"
""
MS
mtDNA
*&!,
NH +"'3
ODC !&
PNS
PP
PTH
QEEG 5
+"
ROS &"
SEMG "
SICEM 3f
&f+"f5
SIDS #
SP
SRI +
SSEP +'
tDCS
TILT &+
TMS "
VNS"
AMA2
ARTAC
$f5
+0f
*$
"
0,
AUVA "
9"
*%
/$',
BUND (
4
CES 0+
"2
COST 0+/
"
DECC "
00"
DH
EEA
"*9,
EHRC 5
$"0*9:,
EPA C
"*9,
ES-UK 9:
EU 9
FDA(W"
FEB
HPAC"9:
IARC %"
$0=/
IBN %;!"
ICD %0
ICEMS %0
"
ICNIRP%0
+%"$
C
IDEA %
3
IEMFA %2(
IEMFC %2(
0!
IRPA %$
C
NCM 02
NHS
PMIDC!2+%&2<%
RCNIRP$0
+%"$
C
SCENIHR 0
""
%$'
*0,
SWI =%
TCO 0
C
UK 9:"
UN 9
USA 9
USSR 9
$!
WHO =/"
3G-
"!
A
AC "
AM
Ca2+
cm *Q)#),
CFL "
CRT !
dBm/m
2
;*=,
5
DECT "
dLAN <'
EF
ELF &5
EMF "
EMR "
E-W +
FFT
FM 5
GHz ""+J*Q)))2J,
GS 4+J
GSM "!!
HF "5
HV ""
HzJ*5,
ICR
K:*,
K+
KHz '+J*Q)))J,
Km '+*Q))),
kV '+K*Q)))K,
LF 5
m
mA
MF "
(MF 5,
mG +4*Q)),
MHz "+J*Q)))'J,
min
mJ/m
2
+F5#
ms +
mV +K*)#))K,
MW +
µW/m
2
+=5#
neg. "
nm+Q)#))))))))))
nT +*Q)#)4,
pos.
PP ''
pT +*Q)#))))4,
pT/s +A
RF 5
RMS 5
SAR !
SR
TETRA '$
TV
UT
UV
V K
VDU
VHF "5
V/m K
W/Kg ='"
W/m
2
=5
Wi-Fi +
'*G=(H,
WiMAX=%+
!2
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8@
REFERENCES
F/*))@,G?+++HElectromagn Biol Med.
8*6,?68+8.BC2%?77.8.6#
'";*)),G2'?HOccup Med (Lond). 8*,?@@+@1BC2%?-8.-#
-
=/"*))8,Electromagnetic fields and public health: Electromagnetic Hypersensitivity
=/#1@*!))8,#
6
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
8
=$*1.),G(5"'"HProc.
IEEE.@.*,?1+8#
@
:;;''F:;"+;'4*))1,G4
""HInt J Public Health.C2%?)))78#
7
4F*)).,G("?&"!"HPublic
Health.*,?-+6BC2%?78768@#
.
$hh2*))@,G0!"+
""HBMC Public Health@?@7BC2%?7)76).)#
1
<"!hF;h2*))8,Gc"ci5"
"HWien Med Wochenschr.88*1+),?-7+6BC2%?8111@-#
)
:</!0/F*)).,GCC&0C9HEpidemiology
1*6,?8-+81BC2%?.6@71@#
2/*)).,GC5!"!2H
Sci Total Environ.6)*+-,?87+@BC2%?.88@)6.#
:22*)).,G&!HInt J Occup Med Environ Health*6,?.1+1-B
C2%?1.87@#
-
:Y2*)).,G&!!HElectromagn Biol Med.7*,?)8+
)1BC2%?.8@.1-.#
6
<"! 2 (' 9 <"" ; $ $ ' 4 C *))., G0"
!" " ? + H Psychol Med.
-.*,?7.+71BC2%?.-@@.#
8
"F4J2(F*)).,G<"+5+" HJ Burn Care Res.1*8,?
77-+777BC2%?.@18@8#
@
!+$4+(/22((+;2*))7,G!
"!!!HNeurotoxicology.*,?6-6+6)BC2%?@1@@@-#
7
C2=C:2*))@,G! "!"
! "!!HOccup Environ Med.@-*8,?-)7+-BC2%?@@.8)#
.
CCF*))@,#-GHElectrical Hypersenstivity, A Modern Illness*C
9:,@@B%;?)1868)-6.#
1
%*))8,Definition, Epidemiology and Management of Electrical Sensitivity*C"
$C09:,))-6B%;?).81887)#
)
2+2*))8,G2!+J! "
HInt J Occup Med Environ Health.*,?8-+87BC2%?@)8.1#
2F22*))8,G ?"
HJ Psychosom Res.8.*,?8+86BC2%?877.7)#
J'';'JJJ'=2'+!'*))8,SG! !
+HTPol Merkur Lekarski1*,?81+8-BC2%?@-71-.#
-
+:2*))6,G!"JJ
!HSaudi Med J.8*@,?7-+7-@BC2%?818)#
6
;'JXj2J''4J'*))6,SG! !"
!?HTMed Pr.88*6,?-68+-8BC2%?8@))68#
8
/!4C2204J+C0*))6,G2+(
”Conference Proceedings#
@
$hh222;N22;+(^0*))6,G!
"&+5HInt J Hyg Environ Health)7*,?6+8)BC2%?8)-18@#
7
/!"$2*))6,G0?iHJ Egypt Public Health Assoc.71*-+6,?
17+-BC2%?@1.67#
.
=$=*))6,G%+HInt J Cancer Prevention
*,#
1
5FC24J+C20*))-,G2?C
HElectromagn Biol Med.*+-,?@+@1#
-)
$CJF2<$JC"2*))-,SG&!!
?%%A%"&!
"HTPathol. Biol.(Paris)8*7,?6+68BC2%?16.7@#
-
/*)),G&"!!
HNeuroreport.-*,?1+BC2%?16.7#
-
$CJF2<$JC"2*)),SG%""
!?%#%"&HTPathol. Bio (Paris)8)*@,?-@1+-7-B
C2%?@.86#
--
$"2;+(<;"2*)),SG!!
HTPathol Biol (Paris).61*-,?+@BC2%?-@788@#
-6
00CF*))),GC""?
HEnviron Health Perspect.).*,?)81+@BC2%?)17#
-8
0&$<&$2*))),G0!!HOccup Environ Med.87*@,?6-BC2%?
)177#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
87
-@
/4=fFh22:*))),G&!”
Occup Med (Lond).8)*6,?-7+68BC2%?)1-76#
-7
02<"FF=*111,G8)J"&
"?!+!&HBioelectromagnetics#)*.,?676+6.@BC2%?
)8817@1#
-.
2:/4h2=fF";"*11.,G0
&!""!#+""H
Arbetslivsrapport-?+67#
-1
"0F*117,G&"5"H
Occup Environ Med.86*6,?.+.6BC2%?1@@-@#
6)
:':'KK*11@,G2""
'$<<”Sci Total Environ..)*,?.7+1-BC2%?.77-)#
6
;"F*118,GC"!!
HActa Odontol Scand.8-*8,?-)6+-)BC2%?.88-.)7#
6
(0:22K="=$*118,GC"
"&HJ Occup Med.6*,?1-+1-6BC2%?7788..#
6-
C0:$(C:0F2*11-,G
&"+"++HAm J Epidemiol.-7*-,?
-.+--)BC2%?.686)#
66
'2*176,G0"H
Biological Effects and Health Hazards of Microwave Radiation. WHO symposium*C2C!,@+@7#
68
4X$*17,Bibliography of Reported Biological Phenomena (‘Effects’) and Clinical Manifestations attributed to
Microwave and Radio-Frequency Radiation*2$%;2))69?$
#$78)7,""!!"
-B)-"#0!??AA##A))#A78)7#
6@
=Fh22:*))-,G! "!+5
!5iHBioelectromagnetics6*-,?8+1BC2%?@@117#
67
$hh222;N22;+(^0*))6,G!
"&+5HInt J Hyg Environ Health)7*,?6+8)BC2%?8)-18@#
6.
=="22<<22F*11.,G0"
8)J"&HJ Pineal Res.8*,?@+7BC2%?1788)--#
61
CC42*188,G!""!B
HAm J Phys Med.-6*-,?68+6.BC2%?6-7@81#
8)
"=2=">X`0;(<XX(4X;2=F*)).,SG0
''"'HT
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi@*,?7+76BC2%?18717
8
;(F$+C2*))7,G$"!?8
HRev Port Pneumol.-*,?1+-8BC2%?7-8)16#
8
CX"<$>CFX"XX20F2*))7,G%+
"HEnviron Toxicol.*,?@1+78BC2%?7-@@87)#
8-
;+C2*))6,GK!HNoise Health@*-,?-+)BC2%?87-))#
86
"X`<"X(>(N*))-,SG""HTZhonghua Lao
Dong Wei Sheng Zhi Ye Bing Za Zhi.*,?7+1BC2%?67@8@@
88
(:$*))7,G$5&<J"=+("HHealth Phys.1*-,?.)+
.1BC2%?71-7))#
8@
"0F/"*))7,GC"*C,&+
5"HBioelectromagnetics.*8,?-.@+-1BC2%?7-877#
87
CWF*))@,The Powerwatch Handbook*<C',#1+@.#%;)7611@.@#
8.
(/$!*))8,Electrosmog in the Environment.
#!##A!'A!'A))@.@A&#i"QW
81
(C2!44;Y"(hF;+(^0;F""2$hh2*))1,
G!&5"HEnviron Res.
)1*@,?771+.8#C2%?167@1-#
@)
F('=*))1,G"&!
HBioelectromagnetics#BC2%?17.))1#
@
2J4:<%<22:2%$:F<*)),G
&@)+J"HJ Expo Anal Environ Epidemiol.*,?6+61BC2%?6@.))#
@
$';F<0';*))1,G!&
""?2$%"HPhys Med Biol.86*1,?
81@8+8171BC2%?17816#
@-
$ 'K22F/*)),G0!&C!2$+
"0JC+(5"(0"02
0?&JiHArch Environ Contam Toxicol.(!#BC2%?)6.66#
@6
(C2!44;Y"(hF;+(^0;F""2$hh2*))1,
G!&5"HEnviron Res.
)1*@,?771+.8#C2%?167@1-#
@8
;*))1,G$5*$($,K$"
'HRadiat Prot Dosimetry))1BC2%?1@781#
@@
K"24<*117,G$5&"+"HEnviron Health Perspect.)8
#@?8@1+87-BC2%?16@7).6#
@7
2/*)).,GC5!"!2H
Sci Total Environ.6)*+-,?87+@BC2%?.88@)6.#
@.
2*))7,G$2"9"0'HSignal Processing Magazine, IEEE.6*-,?66+6#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
8.
@1
2XC*))@,G"!'HScience.
-*8776,?7-#
7)
K 2#*))1,G!?
&HOccup Environ Med.@@*),?@@6+@7BC2%?16@86)1#
7
<!("2F^<$C*))@,G0+"
!HJ Expo Sci Environ Epidemiol.@*@,?8)7+86BC2%?@@7)7-#
7
<0!"22:*))8,G9!'!
HOccup Environ Med.@*@,?-1)+-16BC2%?81)..@#
7-
<(f9KC!("2*))6,G/!
""B&HOccup Environ Med.@*1,?7@1+77BC2%?8-71.#
76
;F('4K;!<*))1,G$+"
"!"HJ Electron Microsc (Tokyo).8.*6,?8+8BC2%?1@..77#
78
<(="*#,*))),The Nordic Adaptation of Classification of Occupationally Related Disorders
(Diseases and Symptoms) to ICD-10 (ICD-10: International Statistical Classification of Diseases and Related Health
Problems)*02,#--8)B%;?1+.1-+)881+#
7@
=/"*))8,Electromagnetic fields and public health: Electromagnetic Hypersensitivity
=/#1@*!))8,#
77
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
7.
F/"2=*11@,G"'"
'!"cc
HExp Dermatol.8*8,?71+.8BC2%?.1.)7#
71
$hh2*)).,G2!!&HEnviron Health Perspect.@*,?@+
@-BC2%?...1@#
.)
C02$4!(*11,G/! 55
&""HAgressologie-*),?67+6#C2%?
.66)@#
.
0=;*1.1,?Electromagnetic Man: Health and Hazard in the Electrical Environment*<
W,.-+)-#%;)6@).@)668#
.
CCF*))@,#8G=3"HElectrical Hypersenstivity,
A Modern Illness*C9:,@@B%;?)1868)-6.#
.-
J '$C!$C!2'J''$4C;';J+;'C'=*)).,G
!!HInd Health.6@*6,?
6)1+67BC2%?.7@-1#
.6
;;0<";F*))7,G"&5
"V!HBiolectromagnetics..*,?@6+@.BC2%?@1..11@#
.8
4K<':J02"(C22*))7,G+
"&!&HEur J Appl Physiol.
)*6,?618+8)BC2%?7@76).#
.@
402JJ<;"<*))8,G8)J"
"HNeurosci Lett.
-.*+,?+7BC2%?81-#
.7
402JJ<2<C*))6,G&-7J
"?!H
Bioelectromagnetics.8*-,?@7+78BC2%?8)6@8#
..
"C*)).,G%&HHomeopathy in practice=)).?
-.+6-#
.1
F22*)),G
!+"HJ Psychosom Res.@.*,?-7+68BC2%?
)))611#
1)
/N*)).,G/""J!W!
;+"/+$""!+C%?
'W!''
'"HAcupunct Electrother Res.--*-+6,?1-+6BC2%?1-)@1#
1
/N*116,G"+"5
+"V>+!
!?C%HAcupunct Electrother Res.1*,?-1+@-BC2%?71@7@#
1
?AA#'"!"#A&#
1-
"h2FF/'$*),G$""
&JK9'HPathophysiology.1*,?.+.7BC2%?-@6.6)#
16
=*))6,G""HJ Altern Complement Med.)*8,?
.@7+.77BC2%?8@8)677#
18
:2F=*)),G;"5"?!
+HMed Hypotheses.8@*@,?81.+@)7BC2%?-11)@#
1@
N2;'<F"C:'<;F*))),G!
!+HMed Hypotheses86*,?--+-1B2%?)71)7#
17
=:2F!!=*))),G0!iH
Integr Physiol Behav Sci.-8*,?6+@BC2%?)--1#
1.
02<;;F$0";!!"2$F*))8,G9
"!"!'5/HNature6-6*7)-),?11+)BC2%?
878.118#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
81
11
;C0F22C(+<F$!2="(*111,G%!
!"!?+HInflamm Res.6.
?7+.BC2%?)-8)6#
))
<:+;CJ;;*)),G&
?JHMedGenMed.-*,?BC2%?
8611@)#
)
k;';";l/:*),G/&!#.4J5"
"&HInt J Radiat Biol.C2%?7..8@#
)
/N<2/:N%''"0N2'*11,G0
!!"&
"+""!'&!!'
"HAcupunct Electrother Res,@*-+6,?6-+77BC2%?@.8@-#
)-
?AA"#"A"++!"A+++JA
)6
J;;;"2J%<!"'*118,G
ccHJ Occup Environ Med.-7*7,?.-.+.66BC2%?7886@.#
)8
F;*)).,G!&+!;"
"'HJ Altern Compliment Med.6*.,?11-+))-B
C2%?.11))67#
)@
<C<;"!":+;*)),G+
""+"HScand J Public Health.-)*-,?@@+78BC2%?-871.-#
)7
%*))8,Definition, Epidemiology and Management of Electrical Sensitivity*C"
$C09:,))-6B%;?).81887)#
).
<*11.,G?""H<"!
International Workshop on Electro-magnetic Fields and Non-Specific Health Symptoms. Proceedings*4J,#
)1
"204:0*))8,GC!!'HRisk Anal.
8*8,?8-+76BC2%?@171#
)
hF<"!*)).,G+"HBMCPublic Health*.,?
-)BC2%?.7.1-7#
<"!hF*))-,G!"HBioelectromagnetics6*@,?
-.7+-16BC2%?1187#
:;;''F:;"+;'4*))1,G4
""HInt J Public Health.C2%?)))78#
-
$hh2*))@,G0!"+
""HBMC Public Health@?@7BC2%?7)76).)#
6
<"!2('9<55;$$ '4C*)).,G0"
!""?+HPsychol Med.
-.*,?7.+71BC2%?.-@@.#
8
<"!2<55;('9 '4C*))7,G&!
! ?HPsychosom Res.@*-,?.-+..BC2%?7-6@77#
@
<'h2:*)),GC
""&""HBioelectromagnetics.
*7,?687+6@BC2%?8@.1-)#
7
$!4F2F=*))8,G"?
HPsychosom Med.@7*,?6+-BC2%?87.67.7#
.
"h2FF/'$*),G$""
&JK9'HPathophysiology.1*,?.+.7BC2%?-@6.6)#
1
$=CNN %$4*11,G"HJ
Bioelectricity)*+,?6I8@#
)
20:"J0*)),GC 2%?8)J"
*!&,HBioelectromagnetics.-*,?@+-@BC2%?71-6)-#
=$"X5':$$(2'+'$C!$(&
*))7,G+&!!"
"i!+!JHEnviron Health Perspect.8*,?
@)-+@).BC2%?.))711#
X*)).,G+&!!"HEnviron Health Perspect.@*,?
@BC2%?...18#
-
!+$4+(/22((+;2*))7,G!
"!!!HNeurotoxicology..*,?6-6+66)BC2%?@1@@@-#
6
2"*11.,G<(*8)J,"*2(,
"2(HToxicol Lett.1@+17?-77+-.BC2%?
1.)@1#
8
$hh2*))7,G2!!&HEnviron Health Perspect.@*,?
@+@-BC2%?...1@#
@
004=24"04F/2/30*)).,
G!!"HEnviron Health Perspect.@*,?@-+@6BC2%?...17#
7
<"!2('9<55;$$ '4C*)).,G0"
!""?+HPsychol Med.
-.*,?7.+71BC2%?.-@@.#
.
$hh2*))7,G2!!&HEnviron Health Perspect.@*,?
@+@-BC2%?...1@#
1
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@)
-)
+J$$!4F0F=F=*)).,G0"!i$
!"!'!"HJ
Psychosom Res.@8*8,?68-+6@)BC2%?.16)-7@#
-
'2!";4*))@,G;HScand J Public
Health-6*6,?-.7+-1@BC2%?@.@.1#
-
!";;5F;'<f4=<*)),G2"
'H
Scand J Work Environ Health.*8,?-61+-87BC2%?6-1.1#
--
'hh"Fh2!";*117,G(''#++
HOccup Environ Med.-1*,?).+.BC2%?1)6.-@#
-6
:;J9*,*117,Biological Effects of Electromagnetic Fields on Humans in the Frequency Range of 0
to 3 GHz: Summary and results of a study of Russian medical literature from 1960 – 1996*;?%(?%
$?$4(2C
,#?AA##A\AAAAA))#m
-8
'$0F:JF#*1@7,G ' ! =0H
SG!&(HTVopr Gematologii i Immunopatologii
1@7?@6#
-@
"'2*1@8,G:'
HSG5!HTGig Tr Prof Zabol.)?7+BC2%?
6-))8@#
-7
%2*1.1,SG0!&+5"HT
Gig Tr Prof Zabol.*),?1+BC2%?81.)8#
-.
CCF*))@,#6G!"HElectrical Hypersenstivity, A Modern Illness
*C9:,@@B%;?)1868)-6.#
-1
/N<2*11-,G+"*K
,!""0+!"
0+!"8!
"!HAcupunct Electrother Res..*,?--+7-BC2%?7@.688-#
6)
/N<2/:'"0' :N%'
:"#*11,G;+!!"
!?,"
B,<"J+
/"0+*;,#!"
""+;+"/+$"HAcupunct Electrother Res.7*,?1+6@BC2%?
-8--.#
6
''%"(2*))6,G8)J0"
HBioelectromagnetics.8*8,?-6@+-8BC2%?817787#
6
<"F$:'=CNF*1.7,G+5
HEnviron Res.6-*,?87+@7BC2%?-)-68@#
6-
<"F$:'NF*1.-,G@)+J"
HLife Sci.-*7,?@1+@1@BC2%?@1.868#
66
(<"(;(X!(*))1,G!+HJ Phys
Chem B.-*,?-@1+-7@BC2%?1)@-@@@#
68
0=$F;F;%NN242":*)),G$!!
!'HJ Occup Environ Med.66*.,?7@1+778BC2%?
.871.#
6@
0 ';4*))1,G+5"&
HWiad Lek.@*,?.+.@BC2%?)6)86#
67
42CC/*))1,G&5"
&!HInt Arch Occup Environ Health..*,?81+@@B
C2%?.8)6@))#
6.
(2!0!20XK<255n22$%0(*)).,
G0&8)J""'"&"
!HInt J Biochem Cell Biol.6)*,?7@+77)BC2%?.8.867#
61
22F<$'F!=F$*)).,G0""
9K"*9K,HJ Pharm Pharmacol.@)*.,?1@1+17@BC2%?.@661)#
8)
'o2*))7,G0&!"HCurr Med
Chem.6*),?6+8BC2%?768@)7#
8
02:;F0*))1,G<!!!
"+""HPhysiol Behav.17*,?-@+6-BC2%?161@76#
8
: "KK<"!2 '4<"";*)).,G"?
"HInt Tinnitus J.6*,?+.BC2%?1)8@#
8-
<"!2':('C '4<"";*)).,G
&++HNeuro Endocrinol Lett.1*6,?
8.+8BC2%?.7@@88#
86
C: "<"!2 '4<"";*))7,G2?
!"HProg Brain Res.@@?-@1+-78BC2%?718@.)#
88
(F2K'%/;""F(2-
*))@,G"!
&HBrain Res..*,?78+.-BC2%?@17166#
8@
<<24*))@,G;""HJ Laryngol Otol.)*,?@8+@@BC2%?
@-81-8#
87
4!%0!2K2(02*))8,SG+
'""HT7*-,?--1+-6BC2%?@6)81)#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@
8.
: "C<"";F!C2"F '4=$JF*))8,G<"+
"*2,HOtolaryngol Head Neck
Surg.-*6,?8@@+8@1BC2%?8.)@)6@#
81
2$:F:4;*))8,G+CiH
Neurol Res.7*@,?@8+@1BC2%?@87)-#
@)
2$$C$*)),G+"!
HNeurosci Lett.-1*,?6+66?C2%?.6@61#
@
( ':'"$4 'N*)),G'""5
HNeuroscience.*,?-@7+-.BC2%?)66686#
@
K:;4"</*117,SG<+"#$
""HTTidsskr Nor Laegeforen.7*-,?--@-+--@8BC2%?16...#
@-
0;4$420<*))1,G&<+(5
"(!;HCurr Microbiol.BC2%?))--7-#
@6
0<4$0;42$!%!/2""2*)).,G;
&8)J"HBioelectromagnetics.1*6,?-)+-?C2%?.78--)#
@8
$;;("02C4"4*))6,GK
<(+2("HRadiat Environ Biophys.6-*6,?@8+7)BC2%?8@68-6#
@@
;K*)).,G""!'
'2(&iHInt J Radiat Biol..6*7,?8@1+871BC2%?.@@-7-#
@7
C'`:!F*)).,G%"JV
HAlzheimers Dis.-*,?61+8BC2%?.--678@#
@.
C2*))6,G""4
"?ST'"
"""iHMed Hypotheses@-*8,?71-+.)1BC2%?86..@8)#
@1
C'`:!F*))-,GC!""
JV!HProc Biol Sci.7)*#,?@+@6BC2%?18@-.#
7)
:'F<*11@,G2!!"?!"
!"HBioelectromagnetics.7*-,?.7+16BC2%?..)1-8.#
7
&F!FN=";<!F&;*))-,G
&"!"&J"*C,
"HMed Hypotheses.@)*@,?.+.-1BC2%?@117)7#
7
!;!F2"<C;$<4*))1,G%!+!!
!!7&42+1))!H
Pathophysiology.@*+-,?)-+BC2%?1-68)7-#
7-
;*))1,G;+!!!+5H
Electromagn. Bio Med..*,?8+BC2%?1.6)-#
76
!F<C;$;<42"</*)).,G;+!!!
"!6.&42!HElectromagn Biol
Med.7*-,?8+1BC2%?..1.#
78
:N0:0N*)).,G"!5!+!
!"HInt J Pharm.-8*+,?7+.BC2%?717@1--#
7@
!44!F<2"<;C;$<4*)).,G$5
&+5"!+!!HElectromagn Biol Med.7*,?)-+
@BC2%?.8@.11#
77
;'J*)),SG!"&!+52(HTMed Pr.8*,?
)+)@BC2%?7@@87
7.
=(4'F:'9$";h"!(*))),G"
*#.4J,!!+!!HBioelectromagnetics*8,?
--.+-68BC2%?).117@1#
71
<4;:!F<C;$*116,GC!!+!!
!182J".@8)))JHMicrosc Res Tech.
7*@,?8-8+86BC2%?.))8@#
.)
(*176,G!""
HAnn N Y Acad Sci.-.?7-+71BC2%?6@--1#
.
';";2<NJ2/J$*))1,G"!
51)).))2J!!"HJ Craniofac Surg.)*8,?88@+
8@)BC2%?1.@18#
.
0!!(0
0<F2*))1,G2!+""'HNeurosci
Lett.-BC2%?11@.1.#
.-
0'0%*))1,G"!&
5"&HMed Biol Eng Comput.67*),?)@-+)7-BC2%?17)7.).#
.6
("(2C'(:'<2"<*))1,G=!&
421))2JHPathophysiology.-)BC2%?11861-7#
.8
2$C($(KK$(*))1,G2!&
"""HNeurosci Lett.6@6*,?71+.-BC2%?1@1177.#
.@
0'022=C(*)).,G0"4"&
"5HBioelectromagnetics.-)*,?1+)BC2%?.@@-7))#
.7
(N="0="F<N2N*)).,G<"+&&+5"
"HClin Exp Pharmacol Physiol.-8*7,?717+.))BC2%?.-6@7#
..
:'%2X3'K/!K:'2*)).,SG!"
!!"HTFiziol Zh.86*,?
1)+1-BC2%?.8.1@1#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@
.1
<="<N:*)).,G&"&&5"
HNeurosci Lett.6-6*,?+7BC2%?.8.-@6#
1)
C0$F2:J$F0'0%*)).,G42+'<(
!"4HConf Proc IEEE Eng Med Biol Soc.)).?8@.)+8@.-BC2%?1@6))@#
1
;2<F:F^''2$'K'*))@,G%"4
$0"40!2HConf Proc IEEE Eng Med Biol Soc.))@B?817+@))B
C2%?716@)8-#
1
:02; h!"0C2<:2$<2^^^
*))@,G2!V+4"'HInt J Radiat
Biol..*@,?66-+68)BC2%?@.6@171#
1-
C""00'K4::":00$!0$
*))@,G!+HNeurosci Lett.-17*+,?11+)-BC2%?@6)@-).#
16
V045<!+9!+=/":0%*))-,G!
"&5!HAustralas Phys Eng Sci Med.@*6,?
@+@7BC2%?6118)@)#
18
!$F4FYJ:;!f:C*))-,G$5"
&?$!!H
Bioelectromagnetics.6*6,?@+7@BC2%?@1@).@#
1@
:'K9*))-,G"+5"4?!"
HInt J Neurosci.-*7,?))7+)1BC2%?..1#
17
!$K;!F4"F2<C=;:;'
C*)),G"!"!!
'"4HJ. Sleep Res.*6,?.1+18BC2%?6@6)1@#
1.
(49"C""$%*))),G2!
!HEur J Appl Physiol..*+,?.+7BC2%?)88@#
11
:02^'<:2^""50$<2^^^*))),G
"!""'"'H
Int J Radiat Biol.7@*,?@81+@@7BC2%?--)6.#
))
J09"C(4!*11.,G2!!
HNeuroreport.1*6,?-1+--BC2%?1.-68@#
)
/' N0'2:*118,G
'HElectromyogr Clin Neurophysiol.-8*6,?8+8@BC2%?78881-#
)
<=004=$*1.6,G"""
'HElectroencephalogr Clin Neurophysiol.8.*,?6+6BC2%?@)-@11#
)-
=004=$*1.-,G;++
'?"&!!JHElectroencephalogr Clin Neurophysiol.
88*@,?@1+@-@BC2%?@.1@1#
)6
0'!:C:2<!<$$=*))1,G;!"
HRadiat Res.7*,?76+.BC2%?18.)8)1#
)8
/F:2*))1,G
V+"HJ Immunol..*1,?87+87BC2%?1-.)..#
)@
=F$22F*))1,G!9K!
9K;HRadiat Res.7*,?)6+BC2%?1@786@#
)7
20242(42!"FC=0;*))7,G$;
%;"!%J"$iHDose Response.8*-,?6+1BC2%?.@6.@)@
).
2!0$(;JJ22JJ4(n42""n2*))1,G2&
"!&5"00?+"+
HFree Radic Biol Med.BC2%?)))8168#
)1
$K'%24C'=(02$*)).,G5+
&+?HRadiat Res.
@1*-,?-1+-1BC2%?.-)6.7#
)
4J'F<":*)),G0"'"?"
HAm J hysiol Cell Physiol..-*8,?0---+-6@BC2%?-7716#
4'F!<;"5;4N*111,G00Z
'+!8)J"HBioelectromagnetics.)*8,?@1+7@BC2%?)6)78#
2"+K0K"+J<42+/J0'+0$*11.,G"+"
0Z"!&5*<(,"
HCell Tissue Res.1*,?7+-)BC2%?16@-)1#
-
=$*11-,G;""HJ Cell Biochem.8*6,?6)+6@BC2%?.-..-16#
6
<!$C0F$NC*11-,G&@)J
""""#&+2N0$
HFEBS Lett.--6*-,?-)+-).BC2%?.6-@-7#
8
=J'F*11,G"?""H
FASEB J.@*-,?-77+-.8BC2%?-17.-1#
@
;'0(:<F=*1.1,G2+!"H
Bioelectromagnetics)*,?8+.BC2%?86)788#
7
;'0(;4F=*1.8,G<(*+)J,*8)J,$(
&!HBioelectromagnetics@*,?+BC2%?-1771@6#
.
;2=$*17@,G!"!'
"5HProc Natl Acad Sci U.S.A.7-*@,?111+))-BC2%?)@6.@1#
1
;2:J'<:=$*178,GK(HAnn
N.Y. Acad Sci.67?76+.BC2%?)868.#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@-
)
<(<2$4<34*))@,G&57J))
"0HElectromagn Biol
Med.8*6,?@1+.)BC2%?77.8.@#
<CJJC54*117,G&5*<(,
"&"!*$ ,HBiochim
Biophys Acta-87*-,?.+1)BC2%?1@.)8#
;2:J'<:=$*178,GK(HAnn N
Y Acad Sci.67?76+.BC2%?)868.#
-
='$%C"'($Y"=*))8,G0"!!
!&&+5"HMutat Res.8.8*+,?6-+61BC2%?
@))1818#
6
22(':;!:$F!<*))-,G&
!"!H
Bioelectromagnetics6*,?.+1)BC2%?86@76#
8
=$*17),GHLife Sci Space Res..?77+.7B
C2%?.@..-#
@
FF*)).,G""iHRadiat Prot
Dosimetry.-*,?.+-BC2%?.17777@#
7
(J2::<=*))6,G""&7+
!J*,+"!"+HCancer Res.
@6*,?6-+8BC2%?671@-#
.
<=*)),G"<("5"+
"i0"2;!HBioelectromagnetics#
*.,?@)-+@6BC2%?76.@71#
1
+;!22<=*111,G&"+8)+J))+
"7'"7+!JST+
!HCancer Res.81*8,?-@7+-@--BC2%?)66@17-#
-)
C'pF*))1,G;HElectromagn Biol Med..*,?)8+-BC2%?
1.-16#
-
C'pF'FKFF'(*)).,G;++"HIndian J
Exp Biol.6@*8,?-)+-BC2%?.@17@-#
-
C'pF*))6,G&!!"HBioelectrochemistry.@-*+,?-+-@B
C2%?8)1@#
--
CJ+0 0CJ+;J$<2C<0("<J220K+42
JJ2F*))1,G&<(+>!
HHistol Histopathol.6*,?88+8@BC2%?1718-86#
-6
%/'<F:2NN2N'::%2J'2
*))6,G$"
?"+'"%%+"HJ
Am Coll Cardiol.66*6,?16+1BC2%?8-..)#
-8
N""F2="C:*)),G%!" !
&+5"!+'HJ Cell
Physiol.1)*,?.)+..BC2%?.)7.#
-@
K22F$!02<:F*))),G/!'"?
"&HC2%?)1-18#
-7
4"$F(<0$2*)),G"!
HNature.BC2%?))1.66#
-.
3%:*))1,G2""&HBiophys J.
1@*,?6.)6+6.-BC2%?187@6)#
-1
N2+(0*))1,G0"+"
V'HPLoS Biol.7*6,?)))).@BC2%?1-8871)#
6)
!:;2:CFF2;;$=!0$*)).,G2"+
HProc Natl Acad Sci U.S.A.)8*-.,?6-18+
6-11BC2%?.71176-#
6
3%0:*)).,G&"!H
Plant Signal Behav.-*1,?@7@+@77BC2%?17)6.-#
6
24C$J='$='=*))7,G2"+
!HPlanta8*-,?@8+@6BC2%?@1887#
6-
$J:*))),G+!"!HBiophys J.7.*,?
7)7+7.BC2%?)@8-7.6#
66
(>*)),G0'!&+5"&
"HBioelectromagnetics.-*,?77+.6BC2%?181-7.#
68
(>*)).,G""HBioelectromagnetics.
1*@,?667+688BC2%?.-.816#
6@
(>*))@,G%"+5H
Bioelectromagnetics.7*@,?8)8+8).BC2%?@788@#
67
/;/:*)).,G&1))2J"
"?""HBrain Res.-.?6+1BC2%?.7@))-#
6.
0425$;C$44$2(K"*)),G$
&""&
"HNeurosci Lett.(!#BC2%?)8@88#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@6
61
(JK!C0";00;((!!*)),G"
!"+5"*42#.4J,!$+.AK
'HMutat Res.@.-*+,?-8+6BC2%?1.@)#
8)
40'K9;4'C2"=*)),G%
!&.))+2J+5!"!
"HInt Arch Occup Environ Health.(!#BC2%?)68168#
8
;%N2'<2"</C;$*))1,G292A42!
"+"!8-;CA"+>HBioelectromagnetics.
-)*,?1+6BC2%?..-166#
8
;%2'2"<*))1,G22!C%!8-;C((
0"0?C!2<'0$'HEnviron Health
Perspect.BC2%?))@67.#
8-
4 '44 +KK*))1,G$!*,"18+2J
+"?HInt J Toxicol..*,?..+1.BC2%?
16..--#
86
4 +KK/K*))1,G!'
&?'!'"HCell Biol
Toxicol.8*,?--+6-BC2%?.6@16#
88
:::;F*))1,G(+""J&!HAppl Biochem
Biotechnol.8.*,?@+-1BC2%?1).1@61#
8@
CF<"C<*))1,G""HPathophysiology@*+-,?71+..B
C2%?1@66@#
87
>X"2X"<XXX"=="N="><20N002X"4NX*))1,
G&.))2J5&"
HBrain Res.-)?C2%?1.71.@#
8.
;'2*)).,GC!"”Electromagn Biol Med.7*,?-+
-BC2%?.-77#
81
!F<C;$;<42"</*)).,G;+!!!
"!6.&42!HElectromagn Biol
Med.7*-,?8+1BC2%?..1.#
@)
N"NF>N0N"F>*)).,G0+!"
*2<C>242>$00>C,+5"'HLeuk
Lymphoma61*,?-66+-8)BC2%?1)81.-#
@
N';'"2X"0'9:J2*)).,G&5"&
"HInt J Radiat Biol..6*),?7.1+718BC2%?.171-#
@
<*))7,G4&*$($<("&,HBioInitiative Report@#
@-
2'<2"<C;$;%N*))8,G242!
8-;C"+>HEnviron Health
Perspect.-*1,?7+77BC2%?@6)@-#
@6
'0JJF$';JJ'C(FF4F:=!2*))8,
G"+"!+
"HFASEB J.1*,?@.@+@..BC2%?@@)6#
@8
=(%;(;"3J240JJ4;0*))8,
G8)+J&5""?!
&HBiochim Biophys Acta.76-*+,?)+1BC2%?8777.67#
@@
N';0'9'52X02*))8,G/&"&&
5"HFree Radic Res.-1*-,?-7+--BC2%?87..-@#
@7
$& *9)))+))6,?'(*))6,G$'CJ<
""(*2(,&9"2Hverum-foundation.deC
??AA#+###&+
#A))6AAA ')A$(<>C"-)6#C!)))+)).?
?AA#+###&+#A))6AAA ')A`<:6+0+111+
)876$(<>C!#($??AA#+###&+
#A))6AAA ')A$(<>E)#
@.
CF<%'/%+FF$0!+;2""=*11.,G"2+6
+!&5HBioelectrochemistry and
Bioenergetics68?)-+)#
@1
4C5;!<<CJJ*117,G&8)J
"+;"HJ
Environ Pathol Toxicol Oncol.@*+-,?)8+)7BC2%?17@))-#
7)
<"C*11@,G"+!+!'!&
5"HInt J Radiat Biol.@1*6,?8-+8BC2%?.@7-6#
7
0=4*118,G'!2(
!HCancer Biochem Biophys.8*-,?8+7)BC2%?.1-77-1#
7
202K<*11@,G1862J"
0HEnviron Mol Mutagen..*,?@+-)BC2%?.@1.)6-#
7-
'";=$*))-,G"!02&HOccup Med (Lond).
8*@,?6)+6-BC2%?8.6#
76
'";=$*))),G"!!HOccup Med (Lond).
8)*8,?-@@+-@.BC2%?)178-@#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@8
78
="0F$"0;'2:!:;0$CF*))1,G$5
J+"HPhys Chem Chem Phys.*-,?@87-+@871BC2%?
1@-1-#
7@
$2'F(F;%*))8,G&<("X
!"HBioelectromagnetics.@*.,?@-+@-.BC2%?@)811@#
77
/"$J+4"*177,G+"&&HProc Natl Acad Sci U
S A.76*,?@+.BC2%?.1-)@#
7.
20':(2N'22*))1,G"!
"&8)+J"HToxicol Ind Health.
8*-,?8-+8.BC2%?16.1).#
71
0>=X="0X`<<`N4X"`"F==*))1,SG""
"HTZhonghua Nan Ke Xue.8*@,?8-)+8--BC2%?181-116#
.)
:N=:<F<:FF":0:4N2*))1,G@)J6"
"HBioelectromagnetics.-)*,?@@+7BC2%?..-16-#
.
+'2*)).,G%8)J"&!"
HElectromagn Biol Med.7*,?88+@-BC2%?.8@.1--#
.
F":<N420*))7,G)'J"&
HJ Microbiol Biotechnol.7*-,?-1.+6)BC2%?.)8)16#
.-
'('"2X:N';:"*))@,G8)+J+"
*,HMed Sci Monit.*@,?;$8+)BC2%?@7--671#
.6
4=00::J<<0F:F*1.8,G"++5
&HTexas, Brooks Air Force Base USAF School of Aerospace Medicine.9(2+$+.8+?1
#
.8
<=!!4<'004<2';2*)),
G2""+")#JHNeuroreport.*-,?1@+
))BC2%?))61)#
.@
' 2F%$J$<'$F <*))1,G!
""++HElectromagn Biol Med..*,?.8+18BC2%?
1--7.11#
.7
<;"204<2';2*))7,G0!244"
+"&HClin Neurophysiol..*,?776+7.)BC2%?
71)8@8-#
..
!(2=;"2*))6,G50+'"
!"!&!HNeurol Clin Neurophysiol.))6?7BC2%?@)@)@#
.1
0*))6,G0"!"?HNeurol Clin
Neurophysiol.))6?1-BC2%?@)@7@#
1)
4"'$J ;*)),GHAdv Space Res..*6,?@--+@-.B
C2%?.)-1@8#
1
4"'*11@,G
;"<"HAdv Space Res..*6+8,?.-+.8BC2%?8-..#
1
0CN0;F*1.),G2"!!HProc Nati
Acad Sci USA.77*-,?667+68BC2%?@11618#
1-
22;<0K0244<"2(*))1,G8)J
&5"!"?
HJ Biomed Biotechnol.))1?.-6-1BC2%?1@768@#
16
''4F''=C':<'2"'FJJJ'+;Jq'2;Jq'*))1,
G8)J"&"!!?HInt J
Occup Med Environ Health.*-,?@1+7@BC2%?1..7-@7#
18
44'JX'*)).,G++<+
"+-+"+&HInt J Radiat Biol..6*.,?@@1+@.)BC2%?
.@@-.#
1@
F''=''4"'FC':JJJ'+;Jq'2:':;Jq'*)).,
SG%"!V&"!++HTC
2'<''6*66,?8-1+8-BC2%?.7)--@#
17
K= '$K= 'C="(%F*)).,G(+
"?HIndian J Exp Biol.6@*8,?7-+-)1BC2%?.@17@#
1.
<'2$JF'o2*))6,G0"8)J"&"
!!+22@HFree Radic Res.-.*1,?1.8+
11-BC2%?8@77#
11
'o2*))6,G%!5"H
ScientificWorldJounral.6*#,?6+BC2%?887)1.#
-))
'o222/*))6,G&5"
?!HJ Cell Biochem.1-*,?.-+1BC2%?8-8@8#
-)
;';2<:*11@,G("
!"HInt J Radiat Biol.@1*,?-+6BC2%?.@)78-#
-)
<'2(F<22'0$;('o2*))@,G4&
<(+2(&"HBiochim Biophys
Acta.7@-*6,?6)+6BC2%?@7-661#
-)-
0JJF4:X"`'2h!(F:=!2*))6,G"
5"*42","&8-+
!HBioelectromagnetics.8*6,?1@+-)7BC2%?86@-1#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@@
-)6
/+;r<4JsJ'+0$*))6,G!
<(2("&H.*6,?7-+71B%?8)11.-#
-)8
2'F';N":'!*11.,G/$+"&!
&0"+8)J"HMol Cell Biochem..*+,?1+18BC2%?
18@88#
-)@
/2'F''2!2'!*118,G!+""
&!&&5"HBiochem Biophys
Res Commun.*,?)6+)1BC2%?7@11#
-)7
K &CF*))1,G4"&&5
+"?+.7!*11)+))7,HInt J Radiat Biol..8*-,?1@+-B
C2%?11@-6)#
-).
K<*)).,G4"! &5HMutat Res.@.*+-,?81+
7)BC2%?1)7-7.#
-)1
$"=*))1,G4&5"”Pathophysiology@*+-,?.1+)B
C2%?1.8.6#
-)
J0:C":'($Y"=*)).,G$5"
*9218)2J,"&!!!HInt Arch Occup
Environ Health.*@,?788+7@7BC2%?.7.8).#
-
2F#$J4:2'!J(2+
2*))1,G!5
"!HInt J Biol Macromol.66*-,?7.+.8BC2%?1@-8)7#
-
K%:'4FC:*)).,G!!HComput Biol
Med.-.*@,?7)1+7BC2%?.6.@1-7#
--
J '$C!$C!2'J''$4C;';J+;'C'=*)).,G
!!HInd Health.6@*6,?
6)1+67BC2%?.7@-1#
-6
$J'N!5:2$2!+J2+%*)).,G("
&!HSaudi Med J.1*,?.+-BC2%?.6@-)#
-8
;'J4J'Xj2JJ'=*))@,G"!'&
8)J"HInt J Occup Med Environ Health1*,?8-+@)BC2%?@..811#
-@
<'h22:*)),G"c
cInt J Psychophysiol#6*-,?--+6BC2%?.-1)#
-7
400'2$4'22:$*))),G0+
5"?HEnviron Health Perspect.).*.,?7-7+76BC2%?)1@6716#
-.
$4/C*11.,G0+"5
&"!HPhys Med Biol.6-*),?-)-.+-)11BC2%?1.68-@#
-1
J"';'J4J'Xj2:!'$*11.,G!
'&5"HBlood Press Monit.-*@,?--+
--)BC2%?)-7-#
-)
F<2*))1,G"5!'&HExp Neurol."#-BC2%?
1@@)68-#
-
2F<;'*))@,G"5HConf Proc
IEEE Eng Med Biol Soc.))@*,?@6+@8BC2%?716@1-#
-
;=F*))8,G@)J"
! HBioelectromagnetics@*@,?6@+6@.BC2%?8..7@)#
--
CC2F*))6,GC!"""
""HIEEE Trans Biomed Eng.8*,?1)7+16BC2%?88-@.1#
-6
F*11.,G"HMagn Reson Imaging Clin N Am.@*6,?7-+7-.B
C2%?1711.8-#
-8
;//:9':0'5*))1,G1))2J"&
55HBrain Res.@8?7.+.8B
C2%?1-).7#
-@
:::;F*))1,G(+""J&!HAppl Biochem
Biotechnol.8.*,?@+-1BC2%?1).1@61#
-7
2':2;CF0%NC':"N:;:4:2F*))1,G
.-82J5&!"!HBrain
Res.6BC2%?11@.17#
-.
F/*))1,G!!"+"
"HPathophysiology@*+-,?
87+77BC2%?1-1.-)#
-1
:"C"2*))6,G&"!8)+7+
J+"HNeurosci
Lett.-7)*+-,?@@+7)BC2%?86..-@#
--)
0'<<C"2*))),G&"5
"HNeurosci Lett.1*-,?7+76BC2%?
).-)6#
--
=">2*))1,SG"HT
Zhongguo Zhen Jiu.1*-,?-+@BC2%?1-8.8)7
--
C$"20!F4*)).,G"!+
5!HNeurosci Lett.666*,?-@+6BC2%?.7)@6.6#
---
+C20;*))7,GK!?!"+
5&!""HProg Biophys Mol Biol.1-*+-,?8@+71BC2%?
7)6.18#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@7
--6
;tt(20*))7,G2HRom J Intern Med.68*6,?6)7+6BC2%?
.7@76.#
--8
CX"<$>CFX"XX20F2*))7,G%+
"HEnviron Toxicol.*,?@1+78BC2%?7-@@87)#
--@
(F$!55F(C20+C20;*))@,
G!!HRev Port Pneumol.*6,?-@1+-76BC2%?@1@18@1#
--7
'*11.,SG"+5!HTMed
Tr Prom Ekol.8?@+-)BC2%?1@@1-#
--.
2':/s<*1.@,GHJ Hyg Epidemiol Microbiol
Immunol.-)*,?-1+66BC2%?-7.).#
--1
;<""(N'%*))8,G+;HJ Phys
Chem B.)1*67,?@6+@6.BC2%?@.8-167#
-6)
<>0="<X"N*)),SG5!
HTGuang Pu Xue Yu Guang Pu Fen Xi.*-,?6)@+6).BC2%?167@.#
-6
(<<20(4*))1,G0<("!
HElectromagn Biol Med..*,?7+1)BC2%?1--7.17#
-6
4$<2;<0%0((%K4<3(42(CJJ
244<*))1,G&
&+5"HCardiovasc Res..*-,?6+6)BC2%?1.7)8#
-6-
<!$*))1,GJ!"?+'H
Electromagn Biol Med..*,?6+-6BC2%?1.-18#
-66
CJ$K*))1,G'"
!HBMC Plant Biol.1?67BC2%?16)816-#
-68
$""(K4$4JJ$$*)).,G<("&!H
Electromagn Biol Med.7*6,?#-8+--1BC2%?1)-77.#
-6@
CJ*))6,G0'"5"!
HBiomagn Res Technol.*,?.BC2%?887@-)#
-67
4(2C44*)),G/c!c<("
HBioelectromagnetics.-*7,?8+8-)BC2%?6)8@#
-6.
2K<CJJ$4<4*)),G&5*8)
J,""!'HBioelectromagnetics.
-*6,?1.+-)8BC2%?16.@)#
-61
%C'=('0C%K*11.,SG2!"
'"#K#%!$
!'+5""
HTBiofizika.6-*@,?177+1.)BC2%?))7117#
-8)
<$$F:':/'':*11,G&50*Z,+
HNeurosci Lett.6*,?-+8BC2%?76-.#
-8
'%::':"(2J'"
*))8,G&8)J"("
'+!HJ Vet Med Sci.@7*),?1@1+176BC2%?@7@)8#
-8
'%::':"(J'"*))8,G
8)J&&HBiolelectromagnetics.@*7,?8.1+
816BC2%?@)-7181#
-8-
4!!(;5"2;4;C*)).,G&<(5+2"(*<(+2(,
&'!HSci Total Environ.6)7*-,?.+
-BC2%?..)6.6@#
-86
2J$:+%;!NF!:$*)).,G%
!&!5
"7HRadiat Res.@1*,?.+-7BC2%?.811-.#
-88
C!$;(02024"2$*)).,G&1))2J
$5$%0-C"<HRadiat Res.7)*-,?-7+
--6BC2%?.7@-.88#
-8@
X/C("22$*)).,G"&
'&18)2J925HBioelectromagnetics1*-,?77+.6BC2%?
.)7.68#
-87
;%N<C202"</C;$4+$"2*))8,
G182J8)J"8-;C
HBioelectromagnetics@*-,?7-+.6BC2%?87@.6-)#
-8.
;;"0pFFC*))1,G&+5"
""HProc Natl Acad Sci USA.)@*6,?87).+87-BC2%?1118)6#
-81
Ks2CJs:s2*))1,G$5""
'HJ Exp Biol.*C,?-67-+-677BC2%?1.-7..1#
-@)
0!!(00<F=!!0<FX!FC2*)).,G2"'?
HNeurosci Res.@)*,?18+)8BC2%?.)-@@1-#
-@
$:'F<'4=''2*)).,G;"V"H
PLoS One.-*,?@7@BC2%?.-)78-#
-@
K2CJ'*)).,G!"!
'""HNeurosci Lett.6-8*,?)-+)7BC2%?
.--7))6#
-@-
0!!(0
0<2*))7,G"H
Neuroscience66*,?-8@+-@7BC2%?7)@11.#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@.
-@6
2N<F*))@,G0"'+
&""HJ Basic Clin Physiol Pharmacol.7*6,?@1+7.BC2%?7--..#
-@8
C"22:;/30:*))8,G&
""""?&
!;!2HInt J Biometeorol.61*6,?8@+@BC2%?87@66.#
-@@
='=='$*))8,G2""!HJ Comp
Physiol A Neuroethol Sens Neural Behav Physiol.1*.,?@78+@1-BC2%?8..@11)#
-@7
C"2C0*118,G&"
""?HInt J Biometeorol.-.*6,?.)+.7BC2%?
7@)88#
-@.
;'$$2F4:"F*1.-,G2"!H-)*8.18,?71+.)BC2%?
@.-.6#
-@1
$ 'K22F/*)),G0!&C!2$+
"0JC+(5"(0"02
0?&JiHArch Environ Contam Toxicol.(!#BC2%?)6.66#
-7)
$ 'K22F/*))8,G"
&+5"HInt J Radiat Biol..*7,?61+611BC2%?
@@-@8#
-7
$ 'K22F/*))8,G&+5"'
++"?HEnviron
Res.11*-,?-1@+-77BC2%?@-)7171#
-7
$ 'K22<J;*))8,G"&
&5""ccHActa Biol Hung.8@*+,?6-+8B
C2%?8.--#
-7-
F/4"<"NN:F"0<CN*)),G0
"KAC0+++&HJ Cutan
Pathol..*),?8-+81BC2%?7-78)#
-76
4"F/*))),G!&
A"GMed Hypotheses86*6,@@-+@7BC2%?
).81@@#
-78
0'<< C"2:*))),G5*L@4,
"!<!HToxicol Lett.
.*+,?1+1BC2%?-7-)6#
-7@
4"F/*117,G'"cc9K+J"+
"+HExp Dermatol.@*@,?.-+1BC2%?16.8#
-77
%$%;2$JK:%C*117,SG2!"
"&"HTAviakosm Ekolog Med.-*,?6-+67BC2%?11)88#
-7.
F/"2; h"K:*116,G'""c
c?++HExp Dermatol.-*8,?-6+-.BC2%?7..7@1#
-71
;:!'<*11),SG0"&
"HTArkh Anat Gistol Embriol.11*,?6+66BC2%?)1))8.#
-.)
F!'C222*))1,G0"""
'"&&<("HBioelectromagnetics.
C2%?17786@#
-.
<=FC2F0*)).,G0!!
"iHJ Pineal Res.68*6,?-6+-8)BC2%?.-.68-#
-.
' ;'F;'4C:4:0'CK*)).,
G2&!&!
!HJ Radiat Res (Tokyo)61*@,?871+8.@BC2%?..76-.#
-.-
0'2<;F;N24XN;2(J'0$F0"<$F*))7,
G;""!""!"
HJ Occup Environ Med.61*),?61+8@BC2%?.)))6)#
-.6
$hh2;52C"20!*))@,G+*@+2J,"
5?J!"+H;"
7*,?6+8)BC2%?@-61.#
-.8
;F;$F0=%;2:!<N24*)),G2!
&"HInt J Radiation Biol 7.*,?)1+)-@BC2%?68@1)#
-.@
;'0(;4*)),G#@)J"+
&+!20(+7"HBioelectromagnetics*,?+.BC2%?.)8.#
-.7
:=2':00$4*)),G$""++"
@+&HAm J Epidemiol.86*7,?81+@))BC2%?8.)1#
-..
<C2N4"2u;4:h";"2C*)),G
""+&@+&HAm J
Epidemiol.86*7,?@)+@)1BC2%?8.)1-#
-.1
;F;$FN24:FC0*11.,G&!
"'HScand J Work Environ Health.6*-,?.-+.1BC2%?17)-7)#
-1)
=="22<<22F*11.,G0"
8)J"&HJ Pineal Res.8*,?@+7BC2%?1788)--#
-1
'$*11-,G='""J!"C'V
HInt J Neurosci.@.*+,?.8+1BC2%?.)@-8.#
-1
'$C*11,G2"JHInt J Neurosci.@-*-+6,?
@8+76BC2%?-)6881#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
@1
-1-
'$C"*11,G2"?
HInt J Neurosci.8.*-+6,?@+@7BC2%?-@8)67#
-16
=;=="0=2F;!$<;C2<+("$<*11),
G<(""HJ Pineal Res.1*6,?81+@1B
C2%?)1@18#
-18
C"2*1..,G%""!?
+J"!iHNeurosci Lett...*-,?7+76BC2%?--.@.7#
-1@
=;=*1..,G0&<(HBioelectromagnetics.1*,?18+)8B
C2%?-..#
-17
20"40(2;C*)).,G$5!
"?HConf Proc IEEE Eng Med Biol Soc.)).?6-.7+6-1)BC2%?1@-@.@#
-1.
K:F<$*))7,G$!
&1)).))68)2JHPhys Med Biol.8*8,?+-@BC2%?7-)68)#
-11
FoJsJJhC*))@,G2+!"
"!1))A.))A))2JHElectromagn Biol Med.8*,?)-+BC2%?@7711#
6))
N2:*)).,G%5&"&
!HMutat Res.@8)*,?78+.)BC2%?.6.7@.#
6)
("0<22K22*))8,G4&&5*<(,
"*2(,!+HEnviron Toxicol.)*@,?8.8+81BC2%?
@-)7#
6)
C5$K2J4("022*))-,G2+
&8)J"!J6+!J*5,6+!JHToxicol
In Vitro.7*8+@,?8.+8.@BC2%?681166.#
6)-
'2:!$<"*11.,G2&8)J2(
JHMutat Res.6.*+-,?)+BC2%?1787)).#
6)6
/'"'"2 N*11@,G6#7"5
!0HTohoku J Exp Med..)*-,?)1+8BC2%?1)8.8)8#
6)8
Kv'%C"'vvK4J*))6,SG+5"
"902N+87HTMikrobiol Z.@@*-,?8+87BC2%?868@.#
6)@
02;F=*)),GC+))+-8)4J
"#HPhys Med Biol.67*,?-.-+-.-1BC2%?
68876#
6)7
:*))),G2&"VVHMed Hypotheses.88*-,?).+6BC2%?
)1.81)#
6).
4=:(*17.,G"HZ Naturforsch C.
--*,?8+BC2%?6166.#
6)1
4!!(;5;4"20<;C*))1,G'
'&&5"&"#HInt J Immunopathol
Pharmacol. *6,?)81+)@@BC2%?))7667)#
6)
4!!(;5"2;4;C*)).,G&<(5+2"(*<(+2(,
&'!HSci Total Environ.6)7*-,?.+
-BC2%?..)6.6@#
6
042%*))@,G'0
!8)J"HElectromagn Biol Med.8*,?71+.8BC2%?@771@#
6
K44(J22C;(C$<<44<0Jw<
*))1,G0&1))2J42+2("H
Neurosci Lett.688*-,?7-+77BC2%?1618#
6-
;0$0$F*))1,G90"&("&C
$5(HPain Pract.#BC2%?17@8-#
66
/ssF$'s/s22's2"s:< s:!s<!F4s'F
*))1,G%C"=+!&"(?
"++$0"$HCell Mol Neurobiol.1*@+7,?1.+11)BC2%?1-)818#
68
'N2"::F!N*))1,G5"
C1+HConf Proc IEEE Eng Med Biol Soc.?816+8168BC2%?11@8)@-#
6@
%2:'N::"(:N*)).,G2
"C0--."+'HNeurosci Lett.6-*,?-8+-1B
C2%?.@@7#
67
<4;!F<2"<C;$*))-,G"!
&42!HEnviron Health Perpect.*7,?..+..-BC2%?7.6.@#
6.
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
61
=$'";*))6,G"?""!
5HNeurosci Lett.-@*+-,?-+@BC2%?8-8..#
6)
'";=$*))-,G"5HOccup Med (Lond).8-*,?-+
7BC2%?@-7817#
6
'";=$*)),G""!!HOccup Med (Lond).8*7,?6-+
68BC2%?6)1#
6
2C02<22*118,G
&HOccup Med (Lond).68*8,?7@+77BC2%?7871-)8#
6-
'52X;"250*))7,G&&
"&+5"HElectromagn Biol Med.@*,?11+)@BC2%?7@-)-7#
66
N'2(/J"(4'/"!*))8,G&
&"HOtolaryngol Head Neck Surg.-*8,?7-+7@BC2%?8..@@-#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7)
68
04<C/':C0:2*))7,GC
"HNeurosci Biobehav Rev.-*6,?@1+@6BC2%?7-76-18#
6@
(;"<0<C42<C(*117,G0"
+'!&""HBrain
Res.7@1*,?-@+-@@BC2%?1-76)7#
67
04<CC(*118,G&""
#%#&"HBioelectromagnetics.@*8,?1)+16BC2%?.886@1#
6.
C(4$00<C*118,G&""
#%%#&HBioelectromagnetics.@*8,?18+-))BC2%?.886@-)#
61
4!: 22"C*)).,GCJ?!
"HCell Biol Int.-*@,?@..+@1BC2%?.11#
6-)
F;"C2'+;!"F$J'F*))8,G%"
!HJ Acoust Soc Am.7*-C,?
6+67BC2%?8.)7)-#
6-
;<";C'22J;;'424*)),G0
"!?HBioelectromagnetics-*7,?6..+618BC2%?6)8#
6-
<"2;'4(2!:*11@,cCJ"c
Bioelectrochemistry and Bioenergetics#6?1+18#
6--
4x;*11),SGCJ!"HTStomatol Glas Srb.-7*,?77+.6BC2%?-@@8#
6-6
;$C*)).,G`"!>!"H
Indian J Exp Biol.6@*8,?6)+6-BC2%?.@17@.#
6-8
0"FF*)).,GC!!"HIndian J Exp Biol.6@*8,?-7+
-77BC2%?.@17@#
6-@
"$:!(K='=:CF2=*)).,G+"
&'!'#%%?!"+
'HSkin Res Technol.6*,?+)BC2%?.@)1#
6-7
""FC4"<2(*))8,G<+++
'HJ Biomed Opt.)*,?)6))@BC2%?81)).)#
6-.
!:*))8,G'!""
"HForsch Komplementarmed Klass Naturheilkd.*,?.6+.1BC2%?81676@@#
6-1
= 'C '$K*))8,G2+"
!HForsch Komplementarmed Klass Naturheilkd.*,?1@+)@BC2%?81676@.#
66)
;$C*))-,G`!"HIndian J Exp Biol.6*8,?86+87BC2%?
86676#
66
K4 h:*)),G="!"!""
5"HBioelectromagnetics.*-,?))+)6BC2%?88@#
66
;$C*111,G0HJ Theor Biol.1.*-,?
.7+11BC2%?)-@@6.7#
66-
/N<2/:'"0' :N%'
:"#*11,G;+!!"
!?,"
B,<"J+
/"0+*;,#!"
""+;+"/+$"HAcupunct Electrother Res.7*,?1+6@BC2%?
-8--.#
666
C(=0'02*)),G"!!&<("
?"+HNeuroreport.*7,?8)+8)8BC2%?-..6-7#
668
=FC(*)),G! &*)),"?
"!HNeurosci Lett.17*,?+6BC2%?..8#
66@
==:CF0'02C(*)),G!"
&*)),"?"!H
Neurosci Lett.-)1*,?7+)BC2%?6.18-@#
667
4/F*))1,G!"HOral
Dis.#C2%?17667-#
66.
NF4"2X"<<NN2!*))1,G`$ +
!'HElectromagn Biol Med..*6,?-.-+-1)BC2%?))7@1#
661
:^$<JJ'*)).,G2!"&
'HBMC Genomics*1,?77BC2%?.@7)-#
68)
C%%*)).,G%""5"
HToxicol In Vitro.*8,?-66+-6.BC2%?.8-1#
68
!!4;"(<JJ<"C0J4<;<*))7,G&5'"
!!+!H
Bioelectromagnetics..*-,?6+-BC2%?7).)68.#
68
2'F2NN""4( *))),G+C+7)!
&8)"HLife Sci.@@*-,?.7+1@BC2%?)7-766#
68-
KJ$''C:*111,G5+H
Biolelectrochem Bioenerg.6.*,?77+.)BC2%?).8.8#
686
$44!;*11.,GC'0"&"
!HBioelectromagnetics.1*.,?6@1+67@BC2%?1.611@#
688
:"4<0F="$0"N<:N0F4*117,G%+
&5""HJ Korean Med Sci.*,?@+-6BC2%?
17)).#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7
68@
44$+*116,G&+6)+
"+"$HBioelectromagnetics.8*6,?-1+--@B
C2%?71.)@@#
687
$"0CF*))1,G0"!?HProc Natl Acad Sci
U.S.A.)@*,?-8-+-@)BC2%?11611#
68.
='$29(:='=*)).,G<"+"?
!"!"HJ Exp Biol.*C),?--66+--8)BC2%?..6)@@1#
681
C$J:='$='=*))8,G2""!
#-82J"HNaturwissenschaften.1*,?.@+1)BC2%?8@68).#
6@)
='$$J:C='=*))8,G"+
"!HCurr Biol.8*@,?8.+8-BC2%?@16@#
6@
$JCCF;='$='=*))6,G$+
"HNature.61*@1..,?77+.)BC2%?86#
6@
(F22/'o2*))1,G&<("&&
"HToxicol Lett.C2%?11-@)-#
6@-
4 +KK4 '4%C%*))1,G!"&
='&HToxicology81*-,?)7+BC2%?16.18)#
6@6
2%22"NN'%N':'*)).,G1))+2J"
!&""HBrain Res.@1?)+
6BC2%?7@76186#
6@8
N:===":NCNNNF<*)).,G"!5
+"&"HMol Vis.1B6?
1@6+1@1BC2%?.8)186@#
6@@
42/J"(/;:2"*))7,G1))2J5+"
"&?!0HToxicol Ind Health.-*7,?6+6)B
C2%?.8-@61-#
6@7
"00F2C*))7,G2!V'+V"4+
HNeurosci Lett.6*,?.+.@BC2%?786.86#
6@.
C^'$<=2"g0<$^*))7,G9
"*%0,?"!'"+HJ
Adolesc.-)*6,?8@1+8.8BC2%?@17178-#
6@1
C2=C:2*))@,G! "!"
! "!!HOccup Environ Med.@-*8,?-)7+-BC2%?@@.8)#
67)
$hh2*))@,G!"&?
+JHSoz Praventivmed.8*6,?)+)1BC2%?71-7.#
67
/!"$2*))6,G0?iHJ Egypt Public Health Assoc.71*-+6,?
17+-BC2%?@1.67#
67
!$40:=<42F:;!fC
*))),G&"+5""'"4HNeuroreport.
*8,?--+--8BC2%?)81.18#
67-
'J;(4C<:*111,G8)+J"HJ Sleep
Res..*,?77+.BC2%?)..6)#
676
'$"C:*11,G2"!$2
HInt J Neurosci.@8*+6,?@+@.BC2%?-6@1#
678
02:;F0*))1,G<!!!
"+""HPhysiol Behav.17*,?-@+6-BC2%?161@76#
67@
!;<4"$4C4%2(C"40"<04*)).,G
&+5"<+"5)6)@)
"HElectromagn Biol Med.7*-,?6+8-BC2%?..))#
677
(4C$2*)).,SG&"
"""?HTMed Lav.11*,?@+.BC2%?.868-@#
67.
C<'2'2F'0=*)).,G
!'HJ Exp Biol.*C-,?-@.+-@1)BC2%?1))7#
671
C=;F2;'F0*))-,G;"+"
"HJ Neurosci.-*6,?61.+8)8BC2%?81.@-.#
6.)
C4:'NK4C"%"K%:'J;KC2
2%*))-,G="$00?!!"
&HBiolectromagnetics.-*.,?86@+88@BC2%?6@)-676#
6.
X2*)),G$!"0+50"H
Bioelectromagnetics.*,?7+68BC2%?61#
6.
'"22N*1..,G"+""!H
Bioelectromagnetics.1*,?8+-7BC2%?--68#
6.-
$'C2$2*))6,G2!"
HJ Comput Neurosci.@*,?8+8BC2%?67)786#
6.6
4'F!F*117,G""!HBiophys J.7-*@,?
-)8@+-)@8BC20%?.)#
6.8
:"'%<"*116,G!'
""HBioelectromagnetics.8*@,?8-1+867BC2%?7..)@7#
6.@
;'24$*))1,G""” Pathophysiology@*+-,?7+7.BC2%?
1@.88)#
6.7
C'F<=4N"F($:<'F4=C0*111,G%
!"<+@)HBioelectromagnetics.)*@,?-67+-87BC2%?
)68-)@#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7
6..
$ 'K22F/*)),G0!&C!2$+
"0JC+(5"(0"02
0?&JiHArch Environ Contam Toxicol.(!#BC2%?)6.66#
6.1
K222J4;;C5$*))@,G+&&
5*8)J,"&!!'HSci Total Environ.
-@*+-,?).+1BC2%?8171@1)#
61)
22K2("0+J42C5$"2
2*))8,G+&&5*<(,"!J!J
!!'HToxicol Lett.87*,?1+.BC2%?8.-@111#
61
J422K2("0C5$*))6,SG"&A+
"&&&+5"HTAnn Ig.@*+,?-+
-6)BC2%?88868-.#
61
+fCs24C(;C2*)),G%
!"&'""H
Cancer Epidemiol Biomarkers Prev.*,?@7.+@.-BC2%?61@)@#
61-
2'N;%N*)).,G2!"?
"HElectromagn Biol Med.7*6,?-6)+-86BC2%?1)-77.-#
616
9'K<5K;%%*))@,SG#
&""HTRadiats Biol Radioecol.6@*@,?71+7-6BC2%?7--7)#
618
9'K<5K;%%*))@,SG5
"8+84J#HTRadiats Biol Radioecol.6@*@,?71+7.BC2%?7--7)#
61@
;%N5K<K*11,G$"
#HZ Naturforsch C.67*7+.,?@+@7BC2%?-..81#
617
< 22!*))1,G"
"!"'!HElectromagn Biol Med..*6,?-1+
6-BC2%?))7@-)#
61.
=C"=2";CC"2*))1,GC&<C+"?
5!5&HInt J Neurosci.
1*,?+6BC2%?1@..#
611
+C<C"2*)).,G;"&&'
"HElectromagn Biol Med.7*6,?-88+-@6BC2%?1)-77.6#
8))
< 2 (*))7,G<"8)J
"!'!HElectromagn Biol Med.@*,?.-+1.BC2%?7@-)-@#
8)
(:F$F*))8,G"!"
"?HJ Toxicol Environ Health B Crit Rev..*,?7+6)BC2%?8.)678#
8)
< 242*))),G"&5"
"6'!HIndian J Exp Biol.-.*7,?@1+@11BC2%?8--#
8)-
;0<:;:=<F<2224#
*11),G'!"HBioelectromagnetics.*,?@1+.7BC2%?
6)8#
8)6
0$4"FC(C*)).,GC+"
*9K0,++!+"!HElectromagn Biol Med.7*6,?
-.@+-1BC2%?1)-77.7#
8)8
99(F9"!(C*))@,SG0+!"&9K0
5HTHandchir Mikrochir Plast Chir.-.*-,?61+88BC2%?@..-611#
8)@
0$(C*))6,G&!+!
'!"&HBioelectromagnetics.8*6,?--+-8BC2%?86@6#
8)7
(;::"(%/J'%:*))),G+"
!HBioelectrochemistry.8*,?1)-@BC2%?)81876#
8).
$ 'K2 2F/*))@,G<""
&+5"HJ Exp Biol.)1*C7,?--+--.BC2%?@1@1@.#
8)1
$ 'K2 2F/*))8,G"
&+5"HInt J Radiat Biol..*7,?61+611BC2%?
@@-@8#
8)
$ 'K22<J;*))8,G"&
&5""ccHActa Biol Hung.8@*+,?6-+8B
C2%?8.--#
8
$ 'K2 24<J;*))-,G""
&8)J"HTissue Cell-8*-,?-+-BC2%?71.-#
8
$ 'xK2 2<'x4x;!x<<Jx;*)),G2"
"!&5"HMed Pregl.86*-+6,?1+7BC2%?
781)#
8-
5(0!"2<*))1,G2!!+
!!?+HEnviron Health..?1BC2%?1-.-8#
86
22$2JCX$*))7,GC
!!!&&+5"HPak J Biol Sci.)*,?6).+
6BC2%?1)1)..#
88
:'':!N%JN2'F*))8,G0!&<(
"&+&+.1HJ Radiat Res
(Tokyo).6@*,?87+@6BC2%?81..68#
8@
"4$N"N22'F*))),G%>++!&"
*@)J8,(+';+!HBiochem Biophys Res Commun.7@*,?-.+6-BC2%?))@#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7-
87
2'F: N=''!*111,G<"+&"*8@)J,
>++HJ Radiat Res (Tokyo).6)*,?-+BC2%?)6).76#
8.
4*)).,G0C0+$0H9?
B?AA#A8@@#
81
;2:J'<:=$*178,GK(HAnn N
Y Acad Sci.67?76+.BC2%?)868.#
8)
4"F/*))),G!&
A"GMed Hypotheses86*6,@@-+@7BC2%?
).81@@#
8
$';F<0';*))1,G!&
""?2$%"HPhys Med Biol.86*1,?
81@8+8171BC2%?17816#
8
"$2"0*17,Program for Control of
Electromagnetic Pollution of the Environment*="CV/C,#
8-
"04X$*177,GJ""!
HJ Microw Power.*6,?-1+6BC2%?61-6#
86
0$C*1.@,Biological Effects and Exposure Criteria for Radiofrequency Electromagnetic Fields*0
$C2;29,$#.@B6.B%;?)1--1.)6#
88
9C"%$C=/"
*11-,GW$HElectromagnetic Fields 300 Hz to 300 GHz*=/?
0,#-7?##6#)B%;1687-7-#
8@
0!!(00<F=!!0<FX!FC2*)).,G2"'?
HNeurosci Res.@)*,?18+)8BC2%?.)-@@1-#
87
4<4<3;!'X2*)).,G!"
5"?"HBiomagn Res Technol.@?BC2%?
..68#
8.
;0!!$%"<FC*))1,G+!"
"HAesthet Surg J.1*,?-8+6-BC2%?1-7.68#
81
$!F*11.,G0""HClin Orthop Relat Res.
*-88,?)8+8BC2%?117@6)#
8-)
'$%$C*11-,G$""!
""HInt J Neurosci.7)*-+6,?88+@1BC2%?.)@-866#
8-
'$*11,G2"'HInt J Neurosci.@@*-+6,?)1+-8BC2%?
-)8@)#
8-
: "KK<"!2 '4<"";*)).,G"?
"HInt Tinnitus J.6*,?+.BC2%?1)8@#
8--
;%*))8,G+;"2HMicrowave Review*,?-I1B;%
*))8,G;"2?0:"(C9"H
Electromagnetic Biology and Medicine6*-,?-78I6)-#
8-6
<"!2('9<55;$$ '4C*)).,G0"
!""?+HPsychol Med.
-.*,?7.+71BC2%?.-@@.#
8-8
<"!2<55;('9 '4C*))7,G&!
! ?HPsychosom Res.@*-,?.-+..BC2%?7-6@77#
8-@
2!;:':CX*1.,SG+!"
'"+5&"HTProbl Khig.7?+1BC2%?77.)@@
8-7
<C$<4<*)),G+"
0HEnviron Health Perspect.)6?@1+-BC2%?16.1@#
8-.
0=*117,G"+HComplement Ther Nurs Midwifery-*6,?+@B
C2%?16-1@#
8-1
;"2J;;<C:*11,G+#"
K9+'HJ Occup Med.-6*7,?@1.+7)BC2%?-.@@@#
86)
h2<';"22:*117,G"'""
GJ Occup Environ Med.-1*,?8+BC2%?1)167#
86
<"!2('9 '4<55;*))1,G"
?"iHPLoS One6*-,?8)@BC2%?1-8.16#
86
NJ'2$$$*))1,G4JHPhys Med Biol.
86*-,?6)-7+6)61BC2%?18)7)#
86-
<F0X="*))7,G"!?H
Health Phys1*@,?@+@.BC2%?7618@@6#
866
FC"'2;*))8,G$!""+"'HJ
Laryngol Otol.1*.,?@-+@--?C2%?@))#
868
F00:*))-,G5"HBioelectromagnetics@?@+
7-BC2%?6@.-#
86@
(*1@,c""cJ Appl Physiol7*6,?
@.1+@1BC2%?-.18).#
867
$<0""F"$*18,SG<!"&
*)))),HTArch Mal Prof.-*6,?-1+-1BC2%?618-81#
86.
4J+"=F;'<;>('9*)),G
&""HSci Total Environ.6).*6,?776+77.BC2%?
11-8))#
861
;"F!"*11.,G/""
!” Acta Odontol Scand.8@*8,?-)-+-)7BC2%?1.@)))#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
76
88)
/N<2/:N%''"0N2'*11,G0
!!"&
"+""!'&!!'
"HAcupunct Electrother Res,@*-+6,?6-+77BC2%?@.8@-#
88
<0!"25(:; ;;<4*)).,G%
"! +"+
HElectromagn Biol Med.7*,?17+)-BC2%?.8@.1-7#
88
'!":$'!":=4"</K%<(: *)),G
'HScand J Work Environ Health.7*,?6)+68BC2%?6)1817#
88-
/4K%$"":*118,G'
HScand J Work Environ Health.*8,?--8+-66BC2%?.87).1#
886
;"2*1..,G'!'"#)HContact
Dermatitis.1*8,?--8+-6BC2%?17@@8#
888
<f0=!"F*1.8,G''iHContact Dermatitis.-*6,?-8+
6BC2%?1-8-@6#
88@
<C*)),y! "&?
HEnviron Health Perspect.)*#6,?@-+@.BC2%?16.18#
887
C(4$00<C*118,G&""
#%%#&HBioelectromagnetics.@*8,?18+-))BC2%?.886@-)#
88.
:''9'K/J'9:0'2*)).,G&5"
"!HCurr Eye Res.--*8,?66+66@BC2%?.8@...#
881
2!<;5F$(4*))@,G+42!
"”Conf Proc IEEE Eng Med Biol Soc.?-78+6BC2%?716@871#
8@)
C5F!F%:*111,G!""
HPanminerva Med.6*-,?)7+8BC2%?)8@.7#
8@
'$*11,G""
"HInt J Neurosci.@7*+,?68+7BC2%?-)8@-#
8@
'$C*11,G&"?H
Int J Neurosci.@@*+,?78+.8BC2%?-)687#
8@-
/!K2'K*))7,SG'
HTMedicina (Kaunas).6-*,?1@+)BC2%?7-116-
8@6
3/(;40"CK;JJ244;K04*)).,G$"
?HNeurol Sci.1*#,?@1+7BC2%?.8681@#
8@8
$2"K4;:N"C*))7,G0!""
++HCephalalgia7*,?88+@)BC2%?7...)71#
8@@
4J+"*))1,G;!""+
"*,HBioelectromagnetics.-)*6,?11+-)@BC2%?1811.6#
8@7
'$*11@,G&""V
HInt J Neurosci..6*,?.7+16BC2%?.7)76.#
8@.
%$0*%"$0,?=/"*)),Electromagnetic
fields and public health: extremely low frequency fields and cancer=/#@-*/!)),#
8@1
F0*))6,G"+"
+HScand J Work Environ Health-)*#,?+-)BC2%?
8888@)#
87)
'4CF0(;*))-,G"
'&""cEpidemiology6*6,?6)+6@BC2%?.6-7@8#
87
<0N"(0*))-,G!&5"
?HAm J. Ind Med.6-*,?+)BC2%?8677#
87
F0/F*11.,G2
'"'HAm J Epidemiol.6.*6,?-@+-@.BC2%?177..)#
87-
J0'<C*11.,G2"&"
"'HEpidemiology1*6,?-1.+6)6BC2%?1@671)-#
876
J<C0:*11.,G"?9##
HArch Environ Health8-*,?7+76BC2%?187)-#
878
""2$hh20*))1,G$
"?"HAm J Epidemiol.@1*,?@7+
78BC2%?.11)77#
87@
42C*)).,G/&&5"
J?+HInt J Epidemiol.-7*,?-1+-6)BC2%?.688#
877
$hh2<h2""2C"<h<C20*))7,G2
"&&+5"?-!
HNeuroepidemiology.*6,?17+)@BC2%?7.88.#
87.
'4CF0(;*))-,#G"
'&""cEpidemiology6*6,?6)+6@#
871
!$%%!2*)).,G+!
'":"K2HAsian Pac J
Cancer Prev.1*6,?@61+@8BC2%?18@786#
8.)
:!2NN"'!N"F%':/ '
N2J%!NJ'' :'N:!/*))@,G0'
"F?+'+5"
FHInt J Cancer.1*-,?@6-+@8)BC2%?@61@6)8#
8.
4K:2F*))8,G0""
"=?+HBMJ.--)*78)-,?1)BC2%?81---8#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
78
8.
<$$F*))8,G"''
iHBioelectromagnetics7?.@+17BC2%?@)811-#
8.-
%+$0F*))-,G2&&5"
""'HEpidemiology.6*6,?6-7+66BC2%?.6-7@1#
8.6
2/2*)),G"
''HMed Hypotheses.8@*-,?1)+18BC2%?-81-61#
8.8
4<22;KCF"4!"2<<F:*111,G+
'/0&"HInt J Cancer..*,?
@+7)BC2%?)-.176@#
8.@
2FYJF2$2"24"FC:C:92;':
:^*117,G0'"?+!+
4HCancer Causes Control..*,?@7+76BC2%?1-66)#
8.7
=<*171,G""HAm J Epidemiol.)1*-,?
7-+.6BC2%?68-@7#
8..
(JJ<KC%%KCC(;0C$;"C0!C
*))1, G2! & & 8) J " ? "
"HInt J Occup Environ Health.8*,?--+6BC2%?161@671#
8.1
:!/NN"'!N"F%':/ 'N
2J%!NJ'' :'N:!2*)),GC+5"
!?+FHJ Epidemiol.)*,?86+@BC2%?118-)6#
81)
KCF"F:02N00$""$4*)),
G;&""?0+!
+HInt J Epidemiol.-*,?)+7BC2%?16--#
81
4"$4K4Y'0*))1,G&+7!"+
""HInt J Gynecol Cancer1*-,?--6+--1BC2%?16)7888#
81
;%;JX%*))8,G"!
HIn Vivo.1*-,?8@-+8@@BC2%?8.78777#
81-
:'F*))6,G$&8)+J"
!?+!HAm J Epidemiol.81*1,?.8+.@BC2%?8)87.#
816
("2(9$5<!*11.,G2"!"
"+"HEpidemiology1*6,?-1+-17BC2%?1@671)#
818
<=22*118,G<!&+"
""&!HCancer Lett.1@*,?78+.)BC2%?78.8686#
81@
<!$C$'$NC*11-,G<("!?@)J
!'V$Z!HJPineal Res.6*,?.1+17BC2%?
.-)@-7#
817
:!<*))-,G$&8)J"
"?!HOccup Environ Med.@)*8,?-6-+-67BC2%?7)181#
81.
0<<02;2'$+(<0*))-,G"
!'HAm J Epidemiol.87*.,?
@.-+11BC2%?@1787#
811
0(;*117,G/&"!
?+HCancer Causes Control.*,?.6+1BC2%?1-66#
@))
(JJ<KC%%KCC(;0C$;"C0!C
*))1,G2!&&8)J"?"
"HInt J Occup Environ Health.8*,?--+6BC2%?161@671#
@)
$2""2C"20*)).,G0&&5
"?'HEnviron Health.7?-8BC2%?.81-677#
@)
C4K4:'N:K2%:'%KC2X;
*11@,G0?''&+5"
HBioelectromagnetics.7*@,?6-@+666BC2%?.1.@-@)#
@)-
:''K*17.,SG0"!&
"HTKardiologiia..*-,?)7+BC2%?@6--#
@)6
($2!+*))@,G4&5
"!%*",HAnthropol Anz.@*,?+@BC2%?@.8)77#
@)8
":$hh2$$*))@,G2"&"+"
HSoz Praventivmed.8*6,?)+)B%?71-7.-#
@)@
F0*))),G&"'
'HEpidemiology.*8,?8-1+86-BC2%?)1886)@#
@)7
C: "<"!2 '4<"";*))7,G2?
!"HProg Brain Res.@@?-@1+-78BC2%?718@.)#
@).
= "*))-,G&"&”J Occup Environ
Med.68*,?1@+)BC2%?88-.6#
@)1
!*)),G"2(H
Bioelectromagnetics.8?-+6-BC2%?7)-#
@)
K'C::FKF$:''^::'2*117,G2"
HAm J Epidemiol.6@*,?)-7+)68BC2%?16)8.#
@
C#C<;$*1.1,GC5"BH
Public Health.)-*-,?77+.)BC2%?76)67#
@
$2C(2;'$/*171,G$!"
H Physiol Chem Phys.*8,?-18+6)-BC2%?868)#
@-
$ 'K2 24<J;*))-,G""
&8)J"HTissue Cell-8*-,?-+-BC2%?71.-#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7@
@6
<0Nf4<$*117,G$&@)+J"H
Epidemiology..*,?8+-)BC2%?1@)1)#
@8
4<0N*117,G$''"""H
Occup Environ Med.86*1,?@8+@.BC2%?16-87-#
@@
f44!"22;";4fCF%!00#
*116,G0'&""'/
`!0(?17)+1.1HAm J Epidemiol.-1*@,?88)+87BC2%?.7@.#
@7
K<2*))1,G+!<
HMed Hypotheses.7-*8,?.)+.)@BC2%?1877-7.#
@.
<$2'2;%0*))7,G$&'
?+HIntern Med J.-7*1,?@6+@1BC2%?
786-))6#
@1
<+:N;<X4224"=">C(!F$N=*)),G&"
'5HReprod Toxicol#C2%?11)8@#
@)
<42$$<N2$*)),G+
""HEpidemiology.-*,?+-BC2%?.)88.#
@
<:/$=F4%;'$$'$%$*)),#c+!
&"""'"c
Epidemiology-*,?1+)BC2%?.)88.#
@
F0*)),SG&"'"
TUgeskr Laeger@6*,?8)+86BC2%?.)71.#
@-
:%%/"N/"2( 2(N:F*))),GS
1 THRinsho Shinkeigaku6)*7,?7-+7-8BC2%?.@16#
@6
C'$2C;F='F;0N24F2*))8,GC
'"HAm J. Ind Med.6.*,?@-+77BC2%?816)7#
@8
0=$FN2F*)),G/&"+
"HScand J Work Environ Health.*,?6+6.BC2%?.7.8#
@@
'$*111,GN""!0"
C'VHInt J Neurosci.17*+,?-1+68BC2%?)@.-#
@7
:'F*))-,G(+"&
"'!HEur J Cancer Prev*6,?-)+-)7BC2%?..--.-#
@.
'2K*11@,G%!"
"HCancer Causes Control.7*,?17+)6BC2%?.76)7-#
@1
2*))1,G2zz"+5&"H
Med Hypotheses.7-*8,?7..+7.1BC2%?16@6.6#
@-)
<24:42CF!;+K":<'F*))@,G0
'"zz"?+-HJ Occcup Environ Med.6.*,?.1+)BC2%?
7)1168@#
@-
'4%$!;C'Jv<K:3C3%C'4<J'K*))6,
SG'!&"HTMed Tr Prom Ekol.*8,?-)+-6BC2%?
8@@6-#
@-
'4%*))-,SG"'"&
5"HTRadiats Biol Radioecol.6-*8,?881+8@6BC2%?6@8.1#
@--
2%<2:F:;04N2C'F:*))7,G$+5&2
'!HAm J Epidemiol.@@*-,?7)+71BC2%?788@7@6#
@-6
C':2%F*))6,G"2!"
?!:HInt Arch Occup Environ Health77*@,?-.7+-16BC2%?8--.6#
@-8
'";4%*))-,G'&HArch
Environ Health8.*1,?8@)+8@6BC2%?8-@17-#
@-@
'";4%$4<4*11@,G0&KH
Med J Aust.@8*+,?@)+@)8BC2%?.1.86-8#
@-7
2'40F"<*116,G%"'
?!HJ Environ Pathol Toxicol Oncol.-*,?--+-7BC2%?7.-1#
@-.
2*)).,G!""!&!
!HElectromagn Biol Med.7*,?-@+6@BC2%?.8@.1-#
@-1
'BN2B:2'F*)).,G&&5"
+"H Bioelectromagnetics1*,?.+6#
@6)
''%:2'F*))6,G&<(52"(
%(%0<$%+HBioelectromagnetics8?@)+@@#
@6
2<F000:N*))-,G%:2H
Arch Environ Health8.*,?78@+7@BC2%?8.818)#
@6
2JJC0:9((;"";C0*)),G
'"+$%HAm J Epidemiol.88*,?)1@+)-BC2%?)6.-#
@6-
2F*1..,G%
"HAm J Epidemiol.7*,?8)+86BC2%?-68#
@66
''4=C40';:%C*117,G0
4;#%#0”Am J Epidemiol.68*,?+1BC2%?.1.)@#
@68
K"24<*117,G$5&"+"HEnviron Health Perspect.)8
#@?8@1+87-BC2%?16@7).6#
@6@
!"/*))@,G&'HMelanoma Res.@*,?8+.B
C2%?@8@71@@#
@67
!"/F/*))8,G(2!"&"H
Electromagnetic Biology and Medicine6B+.#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
77
@6.
!"/F/*))6,G2"'+{HMed Sci Monit.)*7,?
0$--@+-6)BC2%?8-8)1#
@61
!"/F/*)),G25*(2,!"HArch Environ
Health.87*,?-+6)BC2%?)7-8.#
@8)
2*))@,G"?;"!
2HElectromagn Biol Med.8*6,?81I@.BC2%?77.8.8#
@8
22"<<*)).,G"&?"5"
0HAm J Ind Med.8*.,?871+8.@BC2%?.86-#
@8
:</!0/F*)).,GC&!
!HEpidemiology1*6,?8-+81BC2%?.6@71@#
@8-
:$$:*))1,G&+5"
!!;HEur J Epidemiol.6BC2%?11@)-8#
@86
<0!"22:*))1,G"!
HC"#@*+-,?-+BC2%?1@.88#
@88
:K40:2<0!"2*))1,G0!?"
"+"HSurg Neurol.7*-,?)8+8BC2%?1-.8-@#
@8@
2"<<;F/V0CC4$0;*))1,G0;
?8$0#;%H
?AA"#"AA0E)E);+8E)$++0+9#
@87
2":F=2<NF:J40"02'JF2*))1,G2!'
?+HJ Clin Oncol.7*--,?88@8+887BC2%?1.@7.
@8.
<0!"25(2:*)).,G2+"+!
!HInt J Oncol.-*8,?)17+)-BC2%?.68--7#
@81
<0!"25(2:2"<<*))7,G<"+!
?'M)HOccup Environ Med@6?@@+@-#
@@)
<^/04('2*11.,G0+'”Int J
Oncol.-*@,?11+-)-BC2%?1.6@6.#
@@
%"0FF2*16.,c"cProc.
Soc. Exper. Biol. and Med., @1*,?-.+-.@#C2%?.)-@#
@@
'4%$!;C'Jv<K:3C3%C'4<J'K*))6,
SG'!&"HTMed Tr Prom Ekol.*8,?-)+-6BC2%?
8@@6-#
@@-
'4%*))-,SG"'"&
5"HTRadiats Biol Radioecol.6-*8,?881+8@6BC2%?6@8.1#
@@6
;'JXj24J'*11.,SG&"58)J
"'HT Med Pr.61*-,?@+76BC2%?17@)6-@#
@@8
;'JXj24J'JJ'=*11@,SG
"&"5"#%%#
""HTMed Pr.67*-,?6+8BC2%?.7@)8).#
@@@
X22*17@,G""?
"':HMed Res Eng.*-,?-+@BC2%?1167@1#
@@7
^"2F(":F;*))1,GC
!!!HSchweiz Arch Tierheilkd.8*),?67+67.BC2%?
17.)))7#
@@.
;C9<<*)).,G+"
"HOpen Ophthalmol J.?)+)@BC2%?187)-6#
@@1
;$2<<^<*))8,G<J
HBioelectromagnetics@1*8,?-1.+6)8BC2%?
8..78-#
@7)
NFN:X"`<*)),G0"" !!
!HChin Med J (Engl).8*,?.7-+.7@BC2%?@16#
@7
NFN:<=$F"*)),G<"!!
HChin Med J (Engl).6*,?1)+16BC2%?71-.8@#
@7
$*16.,c&!c
Arch. Phys. Med. Rehabil.1*,?7@8+7@1#C2%?.)771#
@7-
K":0%2*))@,G0'5"
HInt J Hyg Environ Health.)1*,?--+-.BC2%?@8)-11#
@76
<$%$2"22*))1,G0"!
?&H-)*-,?1.+)6BC2%?116.@)#
@78
%<$$25224*))@,G5
!"HBioelectromagnetics7*,?1+@BC2%?
@-)6@..#
@7@
2$42*))6,G""+
""HActa Neurol Scand.)*,?6@+8BC2%?8.).)@#
@77
0X<F<X>*))),SG"
!HTWei Sheng Yan Jiu1*,?)+-BC2%?78)..B
@7.
;='$C+"2=C%0K*)).,G+
!"&!42!HOccup Environ Med
@8*8,?-6+@BC2%?71.-.@#
@71
!+$4+(/22((+;2*))7,G!
"!!!HNeurotoxicology.*,?6-6+6)BC2%?@1@@@-#
@.)
<'20!"2h02:*))8,G9'
+"'VHInt Arch Occup Environ Health7.*.,?@8+@-BC2%?@)))1#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7.
@.
02%Cs2*)),G+"'VHInt Arch Occup Environ Health.
76*@,?66-+661BC2%?8@-@).#
@.
J"'*11@,G0!! &"5*5
,"HSci Total Environ..)*,?1+7BC2%?.77-@#
@.-
"$2'':K"2$!"$*))1,
G5"*$(+2=, ?
HFertil Steril.1*6,?-.+-8BC2%?..)6787#
@.6
%4$F:";K'$F*))1,G2!C$%$/&"
C"JIn VitroHPLoS ONE6*7,?@66@BC2%?1@611#
@.8
::/:"*))1,G&!&!
!!?!H%F%$#@BC2%?116).8#
@.@
::/:"*))1,G2!C(;0
$!!?<"HSyst Biol Reprod Med.88?.+.7BC2%?11-.18#
@.7
2''/F2;*)).,G%"&5
"iH;"1*8,?-68+-8BC2%?.6).1#
@..
::/*)).,G&!
!!HInt J Androl.BC2%?1)7@86#
@.1
='='<='*))7,G"!HAnn
Agric Environ Med.6*,?@1+7BC2%?7@8818#
@1)
<>N;>2F>0XF(4X"0X"=<X"X>4*))7,SG$'"
!"HTZhonqquo Yi Xue Ke Xue Yuan Xue Bao1*8,?@@+6B
C2%?.)878#
@1
/+$=(*11-,G2"""+
+5"HAm J Epidemiol.-.*),?778+7.@BC2%?.-71@@#
@1
X:2N2<*))1,G"'!!
5"HCongenit Anom (Kyoto).61*,?8+1BC2%?16-6#
@1-
"4=;:;Fh':*)),G!5
”Epidemiology*,?7+BC2%?-..-#
@16
<C2<"F%+$0*))1,G2&&5"
'!"HCancer Causes Control)*@,?168+188BC2%?16-7.#
@18
C22'22$FC'<*))7,GC&+"
'"?+"HPediatr
Blood Cancer.61*-,?.)+.@BC2%?@16@6@#
@1@
%+$0F*))-,G2&&5"
""'HEpidemiology6*6,?6-7+66BC2%?.6-7@1#
@17
%":Y":'%"<2*117,G2"&"
&+5"HAm J Ind Med.-*8,?887+8@BC2%?1-7).-#
@1.
0NX"N<N*))@,SG&&5"
"HT Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi6*.,?
6@.+67)BC2%?@17.8-#
@11
"$<NNN2:=`*))-,SG&5"
HTZhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi*8,?-6+-68BC2%?67@-18#
7))
:</!0/F*)).,GC&!
!HEpidemiology1*6,?8-+81BC2%?.6@71@#
7)
;K$2;*)).,G$5"B&"H
Eur J Epidemiol.-*8,?-@1+-77BC2%?.68@.7#
7)
="2="=C"$N0N4N;0>X0>2X2<*))-,SG"
HTZhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi*8,?-1+--BC2%?
67@-1#
7)-
<%/F/*11,G4+&"+5
""HScand J Work Environ Health7*8,?-6+-1BC2%?1671.#
7)6
<;"J;;;*)),GC+
"+!5HScand J Work Environ Health..*,?--+6BC2%?
.7.8)#
7)8
hF<"!*)).,G+"HBMCPublic Health*.,?
-)BC2%?.7.1-7#
7)@
'#hh"F2:h2!";*117,G''
"'?HInt J Epidemiol. @*@,?8)+87BC2%?
16676)8#
7)7
CCF*))@,#GiHElectrical Hypersenstivity, A Modern Illness*C
9:,@@B%;?)1868)-6.#
7).
2%C(;JJ<C42=!'$J2;K
C!<*)).,G2!"HNeuroepidemiology
-*6,?7+71BC2%?.178.6#
7)1
$F<"%$$*11,G2?
HMed Hypotheses.-@*6,?-7@+-7.BC2%?.)1.8.#
7)
C!<CJF2$0(0F*)).,GK!
"!!!
?+"HAm J Epidemiol.@.*6,?-8.+-@8BC2%?.88-@#
7
N"NF>N0N"F>*)).,G0+!"
*2<C>242>$00>C,+5"'HLeuk
Lymphoma61*,?-66+-8)BC2%?1)81.-#
7
;42*.@1,c&cBoston Medical & Surgical Journal.)
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
71
7-
44<''42"%*16,Gf5V0
&VcComptes rendus de la Sociftf de Biologie, 1?@@+@.#
76
$*16.,c&!c
Arch. Phys. Med. Rehabil.1*,?7@8+7@1#C2%?.)771#
%"0FF2*16.,c"cProc. Soc.
Exper. Biol. and Med., @1*,?-.+-.@#C2%?.)-@#
78
(*1@,c""cJ Appl Physiol7*6,?
@.1+@1BC2%?-.18).#
7@
2<"F*187,G*,HCalif Med..@*8,?--@+--1B
C2%?-6@.)6#
77
0'F'KF:4<*1.),G!"?
16)+1@)HAm Sci.-7*-,?--+-8BC2%?@)7-)#
7.
=<*171,c""cAm J Epidemiol.
2B)1*-,?7-+.6#C2%?68-@7
71
'#*1-,?G!"!:J"!H*G("H,Deutsche
Medizinische Wochen-schrift-#-8+6)#
7)
0J'C'FJJ''F*1@6,GCJ'!' c*G2
H,Medycyna Pracy8*6,?8+8-#
7
'KK4!%04J2'2*17-,G!
('HJPRS@--#@-
7
"'2*1@6,G:'
H*G0!5H,O biologitscheskom wosdejstwii
biologitscheskich polej radiotschastot#)8#
7-
:*)),G'"'"(?$"!
1@)+11@H*G"(?$1@)+11@H,Umwelt Medizin
Gesellschaft*2,6*-,?+-#
76
4X$*17,Bibliography of Reported Biological Phenomena (‘Effects’) and Clinical Manifestations attributed to
Microwave and Radio-Frequency Radiation*2$%;2))69?$
#$78)7,""!!"
-B)-"#0!??AA##A))#A78)7#
78
;'2*17-,SG0!'&9(HTGig Tr
Prof Zabol.7*),?61BC2%?671@-#
7@
;'0*17@,G+HMed Res Eng.*-,?-+7BC2%?11677#
77
202=C=FF:4F*177,G"
HUS Department of Health, Education and Welfare, Public Health Service, National Institute for
Occupational Safety and Health,*0=",%/7.+1*C;17+.-,#
7.
*1.,G(HContact Dermatitis.?8I.C2%?@6@6..#
71
0$K2FW0=*1.@,G"HClinical Ecology6?1-+)#
7-)
0=0$K2F*1.1,G"HClinical
Ecology@*6,?1+.#
7-
*,*116,COST 244 meeting on Electromagnetic Hypersensitivity#4J?0/66116?@.+76#
;"59K"*,*117,Possible health implications of subjective symptoms and electromagnetic fields.
A report prepared by a European group of experts for the European Commission, DG V.!^'"
'1#%='"<'#%;1+7)68+6-.+.#
?AA"#!#"#AA!A)77A68@AA1171#
7-
$=FCNNF %$4*11,#G"H
Journal of Bioelectricity)?6I8@#?AA##AA##
7--
0/66!*11.,C"066!%='"(+
#!11.4J#
7-6
2:$2$JJC*#,*))6,“"? C"H
%='2(C"/!))6!";*))6,G0J"
HProceedings; International Workshop on EMF Hypersensitivity; Prague, Czech Republic:
1+-7=/"J#?AA##A+A!AAC"F))@##
7-8
hF<"!*)).,GI"HBMC Public Health.?
-)BC2%?.7.1-7#
7-@
?AA##A"A"A%02A)1)1)1"#
7-7
20$JC*))7,G2H>+9C?AA&+
#"AA2)))79'#"11.#
7-.
/!K2'K*))7,SG'
HTMedicina (Kaunas).6-*,?1@+)BC2%?7-116-
7-1
'";*)),G2'?HOccup.Med.*<#,(!B8*,?@@+@1#C2%?-8.-#
76)
/!4C2204J+C0*!))-,G2?
CHElectromagn Biol Med*+-,?@+@1#
76
F<'4*11.,G$5*$(,'<?
iHArch Environ HealthB2+FB8-*-,?-@+-.#C2%?1.67#
76
=/"*))8,Electromagnetic fields and public health: Electromagnetic Hypersensitivity
=/#1@*!))8,#
76-
"4J"F2*117,G+J&
'HJ Psychosom Res.6-*,?6-+61BC2%?1@-1-)#
766
0""*))8,G/"HOccup Environ Med.@*8,?.+.-BC2%?
8.-7.6-#
768
=*11-,G0"2%0+)HLancet-6*...,?67+6.BC2%?71)87#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.)
76@
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
767
'0'FKF:4<*1.),c"9##c
Science. ).*6661,?-)+-7BC2%?@11)61#
76.
F$*171,G;"HBull N Y Acad Med.88*,?
)8.+)7.B#)@7#C2%?.)77-)#
761
'*1.6,The Microwave Debate*0!"2<?2%
"C,%;)@1-)@#-.#
78)
""2":+2:$hh2*))7,G"
!?&HEnviron Health Perspect.8*,?+6BC2%?
7-@@.#
78
;$X!F"*))8,G2&J"""?"
""HInt J Occup Environ Health.*6,?--.+-6.BC2%?@-8)6@7#
78
;'F<N40C*))-,G!?
HJAMA..1*6,?686+6@8BC2%?8--8#
78-
;";""2;2+)).*7
,)).#
786
"00/*))1,GC!"HPathophysiology.@*+-,?--+
6@BC2%?1.8.-1#
788
0/"0*)).,G"!"&HRev Environ
Health.-*,?1+7BC2%?.7@-8-1#
78@
<"0*)).,G;""&!&H
Biomed Pharmacother.@*,?)6+)1BC2%?.6)66#
787
;+%$*))7,A Rationale for a biologically-based public exposure standard for electromagnetic fields
(ELF and RF)#?AA#!#"A&#
78.
4"3%4'KK<*))8,SG;"
*""&!,HTAviakosm Ekolog Med.-1*6,?-+.BC2%?@-8-@#
781
%0%$C*))1,G%0%$Cc4"&+""
"*-))4J,cHHealth Physics17*-,?87+8.BC2%?1@@7.)1#
7@)
:<F'$$2*))8,G"?
")#-)#62("H8*6,?17+1-8BC2%?@@.16)#
7@
%0%$C*11.,G4<"&+K"2""(*
-))4J,HHealth Phys.76*6,?616+8BC2%?18867#?AA##AC!2(#
7@
0=;*1.1,?Electromagnetic Man: Health and Hazard in the Electrical Environment*<
W,@-#%;)6@).@)668#
7@-
<"!0$hF<C9$2*)).,G2"'"
#'HRadiat Prot Dosimetry.1*6,?6-1+668BC2%?.)--7@#
7@6
K"24<*117,G$5&"+"HEnviron Health Perspect.)8
#@?8@1+87-BC2%?16@7).6#
7@8
;9C"*11,Potential Carcinogenicity of Electric and
Magnetic Fields*9C="#0#,C;+$0+1+)-#
7@@
F=K'<2<*))1,G2<("&"!
;"!!HHealth Physics.16*,?87+@@BC2%?.)18#
7@7
":"??AA#'"!"#A&##
7@.
:$*))8,G0?HBioelectromagnetics.#7?78+.8B
C2%?@)-71@)#
7@1
:$X<C$<JJF*))6,G"
"HBioelectromagnetics.8*7,?8-)+8-@BC2%?8-7@6)#
77)
%=*111,SG0&"'
HTBiomed Tech (Berl).66*1,?-+-@BC2%?)8)8-)#
77
$FF4*)),G='HHealth Phys.
.-*-,?-@@+-78BC2%?1188)#
77
<"0*)).,G;""&!&H
Biomed Pharmacother.@*,?)6+)1BC2%?.6)66#
77-
=F ="2(;%*)).,G$(&H
Phys Med Biol.8-*-,?-@.+-@18BC2%?.8@7.)#
776
=`"$0F=:J=*))7,GC!&"
'"HPhys Med Biol.8*1,?87-8+876.BC2%?7..717#
778
;4$"J0*))@,G"!
!HElectromagn Biol Med.8*6,?-61+-@)BC2%?77.81#
77@
:0:=:0:=*))@,G$(&"!02
HBioelectromagnetics.7*7,?8)1+86BC2%?@7-8.7#
777
4"3%4*))8,SG""*
5"'",HTRadiats Biol Radioecol.68*6,?66+68)BC2%?@)11)#
77.
<"!hF*)),G"HJ Med Eng
Technol.@*6,?@.+7BC2%?-1@--#
771
;%N4"N4*))7,GC!'&!
HRadiats Biol Radioecol.67*@,?77+7-BC2%?.-.)---#
7.)
;'0*))1,G0?<($("'
HPathophysiology@*+-,?)8+@BC2%?1@66@)#
7.
J0:C":'($"=*)).,G$5"
*9218)2J,"&!!!HInt Arch Occup
Environ Health.*@,?788+7@7BC2%?.7.8).#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.
7.
K;;0&CJ$42F+!F22F20
*11,G!&+!++
HBioelectromagnetics*,?67+8@BC2%?)@#
7.-
KJ$''C:*111,G5+H
Biolelectrochem Bioenerg.6.*,?77+.)BC2%?).8.8#
7.6
:0!00'2:*))1,G+5"
!!+'HPhys Med Biol.86*.,?861-+88).BC2%?
17)@1@6#
7.8
=4*))-,G+!+
#.4JHPhys Med Biol.6.*,?@78+@.6BC2%?.7)87@#
7.@
!C:22*))-,G"!*$,
$HPhys Med Biol.6.*-,?-1+-1@BC2%?67)-@@#
7.7
%%"'FK<'K*))1,G&!+
"!5*4J,!"
!"HBull Exp Biol Med.67*6,?6-+6--BC2%?17)616#
7..
<$%$2"22*))1,G0"!
?&H-)*-,?1.+)6BC2%?116.@)#
7.1
0=*))8,G"%"(5"(H
Oberfanken Study#;!"#
71)
0=;*1.1,?Electromagnetic Man: Health and Hazard in the Electrical Environment*<
W,@-#%;)6@).@)668#0&)?=C"
=2";CC"2*))1,GC&<C+"?5
!5&HInt J Neurosci.1*,?+6BC2%?
1@..#
71
0=;*1.1,?Electromagnetic Man: Health and Hazard in the Electrical Environment*<
W,#68B%;)6@).@)668#
71
0*11-,G"?+HScand Audiol
Suppl.-7?+-BC2%?.)1@-#
71-
$C*11,G5"$("
#67)2JHMagn Reson Med.*,?17+8BC2%?7681#
716
F$*171,G;"HBull N Y Acad Med.88*,?
)8.+)7.B#)@7#C2%?.)77-)#
718
C<F':*11@,G$JHJ Microw Power Electromagn
Energy.-*-,?@8+77BC2%?.1-)-6#
71@
C"2:/30$C*)),G4!!?0%K#C+5"
*8,&HPercept Mot
Skills.1*-C,?@7-+@76BC2%?68-1#
717
(2"$F*17-,G"+5
""HScience..*17,?-8@+-8.BC2%?6711).#
71.
$N*1.,SG+&HTAgresologie.*,?+8BC2%?7-181#
711
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
.))
'F*11@,G&"+5"HScand J Work Environ Health.
*,?-1+66BC2%?.@.8@7#
.)
F02";4f&C0C2|4*1..,G/
@)+J""+5?&"HAm
Ind Hyg Assoc J.61*.,?6)1+61BC2%?-771#
.)
/J*)).,G<+5""!HRadiat Prot Dosimetry.
.*,?@+7BC2%?78@1#
.)-
*))@,G?%!CHEducation Forum Magazine */
3(,-*-,#
.)6
+C<C"2*)).,G;"&&'
"HElectromagn Biol Med.7*6,?-88+-@6BC2%?1)-77.6#
.)8
;+%$*))7,A Rationale for a biologically-based public exposure standard for electromagnetic fields
(ELF and RF)#?AA#!#"A&#
.)@
?AA##AAAC"$#
.)7
#*))@,G;))@HElectromagn Biol Med.8*6,?17+))BC2%?77.87.#
?AA#"#"AA;+$+/01+)@#
.).
#*))@,G0))HElectromagn Biol Med.8*6,?)+)BC2%?77.871#
?AA#"#"AA#
.)1
2"<*#,*))1,Cellphones and Brain Tumors: 15 Reasons for Concern*%2(0!,
?AA##"AA6#
.)
?AA#A' J
.
?AA##AA))7A)1A-AA6#*0 D0"
'3International Herald Tribune-!))7,#
.
?AA#!'+J#A
.-
?AA#'J#AA'J""#
.6
?AA#!#AA86-).A+<+$
.8
?AA#'"#AA))7))7=&+#
.@
?AA#J'#A$AJ;!"-)7)6#
.7
?AA#+!'#A!#
..
?AA#+ #AAAA%"A))8)-(!*#K,#
.1
?AA#'"#AA))8)@!#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.
.)
?AA##"AAA')8#
.
?AA#'"#AA))8)@)8#
.
?AA##"A))8#
.-
?AA#'"#AA))8)7)-<#
.6
?AA#+ #"A+'AAA&)@#
.8
?AA#'"#AA))8)8'#
.@
?AA#'"#AA))8)8)'#
.7
?AA#'"#AA))8-#
..
?AA#'#"AA%492"#
.1
?AA#J!"#"#AJ!"#
.-)
?AA#"#"AAK$11.#
.-
?AA##A&#i"Q6-@WQ8)W2<0/Q
.-
?AA#"+'#"AA))1+7+)!+"#
.--
=/"J?%"$0*-2),G%$00
5"!"HC$#).#
.-6
=/%$0*)),G+%J"$C?&<+(5*<(,
2"(HIARC Monographs on the Evaluation of Carcinogenic Risks to Humans.K#.)B668"B%;?
1.-.))#
.-8
'(<"<*),GC"$0HF0
<9B?AA###AA)AA.+++
+##
.-@
0*1
!),01)-=0B
?AA#!##'AA))AA1A&A1)))6#
.-7
2$*
(!),G"!H"B
?AA#"##'AAA;+"A1)8-))A+++"++!+
#
.-.
0"<$"C!0
#@).*@
2),G""
HB?AA!##AA'"AA@).#
.-1
4$*),#"##'A"A!+A.86-.)A;+!++++
'+++++#
.6)
<4*))1,###'A+A""++AA+"+!+"++
!+++11@7-#
.6
<+4J$*),#J#A!A'+!'+!+5"++++!++J+
"+#68@77
.6
("4"NF/2"<2"<$"0*)),G
"'?H Rev Environ Health.8*6,?
-)7+-7BC2%?@.66-#
.6-
&"9*),G9"=$
0?="$'0C"=H:'%
'#?AA"#A++Ai"Q-.
.66
:4*),G$?/02%0C4:3/022(
='7
(!)H?AA#!#A}!AA..--16+$C<N+/+0++C+
4+:EE.)E11+++0++$++/02
.68
N''%':'0'K*),G<"+&'
"?!HExp Oncol.--*,?@+7)BC2%?
7@)#
.6@
'2F/*)),G'"?!
"HRev Environ Health.8*6,?-8+---BC2%?
@.668#
.67
("4"NF/2"<2"<$"0*)),G
"'?HRev Environ Health.8*6,?
-)7+-7BC2%?@.66-#
.6.
"00/*))1,GC!"HPathophysiology.@*+-,?--+
6@BC2%?1.8.-1#
.61
!2$ !NC*)),G<"/"K"C<
$'(0<!<'?0+HAsian Pac J Cancer Prev.*,?
6-+67BC2%?).6-.#
.8)
<"!0$*)).,G&"HIEEE
Trans Biomed Eng.88*,?@7+@76BC2%?.7)))-#
.8
0$<"!C2*))7,G(&5"HPhys Med Biol.
8*6,?.71+...BC2%?7@6-8.#
.8
$;%N*),G(J"
?HBioelectromagnetics.-*7,?
87)+871BC2%?8))--#
.8-
<'V4"V%44"V/2'K*)),SG+5
"!""HTRadiats Biol
Radioecol.8)*@,?7+7BC2%?6-6-1.#
.86
4 /C 2" << NN ! $; < *), G& <?
!! HElectromagn Biol Med. -*,? -6+8BC2%?
111..6#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.-
.88
90*),G==<?00
C!3&H%"C"90#
##"AAA"A+++#
.8@
<42$C4K4!*),SG2!?
""HTEpidemiol Prev.-8*-+6,?..+11BC2%?1618#
.87
<42$C4K4!*),G2!#
+"+iHEnviron Health.)?81BC2%?
@7167#
.8.
K(2C"(4<04*),G$!?
+!"H Postgrad Med J..7*)-,?@6-+@8B
C2%?.@8)-#
.81
2;!K;0;((sJ22x2B(
4*)),G0?#$
(4))1HCroat Med J.8*,?7+8BC2%?)@76)#
.@)
2"<<*))1,G"'!?C!+H
Pathophysiology.@*+-,?-7+67BC2%?1-8@1#
.@
""2":+2:$2*))7,G"
!?&HEnviron Health Perspect. 8?+6BC2%?
7-@@.#
.@
<F!"('<:F*))7,G0"/
2*0/2,?HInt J Occup Environ Health.-*6,?
6)6+6@BC2%?.).8)86#
.@-
;$X!F"*))8,G2&J"""?"
""HInt J Occup Environ Health.*6,?--.+-6.BC2%?@-8)6@7#
.@6
=!!4*),G%$C+HJ Radiol Prot.-*,?77+)6BC2%?@71.#
.@8
<;;<*)),G;"&"!!
HEnviron. Rev..?-@1I-18B/%?)#-1A)+).#
.@@
KJ$''C:*111,G5+H
Bioelectrochem Bioenerg.6.*,?77+.)BC2%?).8.8#
.@7
:::;F*)),G2&"HAppl. Biochem.
Biotechnol.@*,?6@+6.BC2%?17@.-.1#
.@.
:::;F*))1,G(+""J&!HAppl. Biochem.
Biotechnol.8.*,?@+-1#C2%?1).1@61#
.@1
CJ+0 0CJ+;J$<2C<0("<J220K+42
JJ2F*))1,G&<(+>!
HHistol. Histopathol.6?88+8@BC2%?1718-86#
.7)
!44C2"<;C;$<4!F*)).,G0"
"+&42+1))!HBioelectromagnetics,1*-,?1+
-BC2%?.)667-7#
.7
<:0*),G":+!"$H
Phys Med Biol.87*1,?7)1+78BC2%?8).16-#
.7
9<'%%'':*)),G$-))8)))2J8&
"H Phys Med Biol.88*6,?87+7@BC2%?))78)#
.7-
=!!4*),G%$C+HJ Radiol Prot.-*,?77+)6BC2%?@71.#
.76
G%K$&"H*),Media Network.
*$=,B?AA!"##A'A++++++++
&+"+
.78
2*
2),GK$'H%B
?AA###'AAAA+++++++++'++
.86#
.7@
*8
F)),GK!"'HDaily Telegraph.
?AA#"##'AAAAA7.18)6AK+++!+
+"++'#
.77
2JJC0:9((;"";C0*)),G
'"+$%HAm J Epidemiol.88*,?)1@+)-BC2%?)6.-#
.7.
2JJC:90((;"";0(CC
C"$$C0*)),S<''K
$$TEpidemiol Prev.8*@,?61+88BC2%?.7.8)#
.71
*.
")),GC!C00"0%H"#"#
?AA"#"A"++!"A++A
..)
02J03;*)
!))1,
?AA#!#A17AA7@.86+02+J+0++++;
..
'0/#@-1@
F))7B##"A"AA&#
..
F07
2))6CCA9)8AA)6A-7-8@B
?AA##AA!#
..-
2K*7
2),G!5!;
"H?AA##AA++!+5+++
!+++!++"+++-)8
..6
#0*),KF+F5?AA#+ #"A(A"A&#iQ-.86B
?AA#'"#AA1$60(#
..8
C!*
))1,G"HTexts Adopted
CB?AA###AA"#i!$Q+AACAA>ZZC@++))1+
)@Z)Z/0Z>2<ZK)AAW""Q
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.6
..@
C!*
))1,G"'"HPress Release
CB?AA###AA"#i""QWQ%2+
C$WQ))1)6)%C$8---
..7
0"<$"C!0
#@).*@
2),G""
HB?AA!##AA'"AA@).#
...
2*),G"$5(
H?AA#"A#
..1
0*1
!),01)-=0B
?AA#!##'AA))AA1A&A1)))6#
.1)
$2!2F*),G+!?
HReprod Toxicol.-*-,?-86+-81BC2%?1)6-#
.1
4F<0*),G"?((iHSci Total Environ.66?)-+B
C2%?8-@)6#
.1
:NF/*),G$F?5
HPathophysiology.C2%?68.111#
.1-
"h2FF/'$*),G$""
&JK9'HPathophysiology.1*,?.+.7BC2%?-@6.6)#
.16
FFhh:F*),G$!+!"
5H Bioelectromagnetics.-*7,?8+8-6B?)#))A!#)@8BC2%?6.)-)6#
.18
!%C'F*))7,G0+*0$C,
HEur J Intern Med..*,?6+.BC2%?7--.1@6#
.1@
420C'0F*),G"&HClin Exp Reprod Med.
-1*,?+1BC2%?8@-866#
.17
%4$F:";K'$F*))1,G2!C$%$/&"
C"JIn VitroHPLoS ONE6*7,?@66@BC2%?1@611#
.1.
$2$N"4;*),G/"+"
HChem Sci.-?6)+66B/%?)#)-1A)))-#
.11
"0*),G+J"+J"!'"
&HThe Environmentalist.-*,?66+8@B/%?)#))7A)@@1+)+1-1)+1#
1))
K!"<0!;FFF!$F<2K(=
=KX$2FC*),G+"0?<+
$HEndocr Rev.C2%?6177.#
1)
;'0(;4*118,G(5+!""
+"C0+HBioelectromagnetics.@*@,?-.7+-18BC2%?.7.1)7)#
1)
;'0(;FC;4*118,G"
HFASEB J.1*7,?867+88BC2%?77-76@6#
1)-
;'0(:<F=*1.1,G2+!"H
Bioelectromagnetics.)*,?8+.BC2%?86)788#
1)6
2*)),Dirty Electricity: Electrification and the Diseases of Civilization.9#B)"B%;?
17.+68)-.-#
1)8
2*)),G)
+G
JHMed Hypotheses.76*,?--7+-68BC2%?176..7#
1)@
2/2*)),G"
''HMed Hypotheses.8@*-,?1)+18BC2%?-81-61#
1)7
!"[F/*),G%"0HPathophysiology..*6,?
--+-8BC2%?@.-8@#
1).
N'' % ' :' 0' K *),G <"+ &
"? ! H Exp Oncol. --*,? @+7)B C2%?
7@)#
1)1
0<22(402020=0K!00=*),
G2!!;J24
;JHSci Total Environ.C2%?76@.)#
1)
:K4<F;'J0!"22*)),G"
$'2!C;HInt J Occup Environ Health.@*-,?@-I@7BC2%?)@@6.#
1
<;;<*)),G;"&"!!
HEnviron. Rev..?-@1I-18B/%?)#-1A)+).#
1
K(;!0((;C0!404 '2"F24!($C2
*)),G2!+"4
"! H Clin Neurophysiol.*,?@-+7BC2%?)))8@7#
1-
K(!2;CJ4C"4;";!0$C2*),G2!
+""
HInt J Psychophysiol.C2%?-@816#
16
K(;C"%$C2;!0*),G2!+
J_"+HClin Neurophysiol.
-*,?+.BC2%?.7-#
18
JN($J2J/$;4/%42"$2*),
G%"!iHAntioxid Redox Signal.C2%?
.16@.-
1@
2J!!4 +:+$C+!;!*))1,G
"2!C9HOman Med J.6*6,?76+7.BC2%?@-.)#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.8
17
<0!"22:'2*),G0+!
'"'"H Pathophysiology..*6,?-8+---BC2%?
7@687#
1.
<4'$4*),G!!!
9##HJ Neurooncol.)*-,?8)8+8)7BC2%?)8.186#
11
h5(0!"22:<*),G0!'
?HEnviron Health.)?)@BC2%?..#
1)
%42NC";"4*),G%"
""5=+(HJ Pediatr Urol.C2%?
6@8.8#
1
r02J04(*),G9
"=+("HFertil Steril.17*,?-1+68B
C2%?@67#
1
fF(0"20*),G<=+(
"HFertil Steril.C2%?-)@7)1#
1-
(;C*),G=+("HFertil
Steril.C2%?-6.1)#
16
C""0002":2$!C400*),
G+"-))+""'HJ Integr
Neurosci.)*,?.1+)BC2%?76-.#
18
r02FJK22JKJ0*)),G<&
"J!+?H
American Society for Reproductive Medicine@@
2"?/+61#
1@
;0KC%;"X;4*),G&"
ccHArch Environ Occup Health.@7*,?-+-@BC2%?-81--#
17
"h2FF/'$*),G$""
&JK9'HPathophysiology.1*,?.+.7BC2%?-@6.6)#
1.
=$*),G$!+!HBMJ.
-6?-6.BC2%?@-@7#
11
2*),G"$5(
H?AA#"A#
1-)
*),#!""#"AA)$(#
1-
F%*),G2?CH$$
##"A&#iQWQWQ7-W%Q1
1-
2:*),G000"$G%
$(52HH?AA"#A++AAA2+
000+-+)#
1--
/0*),G24?"((H
##"A!A+"#
1-6
"*),G$(52$2H
?AA"#A++A
1-8
0J*),C!?2#+
'#AA)))-++J+#
1-@
C $;F*),G;"!&1#14JH
Cell Biochem Biophys.@-*,?17+)BC2%?6@.@#
1-7
C $;F*),GJ"!&+@#84J
HElectromagn Biol Med.-*-,?--+6BC2%?.176)6#
1-.
;FC $*))7,G;'"HIndian J Exp Biol.68*,?77+
.8BC2%?761--#
1-1
C $;F*))@,GC'0"!ʬJH
Electromagn Biol Med.8*,?@+7)BC2%?@818--8#
16)
;%04Ff4!C<!CK<$*)),
G/&"'!?+
4(HInt J Cancer.C2%?)77@#
16
$02("2C<("<F;4J2*)),G='+&
&+5"?+!
HJ Gerontol A Biol Sci Med Sci.@8*,?)+7BC2%?)@-.#
16
""2$hh20*))1,G$
"?"HAm J Epidemiol.@1*,?@7+
78BC2%?.11)77#
16-
4~2C*)).,G/&&5"
J?+HInt J Epidemiol.-7*,?-1+-6)BC2%?.688#
166
F0 'FG*),G%""'HInt
J Cancer.C2%?6-7..#
168
=">=">`4F=*),G/&"
'+2+”Zhonghua Liu Xing Bing Xue Za Zhi.-*.,?.+
.@BC2%?)1-67@#
16@
<2<>N0N:C="*),G&5"&
HChin Med J (Engl).6*),?--@+--@@BC2%?)..8-@#
167
(J'+; CF2*),G&8)J"
HToxicol Ind Health.C2%?-17.-8#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.@
16.
0N4X$J'FX0XX4"0N*),GJ&
!&5"&HPLoS One.7*8,?
-1@BC2%?87)@.8#
161
;'F"FsJCoJ4*)),c5
cRadiat Prot Dosimetry.6*+6,?-86+-87BC2%?)16)#
18)
:<;=;20F*)),c2"!
""+""cBiomed Instrum Technol.-8*,?)6+)1BC2%?-.--)7#
18
;!"2 *))1,#G%0<"?"+"<HWohnung+Gesundeit (“Home and
Health”), Baubiologie Maes (Building Biology Standard)*--,#
18
'F"20'2:;':*)),G2&
"+";!WC!2""HITIS Foundat.C ;4A).#))6-@A6-6#)))A+-W
;(A8-8)B?AA##J#AAAC+$A$A%%+;+(+$+))#
18-
("4"NF/2"<2"<$"0*)),c
"'?cRev Environ Health.8*6,?
-)7+-BC2%?@.66-#
186
2 "22$2*),G9K0(<&
(!!:KHPhotochem Photobiol.?)#A #78+)17#)#)1#&B
C2%?76681#
188
2("F*),G'&"
HPhotodermatol Photoimmunol Photomed. 7*-,?-+-7BC2%?8-8@@#
18@
("F2*))1,G"&
"HBr J Dermatol.@)*-,?@81+@@6BC2%?1.-78#
187
0("K(h<J+/F((w;$sJ+KsJ5J(F;0
('*),G!''H
PLoS Biol.1*1,?))6BC2%?1)1-1#
18.
;F<$F*)),G2H Cell Mol Life Sci.@7*,?11+BC2%?
1.@871.#
181
X(FC=:!4FF;404"+:$JJF(-
0J0($422F<'=*))7,G+""
'"HCurr Biol.7*6,?+.BC2%?.).6)8#
1@)
:F'F*)),G?+
+HJ. Physiol. 8-8?@I@7BC2%?8)778#
1@
0<$;C/C4hJ0 0*),G+"
"?!+"'iHPLoS One.@*,?@61B
C2%?1.)@.#
1@
0 0XJF20J0 'F*))),G+"
"+HBehav Brain Res. 8?78I.-BC2%?)11@6)#
1@-
0$"0$"2$*),G"HCrit Care.8*,?.BC2%?
6878)#
1@6
0$*)),GCHJ Photochem Photobiol B. 1.?)7I7BC2%?
)).)67#
1@8
0 022:!'::$/C/"=J+F*))8,G"
"""HJ. Clin. Endocrinol. Metab.
1)?-I-@BC2%?88.886@#
1@@
2(2*)).,G;+!+
"+!"HJ Am Acad Dermatol.8.*8
,?61+86BC2%?.6).)#
1@7
CF(C2;<<FF*))6,G%&
HBr J Dermatol.8*6,?.7-+.7@BC2%?86161#
1@.
$C*),G9+!"!"'&
+J"HVirol J..?.1BC2%?8-8@-#
1@1
;<*11,G!"HPhys Med Biol. -@*-,?11I-.BC2%?
@6867-#
17)
;'2(%"*161,G+
'&"I"HAm J Public Health Nations Health. -1*),?-I
--)BC2%?.67#
17
0"NN"=::*)).,G9K+""&5
!HJ Food Sci.7-*8,?06))+6)6BC2%?.87@1.8#
17
F<2<"$(!40$"K*),G"
?HPLoS One.@*,?6@)@BC2%?1.)8-#
17-
/2=<0&0K':FC$"K;2'!40
*),G9K&(HNeurology.7@*8,?68+
6-BC2%?.8.1#
176
4$"KC<*)),G""!"
HJ Neurol.C2%?)6.)7#
178
<44!40$"K*)),G4
!HEur J Neurol.7*1,?)+6BC2%?)-6811#
17@
FC!<<<*)),G<&"!
'"?"HBMJ.-6)?@6)BC2%?)-)-@#
177
C00;2(:F*)),GC!+
"+'"HSkin Pharmacol
Physiol.-*,?8+7BC2%?))1)6)6#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.7
17.
2:4'2<F<F*),G&
087;<A@!!!@7)"#HPLoS One.7*,?-)@88BC2%?
1))#
171
"NN:0F!2$*),G;"+H
Dose Response.1*6,?@)+@.BC2%?6@7@-#
1.)
2:$!F!:;"!F;'2=!0$CF
*),G2""+
"HProc Natl Acad Sci U S A.)1*-,?6776+6771BC2%?6--#
1.
:%*)),G2&%$+H
IUBMB Life.@*.,?@)7+@)BC2%?)@.)6#
1.
:</!0/F*)),G0!!"HJ
Epidemiol Community Health.C2%?-..17#
1.-
:</!0/F*)).,GC&!
!HEpidemiology.1*6,?8-+81BC2%?.6@71@#
1.6
<:0/$*),G2&"""'
"HArch Pediatr Adolesc Med.@8*),?168+18)BC2%?.)@7#
1.8
<+:(!F$/$`!0CF*),GCIn-utero&2"(
$'0/!HScientific Reports.?86)B?)#)-.A))86)#
1.@
444>+;*),G(5&.))+1))2J+
!HSci Rep.C2%?6.).6#
1.7
:</F*),GC"H
Scand J Work Environ Health.-7*6,?-6+-6.BC2%?6)-1.#
1..
:</!0/F*)),G0!!"HJ
Epidemiol Community Health.C2%?-..17#
1.1
K 22J(F4&2FJF(2F*)),GC&
6HEpidemiology.*,?81+@#
11)
:</!0/F*)).,GC&!
!HEpidemiology.1*6,?8-+81BC2%?.6@71@#
11
$2'$0=";02(;+0*),G
02C%+"$"i+;$"
HJ Autism Dev Disord.C2%?@.81)#
11
2F04<*))7,G=$"?0/!
2HJ Australasian Coll Nutrit Environ Med.@?*,-+7#
11-
%2*))@,G/?!'!"H
Med Hypotheses.@7*,?-7.+-.BC2%?@8-)--6#
116
K'J+C%<<(20$*),G$&
0$4HEnviron Health Perspect.1*@,?.7-+.77BC2%?8@-18#
118
2;'2"2Y(*),G"!
HBMC Neurosci.?7BC2%?7.1.#
11@
(:''XF(J"C;*),G%""$0"02
='"2C0HFront Psychiatry.?68BC2%?.676#
117
0$C("(=*)),GK!+!HBrain Res.-8-?
@.+78BC2%?)@.11#
11.
"$'22%4"!('4$*)).,G"""
+!+H
Neuropsychologia.6@*,?@+@.BC2%?7.)6)-#
111
;(2CC*)),GC'"?"
!2HNeuropsychologia.*,?-.+-1)BC2%?)@-77..#
)))
2KF"22J:":C/=$(<FC*),G
'"HEur J Pain.?)#))A #8-+
61#)#)))8#&BC2%?--7817#
))
N"<NNF>:=F"<J"/F=K2""4F0*),G2"
!&HNeuroimage.8@*6,?61+87B
C2%?68161#
))
420C'0F*),G"&HClin Exp Reprod
Med.-1*,?+1BC2%?8@-866#
))-
::::;F*)),G$5"=&0
C$C2=$HAppl Biochem Biotechnol.C2%?6)8@1#
))6
::::;F*)),G2!"=HIndian J Exp Biol.
6.*),?1.7+11BC2%?11)6#
))8
<:N;<X4224"=">(!F$N=*)),G&"
'5HReprod Toxicol.1*,?.@+1BC2%?11)8@#
))@
;K2;/4<; •"<2:*),GC"/C
$5(&!(C;HJ Occup Environ Med.C2%?-86.#
))7
/J!!0'0'2/:"2*),G&"
*#.A)#14J,""HRes Vet Sci.C2%?-)881#
)).
2J2$2!"4"X4(*),G+
&"!!+H
Acta Neurol Belg.C2%?6@@7-#
))1
C:2$2 K'$*),G"!?"iHJ
Otolaryngol Head Neck Surg.66*6,?8.+8.8BC2%?61--1#
))
<F0="X*)),G!$("+2$%
HHealth Phys.1.*6,?@)-+@-BC2%?))-@.#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
..
)
C:F$;'F2 *)),G"!"+!H#J
Otolaryngol Head Neck Surg.-1*,?8+BC2%?)--.#
)
NJ'2$$$*))1,G4JHPhys Med Biol.
86*-,?6)-7+6)61BC2%?18)7)#
)-
<F0="X*))7,G"!?H
Health Phys.1*@,?@+@.BC2%?7618@@6#
)6
2J2NJ:!::KJ $; ;4222;*)).,
G2"""""!H
Pak J Biol Sci.*.,?6+6@BC2%?..1886#
)8
/N<2/:N%''"0N2'*11,G0
!!"&
"+""!'&!!'
"HAcupunct Electrother Res. @*-+6,?6-+77BC2%?@.8@-#
)@
2(&C;:!F*),G'
!"HBioelectrochemistry.C2%?71-@)#
)7
F";FXXX"F"F0N*),G$2&1))2J
$5(?C"HPLoS One.7*,?-)6)BC2%?-.1@71#
).
F";FXXX"F"F0N*),G$2&1))2J
$5(?C"HPLoS One.7*,?-)6)BC2%?-.1@71#
)1
2J2F2+J2$2;"X#*),G
"&'
&HIranian J Radiat Res. 1?1I6#
))
X/2$$;;2CFK &2$*),
G%!&1))2J5?
GInt J Radiat Biol. .7*1,?11-+111BC2%?8877)6#
)
X/2$$;#*),G0J$5+
$!?HInt J Radiat Biol. .7?I.#
)
2$;CFK &2$*))1,G%$
;<&$5$HRadiat Res. 7*@,?7-8I76BC2%18.)6.)#
)-
";;(0"$4%$*),G
&<+(5"(4!!
C"HInt J Microbiol.)?8.71-BC2%?877-.6#
)6
'((!+$!*),G"&!!
iHClin Biochem.68*+,?87+@BC2%?-.)#
)8
€'2[•*)),GC1))2J
?"HInt J Radiat Biol..@*,?
)@+@BC2%?).)771#
)@
2J!!4 +:+$C+!;!*))1,G
"2!C9HOman Med J.6*6,?76+7.BC2%?@-.)#
)7
$ 'K2 24<J;*))-,G""
&8)J"HTissue Cell.-8*-,?-+-BC2%?71.-#
).
;:"*),G2
"+5+"+++H*4,Umwelt-Medizin–Gesellschaft. 6
*,?66I87#
)1
:0F($*1.8,G0
HSteroids.68*@,?88+8@)BC2%?-).-)#
)-)
2J2KJ+N"22J$ +(*),G/&
"!"H J Nat Sci Biol Med.
-*,?@)+@6BC2%?@1))8-#
)-
; 2<NJ$Kf"*),G1))2J5
+"HExp Gerontol. C2%?8)78@7#
)-
!J+42J2;;+4'2;+4'$
*),G2!!J?&"
HPathophysiology.1*,?6-+-7BC2%?-8-@1#
)--
4"N44"/%<"'22'K";2K<5C
92/K'K*)),G0"
?$"HBioelectromagnetics.-*.,?8.1+@)BC2%?).87686#
)-6
K KC"0%*)),G$"J!
"HConf Proc IEEE Eng Med Biol Soc.))?.-8+.-.BC2%?)1@--#
)-8
0N4X$J'FX0XX4"0N*),GJ&
!&5"&HPLoS One.7*8,?
-1@BC2%?87)@.8#
)-@
JN($J2J/$;4/%42"$2
*),G%"!iHAntioxid Redox Signal.
C2%?.16@.-#
)-7
<N";"N>*),G$/&"(C;
20%!1)) 2J2!C$HOxid Med Cell Longev. )?76).)BC2%?
77.711#
)-.
4%'X*)),G<(+2(!B&"
CHActa Biol Hung.@*,?8.+@7BC2%?)817)#
)-1
40 'C*)),G&5"
&HJ Physiol Pharmacol.@*-,?---+--.BC2%?)@).@6#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
.1
)6)
22:!2/!J4<;JJJF*),GV!&
!*,&WHNeuro Endocrinol Lett.-*,?7+6BC2%?
6)7@7#
)6
22'(*))1,G="A"*2A0(,'?
&*%/W,&
2A0(HNeuro Endocrinol Lett.-)*@,?@77+@1-BC2%?))-.1#
)6
+<N*),G$!""!+
&HNeurochem Res.-7*,?-16+6))BC2%?1.6)#
)6-
+''2>224=:!*),G;"+"&
*,HCerebellum.)*,?6-+6.BC2%?)1@787@#
)66
22'(*)),G0"?=V*!,
!*,!&HBMC Med..?-8BC2%?
)88)@1-#
)68
;X$C502(24C220$*),
G&8)J"+;4-HJ Cell
Physiol.C2%?-)1#
)6@
N">4<N>N00X"4;NXC*),GʬJ"
C+HBrain Res Bull.C2%?8-)6)#
)67
K'="4FK'C(F"(&<"F="0*),G
5"&!"!HJAMA.-)8*.,.).+.-BC2%?-6-8.)#
)6.
(%%00!!2*),G+"
&"'!HSynapse. @8*7,?@7+@-BC2%?6.6..#
)61
%;'"X;"0'''X2!J0'"2:$NJN4K
44:*),G0&"&5"
iHEur Rev Med Pharmacol Sci.@*@,?7@-+7@1BC2%?1-).#
)8)
:";NJ%'"2X*),G&5"
HEur J Paediatr Dent.*6,?8-+88BC2%?.88#
)8
(*),GJ!HJ Craniofac Surg.*,?7)@+
7)BC2%?68@6)#
)8
9'$'"2X"''X"*),G&+5"
J"HBiol Trace Elem Res.6-*,?-81+-@7BC2%?).7)1#
)8-
X"0X">>X$*),G<+%"(C
02;220HPhys Ther.C2%?877)@-#
)86
;%N2'w<2"</C;$*))1,G292A42!
"+"!8-;CA"+>HBioelectromagnetics.
-)*,?1+6BC2%?..-166#
)88
;%2'2"<*))1,G22!C%!8-;C((
0"0?C!2<'0$'HEnviron Health
Perspect.C2%?))@67.#
)8@
N"NF>N0N"F>*)).,G0+!"
*2<C>242>$00>C,+5"'HLeuk
Lymphoma61*,?-66+-8)BC2%?1)81.-#
)87
(J2$<h=*),G8)J"&'_+
"HInt J Radiat Biol.C2%?8@-.8.#
)8.
hhFFF*))7,G/!&!
&.72J$(HInt J Radiat Biol..-*@,?-@7+-76BC2%?76.7@7@#
)81
<'$;" N*)),G%""5
&"*2(,*K,HGenet Mol Biol.
--*,?86+8.BC2%?@-7@)#
)@)
N:===":NCNNNF<*)).,G"!5
+"&"HMol Vis.6?1@6+
1@1BC2%?.8)186@#
)@
0J'$X"+0*),G$'"%*17)+))@,H
Epidemiology.*,?-)+-BC2%?8)-@#
)@
2!%*)),G'!
J"iHOpt Lett.-8*1,?-.)+-.BC2%?).1)-@#
)@-
24$K2<"<0:J'C2'<0$*))1,G
?VVHMult Scler.8*,?-+-BC2%?1.--@.7#
)@6
2*))@,G"?!"!
HElectromagn Biol Med.8*6,?81+@.BC2%?77.8.8#
)@8
<!FX!"$CC4";CJ4';2$
42*)).,G$!?"
!"""HJ Neurosci..*8,?6.1+6)BC2%?1)18)#
)@@
2!22"!2(F2*),G"(
C"2$!$"!0&
2=2HJ Mol Neurosci.C2%?8..17@#
)@7
'!N4C"K4'%C'C4!K:"%';'K
/2*)),GJ
!!HJ Zhejiang Univ Sci B.*),?.)+.)8BC2%?).71..#
)@.
2<$%$KK$4*),G"
"HIn Vivo.@*,?11+-)6BC2%?-8@7-#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1)
)@1
0242$;N<`;050$$$*),G
"!"+5"HJ Craniofac Surg.-*,?8.@+81-B
C2%?66@6#
)7)
(<20(4<*)),G0*%0$,7#)J1#
"&+)@KHElectromagn
Biol Med.1*-,?@-+7BC2%?)7)7@6#
)7
<<20(CJJ24$0%;<4V4<
(CK4*)).,G%"H
Electromagn Biol Med.7*,?7+--BC2%?.8@.1-)#
)7
4=224JJ$ ;"0*),G"/
JV2$‚+20!;(C0"
;HPLoS One.7*6,?-878BC2%?88.@#
)7-
CJ(CX>2'F%FFF*)).,G""'
"+HRejuvenation Res.*@,?)61+)87BC2%?11.@)#
)76
CJ(CX>2'FF*)).,G"
!'HExp Gerontol.6-*6,?-)7+-@BC2%?.-87)6#
)78; =(X"2"X>>=0*),G8)J"(
000""HJ Radiat Biol.C2%?8@.81#
)7@XC''F$*),G<"+;+"+"$"
"HAltern Ther Health Med.7*@,?+.BC2%?-67@#
)77
C''F:X*))1,G;2$""
?J!+!HJ Altern Complement Med.8*8,?8)7+8BC2%?
16.@#
)7.
(&F/"/"+<F=<$;'0(C"F:=4*),G2"
&""+!)HBiomed Sci Instrum.
67?8+7BC2%?8881@#
)71
(<2V4<*),G&""
""5HJ Altern
Complement Med..*-,?8.+@BC2%?-.8)71#
).)
200!!0F#<(%%04JJ+2*),G"
?"Int J Neurosci.C2%?71-7.6#
).
20:"J0*)),GC 2%?8)J"
*!&,HBioelectromagnetics.-*,?@+-@BC2%?71-6)-#
).
"h2FF/'$*),G$""
&JK9'HPathophysiology.1*,?.+.7BC2%?-@6.6)#
).-
<0$'CKF0:'<*),G!!'
HInt J Environ Res Public Health..*7,?77)+717B
C2%?.688.#
).6
(2%<2''20*),G$"?/
DrosophilaHProc Natl Acad Sci USA. ).*-,?-8)B?)#)7-A#)7@.).#
).8
<*11@,GHChem Senses *@,? 77-I71BC2%?
.1.8@)8#
).@
20*117,G&+ƒ""iHEnviron Health Perspect.
)8*,?668I68-BC2%?1@717.#
).7
F<C"F2:!*))1,G:"/&0!
2"A0("HJ Behav Neurosci Res.7*,?+7BC2%?8-66@#
)..
'!"(!":$2!<"2(!"=*))7,G+
++""+!J"JHEnviron.
Health. @?@BC2%?71-8#
).1
0+;0;JJ<22<<;!<02
*))@,G'"0(?(+.87%(„.76
H Clin Exp Rheumatol.6*,?71I.BC2%?@7@88#
)1)
$;Y"$C$C4'::N;2*))-,,G2'"!
"&"?0NC4"HInt. J. Hyg. Environ. Health.
)@?61I7BC2%?.786#
)1
4F<0*),G"?((iHSci Total Environ.66?)-+B
C2%?8-@)6#
)1
<0$'CKF0:'<*),G$!;'
20/%HInt J Environ Res Public Health..*7,?77)+717B
C2%?.688.#
)1-
4F*)),G+?""
HSci Total Environ.6).*6,?@)67+@)@BC2%?)1)..#
)16
22"FC;:$0$4<*)),GC"
!#64J#0HEur. J. Oncol
Libr.8#7-+-))#
)18
4>2'/'NF2:('2*),G+
O&+5"#++?!+!
JHHypertens Res.-6*-,?-7+-77BC2%?6.781#
)1@
!"0:'*),G0++?
)).HInt J Hypertens.)?-@)68BC2%?@1.@7#
)17
200!!0F#<(%%04JJ+2*),G"
?"Int J Neurosci.C2%?71-7.6#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1
)1.
"0'4=/!4(2J=FC4*)),G&42
2!C;"0+%"!HBiomed Environ Sci.
-*-,?11+)7BC2%?)7).611#
)11
C^/2^$*),G%(2
"HActa Physiol Hung.1.*,?87+@6BC2%?@@776#
))
C^/2^$*))1,G(2+K"
"$(HPathophysiology@*+-,?)+)6BC2%?1@.861#
)
"!"2*),G2!!
""+HBMC Public Health.*,?@@BC2%?.67#
)
…x%C†x%2 x2;… %*),G+;'&
$5A2$HArh Hig Rada Toksikol.@-*),?@7+7-BC2%?86..86#
)-
0*),G?3"HSci Am.-)@*,?6.+8-BC2%?
71.-6#
)6
!0J20$"F"0;2CC02<"2
F:*),G0+!'""
"HNature./%?)#)-.A)6@BC2%?618-)-#
)8
0!!(0(>0<F2*))1,G
"HInt J Radiat Biol..8*7,?@+@-BC2%?1887@)#
)@
0!!(00<F=!!0<FX!FC2*)).,G2"'
?HNeurosci Res.@)*,?18+)8BC2%?.)-@@1-#
)7
0!!(00<2*))7,G4'!+"+
5"HNeurosci Lett.67*,?+@BC2%?7-8)@.#
).
0!!(00<F2*))7,G"H
Neuroscience.66*,?-8@+-@7BC2%?7)@11.#
)1
20!!(00<F*))1,G"
!HNeurosci Lett.68*,?1+-BC2%?1-.-68#
)
0!!(%%00F#<2*)),G
+""!HMed Eng Phys.-*.,?.1.+1)7BC2%?
)@-61#
20!!(%%00F#<4JJ+*)),G2$"
+"!?2$HMagn Reson Med.
@6*,?-61+-87BC2%?)@@877.#
;FC"2*))1,G%5"*`4,
"&&'"HJ Neuropsychiatry Clin Neurosci. *-,?71+.-B
C2%?177@-)7#
-
$=4C"2=!<40'02*)),G!!*C0,
?%"'&
"HInt J Neurosci. ?17I6BC2%?-86)7#
6
;F:C"2*))-,G%'+
)+#7+J!"HPercept Mot Skills.17*-C,?18+
18BC2%?67-.-@#
8
;FC"2*))1,G!!"
"&HJ Neuropsychiatry Clin Neurosci.*-,?71+.-B
C2%?177@-)7#
@
CF$2F0'2*))@,G""&5"
3HSurv Geophysics.7*8,?887+818B/%?)#))7A)7+))@+
1))+7#
7
4'3%%<!KK/'KC<2%3*118,S""!
!TBiofizika.6)*6,?71-I711BC2%?76181)6#
.
42JJ<0C(*11.,G""!"
!iHJ Hum Hypertens.*,?761I786BC2%?1.66168#
1
=$;04=!"<*)),G4"
7)"HBiomed Pharmocother.88*,?87I@BC2%?776.@1#
)
;F;$FN24*111,G4"!&
!HNeurosci Lett.@@?)1IBC2%?)6@87)#
;'22*))@,G!"!i
!""HBioelectromagnetics.7*,?8+88BC2%?@-)6@1@#
/30$CC"2*117,G4!!?<>>>%%#"!
"!""ƒ!
HPercept Motor Skills..6*,?-18I6)BC2%?1)@.@#
-
;:C:N0‡4!"'K;'$2CK2/+4:'
/':=!N0!2*)),G!"HBiomed Pharmacother.8@*
,?7-I.-BC2%?@8-.)#
6
XJKC'*)),G2"""&"
J?!"HInt J Environ Res Public Health.7*-,?1-.+1@8BC2%?
)@7)#
8
;F;$FN24*)).,G4"!&HNeurosci
Lett.6-.*,?7@+71BC2%?.67-1#
@
%K:'vK:*)).,S"""
T Adv Gerontol.*-,?-.+-.8BC2%?16-7)#
7
=="22<<22F*11.,G0"
8)J"&HJ Pineal Res.8*,?@I7BC2%?1.88)--#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1
.
CF$2F0'2*))@,G""&5"
3HSurv Geophysics.7*8,?887+818B/%?)#))7A)7+))@+
1))+7#
1
0K"K*)),G4J0
;?$!$K"!HNat Hazards.-*+
-,?+-8B/%?)#)-A?)).7--76#
-)
=<`'F*),G02"HScience.)??
)#@A#@8@7#
-
0F*),G""!iH
Proc R Soc B.71?).I)1)B?)#)1.A!#)#)-6#
-
N"0(F<";0C"0:="F*),G!
?!HPLoS One#@*,?6@BC2%?1716)#
--
0K"K*)),G4J0
;?$!$K"!HNat Hazards.-*+
-,?+-8B/%?)#)-A?)).7--76#
-6
04!"(;'K;'$==!N/':"F(
;;''*)),G+!H J Atmos Sol-
Terr Phys.@6?7)7I7)B/%?)#)@A-@6+@.@y*),)))-+1#
-8
/':04!"(*117,G0"!
HClin Cardiol. )?@-I@-.BC2%?1)).)#
-@
C"2':<0(;F22";C:=C4"*)),
G0!!! &'!
"HNeurosci Lett.6.@*-,?-+-6BC2%?)..7776#
-7
$*)).,G"!'"HExplore (NY). 6*,?8+-8BC2%?
.167..#
-.
$F<' J2:J'<24*)).,G0
!?V
HExplore (NY).6*6,?-8+6-BC2%?.@)@@#
-1
K'!4F'C"$" $4";*)).,
G%""?(!""HInt J Yoga.*,?@@+7BC2%?
.1.7#
6)
<*))8,Gc'c?"HJ Altern Complement Med.
*8,?1-+1-)BC2%?@1@1.#
6
;F:C"2*))8,G%"""
&"&!'&"HInt J Neurosci.
8*7,?)8-+)71BC2%?@)888)#
6
J$<'/F '0$FC2$<<FF2(F2$*),
H2"!"?"""
"HBMC Genomics.-?8BC2%?1@..)#
6-
F+C<;'0<$2C"2*)),G4
!!&+"'"HInt J
Radiat Biol..@*,?71+..BC2%?)6.@16#
66
0425$;C$44$2(K"*)),G$
&""&
"HNeurosci Lett.67-*,?8+88BC2%?)8@88#
68
('(:C*)),G"!!&
5"&HMutat Res.@.-*+,?76+.-BC2%?1.1@187#
6@
44'/J"*)),G5"
"!!!HGen Physiol Biophys.1*,?81+@@BC2%?)-7..#
67
:::;F:*)),G2"#684J&!HInt J Radiat
Biol..@*6,?6+6-BC2%?)-8--6-#
6.
>X"`X"0"<JJ'>X*)),G.))2J42!
!HBioelectromagnetics Society Annual MeetingB6+.F))B#!
0?1+-#
61
(J
K!C0";00;((!!*))1,G"
!"5"*42#.4J,!$+.AK
'0HMutat Res.@.*+,?-8+6BC2%?1.@)#
8)
>XXX"<NXX"=="N="><20N002X"4X"2*))1,
G&.))2J5&"
HBrain Res.-?.1+1@BC2%?1.71.@#
8
4C2<N2/;<*),G2"!?
+<JHPhys Med Biol.87*6,?6677+66.7BC2%?
766#
8
'4*),G!?"HJ Neurophysiol.).*,?
+6BC2%?68768#
8-
C:2$2 K'$*),G"!?"iH
Otolaryngol Head Neck Surg.66*6,?8.+8.8BC2%?61--1#
86
$!02K4F0FC00X*),G2$%"
!HCurr Biol.*1,?@-8+@6)BC2%?1687@#
88
C:F$;'F2 *)),G"!"+!HJ
Otolaryngol Head Neck Surg.-1*,?8+BC2%?)--.#
8@
+*))7,G2!"HSaudi Med J..*.,?.-+.@BC2%?
7@7@)#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1-
87
4" / *)), G 2( &? C " H EMF RRT. %
2"<#?AA##"AA)))""#
8.
232( ='"4*),G4 2
" 2(+ ! *2( ,H Consensus Paper *7
",##J'#AA)@.A17@1.A2(+4#
81
'((!+$!*),G"&!!
iHClin Biochem.68*+,?87+@BC2%?-.)#
@)
;$;:*))-,GC-))*<,+?
HClin Electroencephalogr. -6?6I-1BC2%?6876#
@
;$0<0FF;:2;K
K'29;==$</+;24F;:*)),G!
*/K,HNeuropsychiatr Dis Treat.
8B@?@.+@1)BC2%?7@.8#
@
;$0FF2J+C2KK'2402"F;
2';;=;:*))@,GC-))!!
*/K,""HAdv Ther. -?8.I@))BC2%?7)8)8)#
@-
""2$hh20*))1,G$
"?"HAm J Epidemiol.@1*,?@7+
78BC2%?.11)77#
@6
(*),GJ!HJ Craniofac Surg.*,?7)@+
7)BC2%?68@6)#
@8
';";2<NJ2/J$*))1,G"!
51)).))2J!!"HJ Craniofac Surg.)*8,?88@+
8@)BC2%?1.@18#
@@
;$0F0<K:22; 0! F;;=;:
*))1,G"+!!HBMC
Endocr Disord.1?BC2%?1.887#
@7
4*))),G2!20HArch Environ Health.88?.6+.8BC2%?))86-8#
@.
4=F0*)),G!*"!,!
?CHAnn NY Acad Sci#1--?-1+-BC2%?))))-#
@1
4=F0*111,G!!!&&#
CH7th International symposium on neurobehavioral methods and effects in occupational and
environmental health#'F)+-111#
7)
4= *11,G"'H?G20
H#Biologic Markers in Immunotoxicology,C="#0#B7+-.#
7
0=F*),G!&+
!HAltern Med Rev.@*-,?8+8BC2%?18)-#
7
/F<*),G0?=2""iH J Altern Complement Med.7*6,?.-I.8B
C2%?6-.@7-#
7-
42J*))6,G!"""!"!
! "HJ Alten Complement Med.)*8,?7@7+77@BC2%?8@8)6@8#
76
"0'4=/!4(2J=FC4*)),G&42
2!C;"0+%"!HBiomed Environ Sci.
-*-,?11+)7BC2%?)7).611#
78
/F<*))7,G0&iHJ Alten Complement
Med.-*1,?188+187BC2%?.)6766#
7@
:"C$F*17@,G;"HScience.1-*681,?)1+-BC2%?181.-6#
77
0(0K"<0*11,G"""
HIndian J Psychiatry.-6*-,?8-+81BC2%?77@.#
7.
%*))6,G"!"!!
!HIndoor Air.6*6,?1-+17BC2%?876.#
71
($F;;*)),GJ!+!"""+
"HPsychiatry Res.77*+,?)+).BC2%?)-.@#
.)
2F*))@,G0"J
HAm J Psychiatry.@-*,?@+--BC2%?78@6#
.
2F$0*11.,G!"""J
HArch Gen Psychiatry.88*)?.78+..BC2%?17.-887#
.
2F*118,G"+"JHJ
Altern Complement Med.*,?.7+1BC2%?1-18@)6#
.-
'/NN/*)),G"&
"+'HInt J Psychophysiol.6@*,?.8+.1BC2%?-76@61#
.6
NCN''2!"N'2$N'N%
*))@,G=+"":!"HCancer Lett. -1?
1)I17BC2%?@7166#
.8
F;""0;0(::4'0F"C*)),G"
!5HBMC Infect Dis.)*,?1BC2%?)-.6111#
.@
::4;""0;4FF:F"C`00*))@,G
A+!
HIntensive Care Med.-*,?-8+-7BC2%?@6-@78#
.7
:2;=C4$:*)),G;"!
"HJ Food Prot.@6*,?-+@BC2%?1.6-#
..
:"C$F2;;':*176,G(!J
HInt J Biometeorol..*,?6@+8@BC2%?6.6866#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
16
.1
!$24$22;'02~J0C$J$
`=4JJ(F0*))1,G9+""J
!HPLoS Med.@*-,?6-BC2%?11@77#
1)
CJ02K*))7,G&?"&"iHInt J Biochem Cell Biol.
-1*7+.,?17+-)6BC2%?78-8#
1
4*)),G$&"!HBiochemistry (Mosc).@7*,?
@+7)BC2%?186#
1
:24"'K'KK' %4:'%<"K
'KC*))),G+!!"A"
HTrans. Plasma Sci. .*,?-)I-7B?)#)1A7#.61)#
1-
;+%%2%;+N4*1.-,G"
&HThorax.-.*.,?8.6+8..BC2%?
@-8--#
16
<%4%N%4*1.6,G
&HThorax.-1*.,?816+81@BC2%?@676-.@#
18
/!/=';!/*171,G%
!HAllergy.-6*-,?.7+16BC2%?61817#
1@
J;2;4*1.-,G"!HAnn
Allergy.8*-,?-@+-@@BC2%?@-8@7@#
17
;'$/F*17.,G"HJ Bone
Joint Surg Am.@)*7,?.7+..BC2%?7)--8#
1.
;"FF;$0;'$/*17@,G""
HAntimicrob Agents Chemother.)*8,?.8@+.@)BC2%?)-66@7#
11
=0(<00F<=*),G""5
"""HInt J Environ Res Public Health..*@,?-)6+-1BC2%?77@-#
))
="F<*))1,G0"""
""HJ. Environ. Manage. 1)?76@I786BC2%?1-8@.-1#
)
2::N"0*),G"HInd Health.61*,?
)7+8BC2%?-67-#
)
<=FC2F0*)).,G0!!
"iHJ Pineal Res.68*6,?-6+-8)BC2%?
.-.68-#
)-
4'K*117,G%&i
5+HZ Naturforsch C.8*8+@,?-1@+6)6BC2%?1-.1@#
)6
":('"2*)),G8)HPhysik in unserer Zeit--*@,?8@+7@*
4"0))7,#
)8
C0*))),G'!"!""HNature.
6)@*@71-,?1)+1-BC2%?)1787#
)@
=$*11,G?"!HScience.8@*8)@),?.6BC2%?
7718-#
)7
/';F':'C$!"<*)).,GC
!!&HJ Atmospheric Solar-Terrestrial Physics.7)*@,?1-7+16@B?
"A)#)@A A ))7#)6#)-#
).
NN$$4N$X;C0*))@,G""'
HJ Atmospheric Solar-Terrestrial Physics.@.*,?6)+68B?
"A)#)@A A #))@#)8#)#
)1
/F<*))7,G0&iHJ Altern Complement Med.
-*1,?188+1@7BC2%?.)6766B?)#).1A#))7#7)6.#
)
0K"K*)),G4J0
;?$!$K"!HNat Hazards.-*+
-,?+-8B/%?)#)-A?)).7--76#
2'4/':'2'"20f4!"(*))8,G
!HBiomed Pharmacother.81#?)+6BC2%?@78677#
=$*1@.,Gˆ'"(C'2H
*%'",Naturwissenschaffen.88?1#
-
;:;'v$2'40!20'4C''2/'vK!"(
04CK2#*11.,S""!&
!!TBiofizika.6-*8,?.+..BC2%?116.6#
6
/'vK;:;'v$2$%CK2;'XK4'V%%$"J*11.,
S""!T Biofizika.6-*8,?.1+.@BC2%?116.6-#
8
0*)),G$!!
A4"H<9X#
?AA##AA1)2$$#
@
:h"<*177,G9!9HS9T2Y#
7
0%*))@,G""<($
"(HFME Transactions.-6*,?1-+)-#
.
(Y'"2*118,G"HJ Atmospheric Terrestrial Physics.87*8,?
671+6.6B?"A)#)@A))+1@1*16,)))78+N#
1
'$K*11.,G;"5*K<(,?
HJ Sci Explorat.*-,?668+6@.#
)
=$*176,G<(+0$HC"2*#,ELF and VLF Electromagnetic Field
Effects CCN'B)+66#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
18
0*)),G$!!
A4"H<9X#
?AA##AA1)2$$#
/!0X'2*)),Earthing: The most important health discovery ever?*<";0?
;,%;17.+81).-7B@)"#
-
042:/F<*))7,G"*"","HEur Biol
Bioelectromagn.?@))+@#
6
;042*)),GC4"+/2HJ
Altern Complement Med.@*-,?@8+7-BC2%?)11#
8
$:%'N2%'2N:*11.,G&"
"&HInt J Biometeorol.6*-,?-+
-@BC2%?18-.8.#
@
$%0*11-,G""!&
&HJ Hum Ergol (Tokyo).*,?+1BC2%?.)@66@#
7
04/F<':'C*),G"?"
!VHJ Environ Public Health.)?186BC2%?17#
.
':'C*),G""!HJ Altern Complement
Med..*-,?1+-6BC2%?6)7-@#
1
'C':*),G"HMed Hypotheses.77*8,?.6+.@BC2%?
.8@).-#
-)
04*)),G0"!&"&'
!"""! 6)HJ Altern Complement Med.
@*,?.+.7BC2%?))@6))#
-
/F<*))1,G0""&HJ Bodyw Mov Ther.-*-,?8+.BC2%?186.6@#
-
/F<*))7,G0&iHJ Alten Complement
Med.-*1,?188+187BC2%?.)6766#
--
F<*)),Healing Is Voltage: The Handbook*0,%;?17.+68-@61@1B-.@"#
-6
N'N'J:*))1,GC
!""*K$,
/'""HAnim Reprod Sci.-*+6,?-+-@BC2%?.7.1@8#
-8
$JC*)).,GC5H
Theriogenology.7)*,?+6BC2%?.6--.8-#
-@
(J!"22:+(*11),G"
H-8*,H)@+BC2%?17)17.#
-7
=0<F0/3;:4C22'F:!*11),G
"+""J"
'HProc Natl Acad Sci U S A..7*,?.8.)+.8.BC2%?-@)@1#
-.
:!*1.1,G"4$"'HJ Steroid Biochem.
--*6;,?@@1+@7BC2%?@.1778#
-1
;*16,G0"HYale J Biol Med.-?7.-+7..#
6)
;42"<0*1-.,G;+++!HAm
J Cancer.-?6)+6.#
6
;*1-@,G+""HAnat Rec.@6?7+.#
6
=*1..,G/"HJ Adv Med.?6+8@#
6-
;"/=+*17-,G'!
'HAm J Acup.?7+-#
66
$J<:*18,G"! BHYale J
Biol Med.6*,?+8BC2%?6..68@6#
68
F/2C*),G2+"!"HIntegr Biol (Camb).-*,?.@+
1@BC2%?..#
6@
("(00*),G$HInfect Immun.71*6,?6)+6)6BC2%?
-)7@#
67
!*)),G;!"HPhilos Transact A Math Phys Eng Sci.-@.*16,?8+-1B
C2%?)-78)#
6.
0<*)).,G"!"?#("
H Prog Biophys Mol Biol.17*,?71+6BC2%?7118#
61
<0*)).,G"!"?#25+
HProg Biophys Mol Biol.17*,?8+87BC2%?7118-#
8)
('/2N;+K24/'*),GC+
HAnn Bot.)*,?7+.)BC2%?6)..@#
8
4"2$222*),G/"!?
HPLoS One.7*8,?-7-.BC2%?@1-.7#
8
('/2N`<('*),G$###?
HPLoS One.@*,?-@8BC2%?)7--8#
8-
; $C*)).,G`"!>!"H
Indian J Exp Biol.6@*8,?6)+6-BC2%?.@17@.#
86
;C*),GC?5!"HNature.676*7-8,?7+6BC2%?@777-#
88
02(FX(*),G"HProg Biophys Mol Biol.)8*-,?-+6@B
C2%?)@768..#
8@
2FKK*))1,G`!"HHFSP J.-*@,?-.@+6))BC2%?)-6.)@#
87
0=*))6,G`"HJ Altern Complement Med.)*,?
@1+7.BC2%?8)8..)#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1@
8.
F;*)),GV;5?+!"VH
Biosystems.@6*,?6-+68BC2%?7886.7#
81
C"'4KK!0F$<2'"4*),G
5"+"&H Proc Natl Acad Sci U S A.).*8,?
)1).+)1BC2%?@771.#
@)
C"'4(:0F$=F;'$"4*)),G<"+
5&"HProc Natl Acad Sci U S A.
)7*1,?7@@+77)BC2%?)@81.8#
@
2%J'("4$=:;*)),G`""+"
&HNat Phys. @*@,?6@I6@7B/%?)#)-.A@8#
@
"40$$<:20"N0;'$("4$*))7,G
'""5HNature. 66@*7-7,?7.+7.@BC2%?
761-17#
@-
:%:*),G5XJ"
&"HBiosystems.)7*-,?8-+87BC2%?6.-1#
@6
$"0CF*))1,G0"!?HProc Natl Acad Sci
U S A.)@*,?-8-+-@)BC2%?11611#
@8
"4*),G`&!"+
"&*<,HProc Natl Acad Sci U S A.)1*-,?7)@+7BC2%?88.8#
@@
4"2$2FF; 0KK*),G5"
HPhys Rev Lett.)@*6,?)6)8)-BC2%?6)8--#
@7
0="0N=':0C2;C4*)),G0"+"
"!H Nature.6@-*7.,?@66+@67BC2%?)-)@67#
@.
4*)),#G`+0"?'%(iH#J Phys Chem
Lett. ?I.B/%?)#)A J1)))@#
@1
; $C*))-,G`!"HIndian J Exp Biol.6*8,?86+87BC2%?
86676##
7)
0FN*),G/"HBiosystems.).*+-,?
.+--BC2%?1771#
7
0=4*))1,G5""
HBiosystems.17*,?7-+.1BC2%?167-88#
7
<*11@,GHChem Senses *@,? 77-I71BC2%?
.1.8@)8#
7-
:%:*))1,G`X&"+++HPhys Rev E Stat
Nonlin Soft Matter Phys. .)*8C,?)8@8BC2%?)-@8)8#
76
0F444;"F*)),G`"HPhys Rev
Lett.)6*,?)8)BC2%?).@78@#
78
0:"<F:!F*)).,G2""5H
Nature.68*7.-,?@7+7BC2%?.-81#
7@
4h;!'K2'X:24(K"X$X*),G
"+!2!+HScience.
--*@)1,?.16+.17BC2%?--)86#
77
$K"X*),G"HTop Curr
Chem.1.?-7+87BC2%?-.)6#
7.
$''4<*),GC#HScience.--*@)1,?.@6+.@8BC2%?--)8#
71
'02:†/C'pFK!F*),G"+5
!'HJ Theor Biol..@*,?-+6)BC2%?7..-)#
.)
02C'F':/*)),G"!&"!
!HBiosystems.))*,?+-BC2%?)7..@#
.
2/C/*)),G<5HNeuron.@7*,?-+8BC2%?
)@68.8#
.
F'(02C'FKFF'F(%*))1,G2
!!'JHElectromagn Biol Med..*,?-+-BC2%?
1.6)6#
.-
=0<JJ2<;*))1,G""""+5
H)*6,?-6+-87BC2%?1@87)77#
.6
4C:=$:=2$*))7,G%5""
HNature.68)*77-,?)+-BC2%?.)176)6#
.8
((;J2%2 'F*))@,G
!+&!HJ Neurosci.@*-,?@8-+@@BC2%?
@7@-)-#
.@
((FJ'*))6,G"!!'HJ
Comput Neurosci.7*,?@8+7.BC2%?8-)@7-.#
.7
!$"="2;";!!";J*)),G&"
!?'"HRev Neurosci.-*,?
+-)BC2%?)-)6#
..
"$FFCF(F=*1.@,G2!!
&&++5HBioelectromagnetics.7*-,?18+-)@BC2%?-78-8-#
.1
0*)),G0&HTheor Biol Med Model.6B7?@BC2%?
)87@#
1)
:NN*)).,G""HInt J Dev Biol.8*8,?
8.8+816BC2%?.@617#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
17
1
;$4$$*))7,G0""
JHTheriogenology.@.*#,?8@+@6BC2%?7876.-#
1
;$*))6,G""JHHum
Reprod Update.)*,?8-+@8BC2%?8))86@6#
1-
X20<0<K022$;*),G""
!HProg Retin Eye Res.-*,?@8+..BC2%?))7#
16
$C<0"C2<:*),G'
""HWound Repair Regen.1*8,?@68+@88B
C2%?)1.)#
18
4";$;4N(FKF0X2*)),G"
"!!HJ Invest Dermatol.-)*1,?-)+-7BC2%?)6)1#
1@
2J'F="22J'2*)),G%?""HMol
Plant.-*6,?@6+@8BC2%?)6)86#
17
="X2*)),G$""!HChin J Traumatol.-*,?
88+@BC2%?))1-7)#
1.
*))1,G%%#2!"?"
!&""*%,H
Electromagn Biol Med..*-,?.-+-)1BC2%?)))7)6#
11
20"0";$ '2*))1,GHJ Cell Sci.*C#-,?6@7+67@B
C2%?11-7)#
-))
K022N2C$;(*))8,G"
"&5"HFASEB J. 1*,?88I87BC2%?88)767)#
-)
2'2 "J2;*))6,G0+?"&
HJ. Cell Sci. 7*C#1,?@-I@-1BC2%?8)788#
-)
$*))-,G"!"""H
Radiat Prot Dosimetry.)@*6,?-78+-.-BC2%?6@1).#
-)-
(!;$!%$%$$*))),G0"
HExp Eye Res.7)*8,?@@7+@7-BC2%?).7)88#
-)6
X220"0"+(J(FK'+':*117,G
"HCurr Eye Res.@*),?17-+1.6BC2%?1--).6.#
-)8
X'2(*1..,G$""?
HAcupunct Electrother Res.-*,?67+87BC2%?.1.11#
-)@
K%K;<K*))7,S9'">""!T
Ontogenez.-.*8,?-.@+-1-BC2%?.)-.@87#
-)7
F0FF;4$*),G!?0!"HBiochim
Biophys Acta.C2%?7.)8)#
-).
K'2$0F2F%J'22J2*))@,G(&&
+HChem Biol Interact.@)*,?+6)BC2%?@6-).71#
-)1
;'/K(":K*))-,G&&"&"?
HAnn Bot.1?71+16BC2%?8)1--1#
-)
X2*))1,G"+"""HSemin Cell Dev
Biol.)*@,?@76+@.B#C2%?16@1@1#
-
<(;(4"000!$"F4;0*)).,G<&
HJ Immunol..*6,?6@8+67BC2%?.@.61-7#
-
N>FX"X="F0"`4:N="N*))1,G<"861"
0J4($HBioelectromagnetics.-)*,?1+-8BC2%?
.@.@)7#
--
X2'2 "J2;*))-,G
?"'HEur Biophys J.-*,?+BC2%?
@-)#
-6
"J2;2'22 X(C:=*)),G
+?""ZHJ Cell Sci.6*C#6,?
@17+7)8BC2%?@.--1@#
-8
2F:"='<'"CFN"92*))1,
G"+"+"!"
""HProc Natl Acad Sci U S A.)@*@,?@@@7+@@7BC2%?1-6@6.6#
-@
:K0C4($*)).,G"&!""HJ
Cell Sci.*C#8,?88+881BC2%?..78.6#
-7
220<02C2J(*))7,G-68+
-+''C?""'"+""
"HEur J Histochem.8#?8+-BC2%?77)-@)-#
-.
X2";CF=$;4="(4=J'C4N'J'(FK
;$C20"0C"F2*))@,G"""
+-+/'+"CHNature. 66*7),?687I6@)BC2%?@.77#
-1
(*)),GHDose Response..*6,?8.+8@BC2%?
16..#
-)
C'pFK002:†/*),G0?"!
!!HEur Biophys J.6)*@,?767+781BC2%?-168)#
-
C'pF*))1,G;HElectromagn Biol Med..*,?)8+-BC2%?
1.-16#
-
C'pF'FKFF~'(*)).,G;++"HIndian J
Exp Biol.6@*8,?-)+-BC2%?.@17@-#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
1.
--
"/>N*)),G+!"HJ Accoust Soc Am..*8,?<@+@7B
C2%?)8-@#
-6
;JCC*))8,G2'+
HLab Chip.8*1,?161+18.BC2%?@))871#
-8
:!CC0*))8,G""
&HLab Chip.8*6,?6)7+68BC2%?871--.#
-@
4 $20F2'2C$*))6,G0
HElectrophoresis.8*-+6,?6)-+6)87BC2%?88176.#
-7
$K"'$';F'4*)).,G!HIndian J
Pharm Sci.7)*,?8+)BC2%?)-1))7-#
-.
; C'$2';*))@,GHExpert Opin Drug Deliv.-*,?7+-.BC2%?
@-7)168#
-1
$F20*117,G+"HPharm Res.6*@,?@.7+@17BC2%?
1).-#
--)
<NC;'J:;"F$42"CJ2$*)),G9+"
!!HAAPS PharmSciTech.*-,?))8+)7BC2%?)8-7#
--
$$*))1,G?HJ Pharm Pharmacol.@*@,?@.1+
7)8BC2%?18)8-81#
--
2":F*))6,G<+5?HAdv Drug Rev.8@*8,?8.1+@)BC2%?
8)176.#
---
$%FX$JC*))6,G++""
H*@,?-61+-@-BC2%?8-)))#
--6
;'(/J"0*))-,G0&
HClin Rehabil.7*,?1@+))BC2%?@7-.6#
--8
2";'<"$*11@,G""+5H
Pharm Res.-*-,?6+6)BC2%?.@17-6#
--@
5C<5*))1,GHInt J Psychophysiol.
7*,?8)+8@BC2%?.7-)86#
--7
:$F'2(J;!=*))7,G
"HEur J Neurosci.@*,?--.+---.BC2%?.).7#
--.
:%!CF+C;2$*)),G+'
HNeurosci Lett.-.*,?68+61BC2%?--87@#
--1
;':C"2*),G%"""
'""?;o''V!H
Neurosci Lett.8-*,?8+86BC2%?-6--#
-6)
;;'0<$2C"2*),GC!
&""!"+!HBrain Res.6B-..?
77+..BC2%?-1@-8-#
-6
$2J'F;o''%02CK*),G!
!!HJ Integr Neurosci.)*,?@8+..BC2%?686.-#
-6
N="0F*)),G;"!!
"HPhotochem Photobiol Sci.1*-,?-8+-BC2%?)687#
-6-
(*))1,G0""HPLoS One.6*6,?8).@BC2%?1-6)-)-#
-66
K= '$*1..,G$"HExperientia.66*7,?8.@+
81-BC2%?-16)-6#
-68
0J<*))1,GA""HJ Biol Phys.-8*,?6-+
66BC2%?1@@18@.#
-6@
942:5':2:"$;';!*)).,G%""
"HPhotosynth Res.17*,?--+8-BC2%?
.67.-86#
-67
;J'<*)).,G'!HIndian J Exp Biol.6@*8,?-8-+
-87BC2%?.@17@1#
-6.
;J'<'C;X'J'=*))6,G+HPhys Rev E Stat Nonlin Soft
Matter Phys.7)*-C#,?)-16BC2%?88688@#
-61
<(2F00";;"$$*1.7,G+
HBiophys J.8*8,?7.8+71-BC2%?-81-.76#
-8)
*177,G""HJ Theor Biol.@@*,?-71+-.7BC2%?
..@.7#
-8
*176,SG`HTBiofizika.1*6,?@7)+@7@BC2%?668@.7#
-8
*17-,G&HJ Theor Biol.-.*-,?881+8@1B
C2%?6@@-@#
-8-
<;$F'!"*),G!!!HEur
Phys J E Soft Matter.-6*@,?+1BC2%?@8@-7-#
-86
!"*)),G<HBiophys Chem.8)*+-,?+BC2%?)-.866)#
-88
C9$C4;F0*)),G0+"
!?HJ Phys Chem B.6*@,?6+-)BC2%?))188.7#
-8@
<F'!"*))1,G"c
Prog Neurbiol...*,?)6+-BC2%?16.7#
-87
;=J':(2=2!"*))1,G
!!5JHBiophys J.1@*,?68.+681BC2%?
16.@@.)#
-8.
!"F'*))8,G/"!!HProc Natl Acad Sci USA.
)*.,?171)+1718BC2%?8116-8#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
11
-81
2'2;2;(2<'(9K;'9;"9*)),
G"J+"HNature Physics.@?6-+6@B
?)#)-.A8))#
-@)
;'24$*)).,G!!"?"
!HJ Cell Physiol.6*,?)+@BC2%?7@)--#
-@
*),G`";"C!
$&+'22?$HNeuroQuantology.1*-,?68+6.#
-@
F</2F*)),G;!!
5JHBiophys J.1.*,?+.BC2%?)).876#
-@-
:0=*)),G$("%J
0%<"0!"HJ Phys Org Chem.-*7,?@77+@.6BC2%?
61666#
-@6
C$ '2F<2<0C2*)).,G"
"J+!&HChembiochem.1*7,?.-1+.68B
C2%?1).7#
-@8
2F*))@,G0J?'"&
J+"HPhys Chem Chem Phys..*-1,?68)+68@BC2%?7)6776.#
-@@
%%XK4"00*)),G"+"JH
Phys Rev Lett...*.,?.76)BC2%?))871#
-@7
4;='F$*)),G"HBiochim Biophys Acta.717*1,?8@-+87B
C2%?)6@))#
-@.
4;='F$*))1,G("CHChem Phys Lett.6.-*+-,?+1BC2%?)@8#
-@1
;!"F*)).,G("!"`2A22?
HPhys Chem Chem Phys.)*-7,?8@8+8@@7BC2%?.18@))#
-7)
4;='F$*))-,G""HQ Rev Biophys.-@*-,?-6+-7BC2%?
8)1..#
-7
%+*)),G""'+
&HJ Am Chem Soc.6*7,?6.6.+6.8@BC2%?
177-8#
-7
(2%<2''20*),G$"?/
DrosophilaHProc Natl Acad Sci USA. ).*-,?-8)B?)#)7-A#)7@.).#
-7-
(2%<2''2*),G2!+"
"HProc Natl Acad Sci U S A.).*1,?-717+-.)BC2%?-1#
-76
:02F=*)),G&"!"
!HFEBS Lett.8.6*-,?781+7@@BC2%?
)6--.-1#
-78
;'F0(C2*))7,G0"J!
"iHPhys Rev Lett.1.*-,?)-.)BC2%?7-8.7--#
-7@
2F2"<$ 'F</C;F$":2F<
*))@,G""J++?5
HPhilos Trans R Soc Lond B Biol Sci.-@*67,?-78+-.@BC2%?@.7-8#
-77
;C*))6,GJ?!"iHNature.6-*7))7,?-1@+-17BC2%?8-.81.#
-7.
<*11@,GHChem Senses *@,? 77-I71BC2%?
.1.8@)8#
-71
J*)),G&&?""
HExplore (NY).@*6,?7+-@BC2%?)@--.-7#
-.)
N'*))1,SGC!5HTJ UOEH.-*6,?-68+-8B
C2%?)))))).#
-.
C"2:*))7,G5?!
HInt J Neurosci.7*,?87+78BC2%?7-@8)@#
-.
;:'*))@,G"!'"?!""
!"!!'&HInt J
Psychophysiol.@)*,?16+)BC2%?@@66)6@#
-.-
2(*))@,G0;90?C
0<";0$HWorld Futures.@*+,?7+--B/%?
)#).)A)@)6))8))671)#
-.6
K"(!"+2$2<2'F*))@,G%>?
HScientificWorldJournal.@?686+
681BC2%?78).8#
-.8
0'0*))8,G;"(?$HJ Consciousnes Stud.*6+8,?-8+-1#
-.@
;FC''C*))8,G0iHMind & Matter. -*,?7+7#
-.7
JF2C;"2*))8,G`"?
+!HPhilos Trans R Soc Lond B Biol Sci.-@)*68.,?-)1+-7BC2%?@6786#
-..
$4*))6,G;!?!!"HJ Altern Complement Med.)*,?
81+@.BC2%?8)8.71#
-.1
2(F*)),G("%;V"(?
"(0HJ Consciousnes Stud.1*6,?-+8)#
-1)
0':;*)),G+'5"!ccHCommun
Integr Biol.-*@,?86)+866BC2%?---6#
-1
0':;*)),G;+!""VV
HBiosystems.11*-,?@7+7.BC2%?1..-7@#
-1
0':;*)),G/5+HCommun Integr Biol.-*6,?
-76+-7.BC2%?)71..-#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
))
-1-
0"0$*))1,G!?HAust N
Z J Psychiatry.6-*,?116+))@BC2%?)))-18#
-16
(!"<$;(":CK<=0+%"$*))1,G$
"25+!?HJ
Altern Complement Med.8*,?8+--BC2%?17@167-#
-18
(!"<$;(":CK<=0+%"$*))1,G$
"25+!?HJ
Altern Complement Med.8*,?8+--BC2%?17@167-#
-1@
C 4C2F!!=F=*))1,G"A'!
+HJ Altern Complement Med.8*1,?1@-+1@.BC2%?178717-#
-17
=!!=*))7,G"&!
?#)"!!
"HJ Altern Complement Med.-*,?--+61BC2%?7-)1-..#
-1.
=!!=/42"$4/F*))8,G"&
!?%K#2"!&@)))
HJ Altern Complement Med.*@,?17-+17@BC2%?@-1.8..#
-11
=!!=F$0*))6,G"&
!?C%#&""HJ Altern Complement
Med.)*,?68+87BC2%?8)8...#
6))
=:2F!!=*))),G0!iH
Integr Physiol Behav Sci.-8*,?6+6@BC2%?)--1#
6)
=*)),G/""02&
?C%%+C%+&HJ Altern Complement
Med.@*6,?8)7+8@BC2%?)6-)#
6)
= *)), G/ " " 02 &
?%+HJ Altern Complement Med.@*-,?-7+--8BC2%?)8.6)#
6)-
"N0*),G&!"H
Science.--*@)7,?---+--@BC2%?61-.86#
6)6
=*11-,G=!"iHJ Sci Explorat.7*-,?1-+-)6#
6)8
<"0!2;2F4C(=*),G"
!@)J.))"HEur J Appl Physiol.C2%?.1668#
6)@
$"4*),G=!"HTrends Microbiol.1*-,?)8+-BC2%?
-17#
6)7
02(FX(*)),c"cProg Biophys Mol Biol.)8*-,?-I
6@BC2%?)@768..#
6).
=*))-,G$!""&?
"5"!"HBiosystems.@.*+-,?1+68B
C2%?818-#
6)1
2CF=*117,G2='"!`"HInformatica.(Slovenia)?
81+8-6#
6)
=*11-,G;V5"+'
+"J"""
"HNanobiology.?)1+@6#
6
=*11,G`"HJ Math Imaging Vision.?71+-@#
6
;'24$*),G"HInt J Radiat Biol..7*6,?6)1+68B
C2%?6877#
6-
;'24$*111,G"HJ Cell Biochem.78*-,?-@1+-76B
C2%?)8-@-@)#
66
>X2'X0$K"X4J$$*),G"
"HNano Lett.*,?6@8+6@88BC2%?1@1-#
68
'0<*)),G"!""
HJ Vis.)*,?#+1BC2%?)6@--#
6@
FFFC'44!0>==;F2=""F2
(&*))7,G"C0Z!!!HMol
Vis.-?..7+11BC2%?7@8-)-6#
67
="X0C<F;N:F*)),G"&
C'V"X26-.8HPLoS One.8*,?-..-BC2%?)717-8#
6.
="X 0C<N:F*))1,G2"*)#-+)#.,"*2(,
""!HBMC Genomics.)?-8@BC2%?1@8-1)1#
61
04<`F">XC*))@,SG8)J""&20(+7HT
Zhejiang Da Xue Xue Bao Yi Xue Ban.-7*,?8+BC2%?.786#
6)
%+4J>$!$*),G"?"'
!"iHClin Genet..)*,?+6BC2%?86.-7#
6
;!'/:'%2J4*),G""""!
HBrain Res.666?1@+BC2%?--)7#
6
&;$:‰;$9&<;0""N;<42'0
C2<2JF0$"J4*),G+J"&
HBiomed Opt Express.*1,?@71+@.1BC2%?1188@#
6-
;'F('N:"C2<&<;$:‰;$$2JF0
$"J4&;9*)),G2""J
HPLoS One.8*,?8.)@BC2%?)1.#
66
$4*))6,G;!?!!"H J Altern Complement Med.)*,?
81+@.BC2%?8)8.71#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)
68
$!';*)),G!?!!HJ Altern Complement Med.
.*@,?7)-+77BC2%?@686#
6@
'F4'X*)).,G%""!' "6?
"HIndian J Exp Biol.6@*8,?-6)+-66BC2%?.@17@7#
67
2:*),G?"!HDNA Cell Biol.-*6,?6+
6@BC2%?)@#
6.
2:*),G'&!HJ Cell Commun Signal.@*,?8-+
8.BC2%?1.)77#
61
4CCF2*1.1,SGC#2iHTEnergy.)?6@+8#
6-)
04:: C00*171,G"H
J.Inst.Eng.*%,@)?@+@@B@7+7-#
6-
4CC44K*))7,c&"
cNew Med Techn J.1?6+8-#
6-
4CC4"3:KK3CKC"K*11,G%"(
!<0HBull Lebedev Phys Instit.+?-+-)#
6--
<'2*))-,G$"+?
&HIndian J Exp Biol.6*8,?687+67BC2%?866@.#
6-6
2"<F4<0K4*),G
HJ Phys. Conf. Series.,DICE2010.>?)#8@@#
6-8
0"*),GHNew Scientist.*F,?718#
C'2*),GW=2?02""V$("HDNA Decipher J.*,?
.+1)#
6-@
2"<F(2"F<<0*))1,G""!
5!5HInterdiscip Sci.*,?.+1)BC2%?)@6).#
6-7
J<N"2!!"*)),G9!
HAngew Chem Int Ed Engl.61*,?-81.+-@)BC2%?)66@71#
6-.
2"<F(2"F<<0*))1,G""C!
5;5HInterdiscip Sci.*,?.+1)BC2%?)@6).#
6-1
2"<F<02!2KF0*))1,G"%K
!%!HInterdiscip Sci.*6,?68+8-BC2%?)@6).)#
66)
<>4!4;<0;''*)).,GJ!&HJ Phys
Chem A.*67,?)1)+)1@BC2%?.1.@1#
66
=<4!$4;<;''200'F<0=F
F/FF<<=$*)),G!+HPhys Rev E Stat Nonlin
Soft Matter Phys. @8*8C#,?)81)-BC2%?)818.1#
66
K':2*11,G+5!HJ Biomol Struct Dyn.
.*8,?)@1+).-BC2%?.7.@8#
66-
0:0*1.6,G<+5!HBiochem J.*,?7+-BC2%?@6@@-7#
666
2"<F(2"F<<0*))1,G""!
5!5HInterdiscip Sci.*,?.+1)BC2%?)@6).#
668
2"<F<02!2KF0*))1,G"%K
!%!HInterdiscip Sci.*6,?68+8-BC2%?)@6).)#
66@
0=*))6,G`"HJ Altern Complement Med.)*,?
@1+7.BC2%?8)8..)#
667
4C4K4*1..,G=HPhys. Rev. Lett.@?).8+)..B
C2%?))-188#
66.
<N<0"<=J"<<4">*11@,cCC=%
cMod
Phys Lett B.)*1,?1+1-)#
661
2"<F4<0K4*),G
HDICE2010.>?)#8@@#
68)
;FF"C=F*117,G"J""!
'HJ Allergy Clin Immunol.11?78*!#,#
68
;FF"CŠF*11@,G""A""HFASEB J.)?
671*!,#
68
ŠFF"C<2;f%;F*118,G""H
FASEB J.1?@.-#
68-
'(C0CJ=0=*118,G!0AHFASEB J.1?
-1#
686
N2<2;'<;F*118,G"
*!C2,HFASEB J.1?7#
688
;FŠF<2"4N*116,G"!
HFASEB J..?-1.#
68@
ŠF<2;F*11-,G2"""!
HJ. Immunol.8)?6@#
687
;(F/!!2$!J;2CJ;(C;
C+<FC;;F*1..,G!"""!
"%"GNature.---?.@+..BC2%?688-#
68.
;F*1..,G;"HScience.6*6.@1,?).BC2%?-6-67-#
681
=CC"2*))7,G"""!""+'
"?"+HCurr
Neuropharmacol.8*6,?7.+..BC2%?1-)8766#
6@)
;<K/JF24!(*117,G<&4#4!
"HInt J Dev Biol.6*@,?77+777BC2%?166168#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)
6@
0"FF*)).,GC!!"HIndian J Exp Biol.6@*8,?-7+
-77BC2%?.@17@#
6@
0;'FF*))6,G05"?"
"HJ Altern Complement Med.)*,?7+-1BC2%?8)8.7@#
6@-
(F(':*),G0""""HPhysiol Plant.6*6,?-)8+--B
C2%?6877)#
6@6
="0;''%F%*)),G!"+'
HBrain Res.C2%?)-678#
6@8
:!2:'/'*))1,G%""'!
"HPLoS One.6*7,?@8@BC2%?1@)@8#
6@@
K= '$K$ 'C="(%F*)).,G(+
"?HIndian J Exp Biol.6@*8,?7-+-)1BC2%?.@17@#
6@7
C(*))-,GC!HIndian J Exp Biol.6*8,H-1+6)B
C2%?86681#
6@.
:'N0NN""'2/=!N*)),G+
&'HBiochem Biophys Res Commun..8*6,?))7+)BC2%?
6@7.8#
6@1
:!2'2NJ'N:':%::%!*111,G%""
'V!!"!&
HNeurosci Res.-6*,?)-+-BC2%?)61.--@#
67)
C(<:2=C42$*1..,GC!HExperientia.66*7,?87@+8.8B
C2%?-16)--#
67
C("=<:J=="/=$*1.6,G;#
HCell Biophys.@*,?--+8BC2%?@)67@#
67
$;C(*17@,SG&"'!"HTZ
Naturforsch C.-*+,?76+768BC2%?-.1@#
67-
'F*))8,GC!""?!HForsch
Komplementarmed Klass Naturheilkd.*,?1)+18BC2%?81676@7#
676
‹'F*))-,G;""?&"HIndian J Exp Biol.6*8,?
6.-+61-BC2%?8667)#
678
<;'N'=!!F"(*),G
'"HScience.--*@)7,?--)+---BC2%?61-.8-#
67@
F";F0F%(s'FCJ'*))6,G&5
"HNature.6-*7)@,?6.+6.@BC2%?88@86.#
677
(F<;<(0:!FCJ'*11.,G95
H Science..*8-.1,?7)@+7)1BC2%?17.6-#
67.
;CF+=2:!2=X"*117,G&5H
Nature.-1)?878+871#
671
4CC;;%%'22CF44<:9*)),G+
!HCASYS: Internat J Computing Anticipatory Systems.)?1)+-)#
6.)
2;C=:"f402*),G+'"
"J"HNaturwissenschaften.
11*@,?6@8+67BC2%?@-1)7@#
6.
F$"%$2*)),G&'"!9K+
'HSkin Pharmacol Physiol.
-*8,?@@+7BC2%?)6.61@.#
6.
FK= 'CK= '$2CF*)),G;+"?
HPhotomed Laser Surg..*,?-+-)BC2%?1786@7#
6.-
:!("$0K='=:CF2=*)).,G+
"&'!'*9C,+#%?9C
!"#HSkin Res Technol.6*,?)-+BC2%?.@).#
6.6
"$:!(K='=:CF2=*)).,G+"
&'!'#%%?!"+
'HSkin Res Technol.6*,?+)BC2%?.@)1#
6.8
K= '$K$ 'C="(%F*)).,G(+
"?HIndian J Exp Biol.6@*8,?7-+-)1BC2%?.@17@#
6.@
2("<C4""F*))8,G+
'?HJ Photochem
Photobiol B.71*,?1-+11BC2%?8.7.6#
6.7
!:*))8,G'!""
"HForsch Komplementarmed Klass Naturheilkd.*,?.6+.1BC2%?81676@@#
6..
'F*))8,GC!""?!H Forsch
Komplementarmed Klass Naturheilkd.*,?1)+18BC2%?81676@7#
6.1
= '$K= 'C*))8,G!HForsch Komplementarmed Klass
Naturheilkd.*,?77+.-BC2%?81676@8#
61)
= 'C= '$K*))8,G2+"
! Forsch Komplementarmed Klass Naturheilkd.*,?1@+)@BC2%?81676@.#
61
'2:!2'2J'%/':2/*))6,G;
5""HCancer Sci.18*.,?@8@+@@BC2%?81.7.#
61
:!2 ;92%!*118,G9'!""
!HUrol Res.-*8,?-8+-.BC2%?..-1-..#
61-
'F4'X*)).,G%""!' "6?
"HIndian J Exp Biol.6@*8,?-6)+-66BC2%?.@17@7#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)-
616
<2(F4N<0X"F<*))7,SG&!cJc*4K6,
!!"4K6"HTZhen Ci Yan Jiu.-*8,?-7+-1BC2%?
.)8)@8#
618
!:C2+/=C(*))8,G;"
!HJ Altern Complement Med.*,?7+7-BC2%?878)-7.#
61@
(:J242$2C*)),G2"!H
Neuroimage.-.*-,?8+8.BC2%?7..18@#
617
"C/20<C$=KF2$FC4C*)),G=
"!HProc Natl Acad Sci U S A.
)7*66,?1)@7+1)7BC2%?)18@-.#
61.
:(%0*))1,G2'HFront Neuroanat.-?BC2%?
18178@#
611
JF:20;F+;"*))1,G""+H
Nat Neurosci.*,?-7)+-7BC2%?1.)7)7#
8))
':222K*))1,G"+!'HPLoS
Biol.7*7,?)))87BC2%?1@)@@#
8)
N"F=">X"N>2>>*)),G'"
'HCortex.6@*-,?-86+-@@BC2%?1881))#
8)
42:;$<2K*))-,G("!?'
HProc Natl Acad Sci U S A.))*,?8-+8.BC2%?8)@16#
8)-
<4N"*),G2$%+!'H
Complement Ther Med.#?61+81BC2%?1818#
8)6
<4<<0"$"N0="::442`NN"*))-,G2$%"!
!"""+HHum Brain Mapp.
.*-,?--+-.BC2%?811.#
8)8
0C$2':0*),G"HNat Neurosci.6*,?
7+-BC2%?6)7-#
8)@
F'CC0"=0FF4*)),G""+5HEpilepsy
Res..1*,?@)+@8BC2%?))--7-#
8)7
=(!*)),G(0HFront Neural Circuits.6?8BC2%?
)8).761#
8).
C4*))1,G""?HNeurologist.8*,?@7+
16BC2%?17@7.@#
8)1
F:CFF4*))7,G0
HJ Physiol.8.-*C#,?888+8@8BC2%?78111@#
8)
(49J"N44;2JC<*))7,G$'+"!
"HNeuron.88*@,?1-)+16BC2%?7..).1@#
8
$NFC<0;'2*))7,G'"?
"HJ Neurosci.7*,?-)-)+-)-@BC2%?7-@)1@#
8
(F4';FF*))-,G'HJ Neurosci.-*1,?788+
7@BC2%?17-8.#
8-
4(%02*))-,G
"&HNeuroscience.1*,?77+1BC2%?7@-)..#
86
:F2=%*111,G"?"
HPhilos Trans R Soc Lond B Biol Sci.-86*-1),?@61+
@7-BC2%?)@)-@.#
88
;'*117,G""?!!
+HProc Natl Acad Sci U S A.16*,?+@BC2%?.11)61#
8@
N00: :'*11@,G"0V
HJ Neurophysiol.8@*,?11+BC2%?-76@6)#
87
FF4*118,G!?&
HC$#78*6,?@.1+7-BC2%?76.)81#
8.
$'2*1.),G!"!
HJ Physiol.-)8?8+@1BC2%?@886-#
81
: $/*)),G%"9"";C`;
0:0"05JVHFront Neurol.?8BC2%?
..86#
8)
4F2%2*))1,G"""HEur J Neurosci.-)*,?+.BC2%?
18).@17#
8
<N2":<;+K:4>*),G
"HNeurology.7.*1,?8))+8)@BC2%?8-18@@#
8
C+(<CF2<2==*)),G0"?!
!HPLoS Genet.@*,?))87BC2%?)-61.#
8-
24J0<'2!'J$*)),G4(C&!
"!+&1))2J""HInt J Radiat Biol..@*8,?-@7+-78BC2%?
)-17.6#
86
;C'J$*))7,G1))2J42&"!?
+HToxicology.-.*,?-+--BC2%?7@6@8#
88
2+;<!;>CK"F|J$*))6,G&421))+
2J""!!HNeurobiol Dis.7*-,?
668+686BC2%?8871.)#
8@
/F<*))1,G0""&HJ Bodyw Mov Ther.-*-,?8+.BC2%?186.6@#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)6
87
;'$/*11,G0""!HSubtle Energies.
*,?7+..#
8.
0C'2F$220:'F<"2*)),G
?!"!HPLoS One.8*7,?1)7BC2%?)@.1816#
81
00!C;F2/4"$0=C2<"2*)).,
G?HBioelectromagnetics.1*6,?68+8@B
C2%?.6).7#
8-)
$C=J2:K*)).,G"
24HJ Altern Complement Med.6*@,?@71+@..BC2%?.@.6)78#
8-
XX`*)).,G""HProg Neurobiol..8*6,?-88+-87BC2%?
.8.81#
8-
(:N'2'="XNN"=<N'N*))7,G+(&
5"!!4;"H
Okajimas Folia Anat Jon..6*,?+1BC2%?7@86.-.#
8--
2=:"C*11.,G5"!
HAm J Chin Med.@*-+6,?8+@-BC2%?1.@)-#
8-6
"0`2F+4*))8,G!
HJ Mater Sci Mater Med.@*6,?-88+-@)BC2%?8.)-.#
8-8
;3C*1.6,S+"5JTBiull Eksp Biol Med.17*@,?@78+
@77BC2%?@--868#
8-@
:JKC2'<C$%(%2C*171,SG0"
"HTBiull Eksp Biol Med..7*8,?6@.+67BC2%?686.7#
8-7
4CC4"3:KK3CKC"K*11,G%"(
!<0HBull Lebedev Phys Instit.+?-+-)#
8-.
;<K;';<'*))-,G;!""
!HIndian J Exp Biol.6*8,?66+6-)BC2%?866@-#
8-1
;(F/!!2$!J;2CJ;(C;
C#*1..,G!"""!"%"HNature.---*@7@,?
.@+..BC2%?688-#
86)
2"<F4<0K4*),G
HJ Phys. Conf. Series.,DICE2010.>?)#8@@#
86
4CC44K*))7,SG&"+""
" +"HTNew Medical Technologies#
1?6+8-#
86
=*))-,G$!""&?
"5"!"HBiosystems.@.*+-,?1+68B
C2%?818-#
86-
$ 0 ( 2" < *), G ? ;"
HSemin Cancer Biol.*-,?)7+6BC2%?8@1.61#
866
:FF*))7,G4"?""#+
""&"!"HTheory Biosci.@*+-,?
@8+-BC2%?.).77@)#
868
(44C('!"4(4*))7,G(++!
"?"!'""H
Naturwissenschaften.16*.,?@-I@6BC2%?7-@-11#
86@
<:F<02(C(*))7,G2"?V4CHJ Exp Biol. )*C#,?
-@17I-7)8BC2%?7186)#
867
C$J:='$='=*))8,G2""!
#-82J"HNaturwissenschaften. 1*,?.@+1)BC2%?8@68).#
86.
='=='$*))8,G2""!HJ Comp
Physiol A Neuroethol Sens Neural Behav Physiol. 1*.,?@78I@1-BC2%?8..@11)#
861
$J:*))),G+!"!HBiophys J. 7.?7)7I7.B
C2%?)@8-7.6#
88)
<!$F:*))),G"HBioelectromagnetics. ?888I8@8B
C2%?)168#
88
$J*)),G0!"iHJ R
Soc Interface.7#?@8+7BC2%?11)@@7@#
88
:'F<='2='22*)),G;"?""
!&"HJ R Soc Interface#7#?71+1BC2%?))7-1)#
1553
='2:'F<*)),G55+"H
J R Soc Interface.7#?7-+.1BC2%?)).@)86#
886
:':K*))1,GJJ"""!H
Bioelectromagnetics.-)*8,?6)+6)BC2%?117#
888
$"0CF*))1,G0"!?HProc Natl Acad Sci
U S A.)@*,?-8-+-@)BC2%?11611#
88@
2:!:;0(:%$"0<C40$CF*)).,G0
"HNature.68-*71-,?-.7+-1)BC2%?.66117#
887
2$CF;2*))1,G=+!"!
J""!""HJ Exp Biol.*C#,?-6@@+-67BC2%?1.-7...#
88.
2$CF;'*))@,GCJ"!""!H
Science.--*87..,?.-7+.-1BC2%?@1)-.#
881
0==2=''2*))6,G2"""!!"
"HScience.-)6*8@@1,?6)8+6).BC2%?8).786#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)8
8@)
2$;'F'*)),G2"!!
""HJ Exp Biol.)8*C6,?-.68+-.8@BC2%?6-)).#
8@
:$KFC='$='=;F*))1,G/""
"X!""HFront Zool.@?8BC2%?1.871#
8@
02"C*)),G"+!"?"VHJ R Soc
Interface.7#?1-+)8BC2%?))@.78#
8@-
='$4"J4'/='=*)),G%"+!
!'"V&V!HFront Zool.7?6BC2%?)7)71)8#
8@6
='$:C='=*)),G!!"
"HJ R Soc Interface.7#?@-+@7BC2%?1.@6@-#
8@8
='=<:C='$*)),G2"!?
c&cHNaturwissenschaften.17*,?-7+6BC2%?17@)78#
8@@
2$CF;2*))1,G=+!"!
J""!""HJ Exp Biol.*C#,?-6@@+-67BC2%?1.-7...#
8@7
20K2=F2='22*))6,G2"""
"HNature.6-*7)@,?8).+8BC2%?88@88@#
8@.
=<+`'F*))G2";C2!%<"HCurr Biol.
*6,?)#)@A #!#)#)#)8.#
8@1
XN"N<0<*))1,G"""
"HNeurosci Bull.8*-,?)+).BC2%?166.@.-#
87)
N"2%*)),G2"!"
HActa Otolaryngol.*8,?81) 818BC2%?8.--1#
87
$:'F<'4=''2*)),G"+!
!"!HProc Natl Acad Sci U S A.)7*8,?@16+@168BC2%?)-81@#
87
$:'F<'4=''2*)).,G;"V"H
PLoS One. -*,?@7@BC2%?.-)78-#
87-
="NCNC='2X"*))7,G;"HProc Biol Sci.
76*@7,?1)+1)8BC2%?7.6.-@8#
876
$:K20===''2*))@,G"?!"V
"HNature. 666*7),?@8-I7)BC2%?78@8@#
1575
$;%;2*)),G"+!!
"!HProc Natl Acad Sci U S A.)7*8,?@16+@168BC2%?)-81@#
1576
$:'F<'4=''2*)).,G;"V"H
PLoS One.-*,?@7@BC2%?.-)78-#
877
="NCNC='2X"*))7,G;"HProc Biol Sci.
76*@7,?1)+1)8BC2%?7.6.-@8#
1578
$:K2F0===''2*)).,G"?!"V
"HNature.666*7),?7)BC2%?78@8@#
871
$JN+(02*)),G0?
"iHCommun Integr Biol.-*,?6+7BC2%?)8-1777#
8.)
C$J;="$='$*))@,G"!
!HJ R Soc Interface.-*1,?8.-I8.7BC2%?@.6186#
8.
="$;";*))@,G2"?<
HJ Exp Biol. )1*C#-,?6767I678)BC2%?766)7#
8.
:'F*)),G2"!Spalax ehrenbergiHJ Exp Biol.
)6*C#6,?78I78.BC2%?7-87#
8.-
;2=!"='$='=*117,G2"
!0*;",HExperientia.6@*8,?8.+8-)BC2%?-676)7#
8.6
2='=;*117,G""!
HNaturwiss. .6?6I6-#
8.8
;;"0FFC*))1,G&+5"
""HProc Natl Acad Sci USA.)@*6,?87).+87-BC2%?1118)6#
8.@
;"0FFK /;*)).,G2"""J""H
Proc Natl Acad Sci USA. )8?-68I-688BC2%?.78@1#
8.7
ŒCF2;/^"*)),G"?
"HScience. 16?-@@I-@.BC2%?81.11#
8..
$J*)),G0!"iHJ R
Soc Interface.7#?@8+7BC2%?11)@@7@#
8.1
20:=<*))1,G"!+!"!HJ
Biophys.))1?-.)17@BC2%?)-)71-#
81)
='22:'F<4J*11,G""
""HJ Exp Biol.7?@7+7.BC2%?6-7-#
81
C$0<;;(*))7,G/5!
""HBiol Rev Camb Philos Soc..*-,?-@+-7-BC2%?7@6181#
81
:'F<J=F*1.@,G"""HJ
Exp Biol. )?I6#
81-
C"*171,G2HJ Physiol (Paris).78*6,?-61+-8-BC2%?
81@1#
816
K*171,GC"?"HJ Physiol (Paris).78*6,?-+
---BC2%?-1).#
818
;N'$(*))7,G+!"
HJ Neurophysiol.1.*8,?718+.)@BC2%?7.888.)#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)@
81@
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#@8#
817
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#@)#
1598
22;=$420;'0K*),G"
!HNat Commun.?61@BC2%?1..1#
811
C(0<02(<:F*),G<"C;2"
2HCurr Biol. *8,? ?)#)@A #!#)#)#)87#
@))
422<:F*11.,G"!"
HAnim Behav.88*,?@1+77BC2%?16.)@7-#
@)
<:<0*116,G5""""H
J Exp Biol.1)*,?+.BC2%?1-7)#
@)
204:CNC*))8,G'"""HJ R Soc
Interface.*,?1+-)BC2%?@.617#
@)-
: 2:*)),G !'HJ Exp Biol.
)8*C#-,?-@)1+-@BC2%?6)16.7#
@)6
;<0<:F*))-,G""!HNature.6*@1.,?@)+@-B
C2%?818-#
@)8
<:C44X+($F;<*118,G2"
!?&HJ Exp Biol.1.*C#),?)6+)6.BC2%?
1-1161#
@)@
CF;;0('2F;F:'F<*)),GV(&+&V"!
!?++"""+!
""iHJ Exp Biol.)8*C#6,?-1)-+-16BC2%?
6-)#
@)7
CF;*1.7,G<!"+
HJ Exp Biol.-?8+1BC2%?-@166#
@).
CF;*1.@,G""HScience.--*67@8,?7@8+7@7B
C2%?-7-.8).#
@)1
/F(=!"52='='2J'2*)),G?
"iHJ R Soc Interface.7*6,?6-+8BC2%?1676).#
@)
$J*)),G0!"iHJ R
Soc Interface.7#?@8+7BC2%11)@@7@#
@
=!"+/0/F("$;52*)),G2"
?HJ R Soc Interface.7#?)7+8BC2%))@.7@#
@
='2:'F<*)),G55+"H
J R Soc Interface.7#?7-+.1BC2%)).@)86#
@-
C;=2<*)),G2'"HJ Exp Biol.-*6,?@8+@87BC2%?
).-@#
@6
4;:;;"F(J(0*)),G-+C"
='C(HFront Behav Neurosci.6?@BC2%?)877@-8#
@8
"F;F2J2C$;;2"0;$4:4
*)).,G"""?&HBiol Cybern.
1.*@,?81+8-1BC2%?.61@6#
@@
;!<F<"*))7,G'HPLoS Comput
Biol.-*-,?-.BC2%?7--8-6@#
@7
0;$*))@,GC""!'HJ Comp Physiol A
Neuroethol Sens Neural Behav Physiol.1*@,?8.7+@))BC2%?@8)1.)#
@.
(*))@,G"HCurr Opin Neurobiol.@*6,?676+6.)BC2%?
@.-7.7#
@1
2220!*)),G2"""
!'HBrain Behav Evol.81*6,?11+)BC2%?-.-6)#
@)
222*111,GC'!?5
"5HJ Exp Biol.)*C#),?18+)-BC2%?))@@#
@
$!C<:*)),G+!!'+"+"H
Front Comput Neurosci.6?8@BC2%?.18#
@
0;*)).,GC!?!""'
HJ Physiol Paris.)*6+@,?)1+BC2%?.1.6)6#
@-
0;:'2*)).,G(!?""
""HJ Comput Neurosci.8*,?+6BC2%?
.7@.8)#
@6
$!C*))),G2"!HJ
Neurophysiol..6*6,?)-8+)67BC2%?)6)1@#
@8
;F*111,GC!'HJ Exp Biol.)*C#),?
-7+--7BC2%?))@7-#
@@
;F*118,GC+'?"
HJ Comp Physiol A.7@*,?@-+7-BC2%?7.--)1#
@7
F4*116,G""'HBiol Bull..7*,?@6+78BC2%?
71.717#
@.
020;;$*))7,G("?'H
PLoS Comput Biol.-*@,?-BC2%?7871.#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)7
@1
F4;J'*11),G2"'#%%#+
""HJ Comp Physiol A.@7*,?18Q-)7BC2%?-@81#
@-)
;*18,G"HYale J Biol Med.8*,?@7+78BC2%?-))@6)8#
@-
;*1-7,G;+!HYale J Biol Med.1?86+861#
@-
;*16,G(C"("V""HProc Natl Acad Sci U S A.7*@,?7@+.BC2%?
@8..68.#
@--
;N*11@,G"+
8)+J"HLife Sci.@6*6,?1+17BC2%?)-7611#
@-6
;N*118,G8)+J"
#$&HLife Sci.87*6,?-8+-8.BC2%?78@6..#
@-8
$$F*11-,G&5"&?
HJ Cell Biochem.8*6,?-16+6)-BC2%?.)1.7-#
@-@
<J+2$+`F<4"+4J$C+(J2F"+;(F+C(F
*))@,G42""J!+(!
&HNeurosci Lett.-1.*+,?-1+66BC2%?@66.78)#
@-7
//;'20/J//J'";//J4*))-,G"
1))2JJ"HNeurol Sci.6*-,?+@BC2%?6@)).#
@-.
J2C'(2"<*)),G+!
!HPathophysiology.C2%?1#
@-1
=";<*))),G&68)+2J+JH
Bioelectromagnetics. ?8I8@BC2%?)@8)1#
@6)
<00:4=*1.7,G<+"
HJ Neurochem.6.*,?6)+68BC2%?-7167).#
@6
$!'J;*))1,GC"'"""*42(,
HBioelectromagnetics.-)*,?+.BC2%?.8@-7-8#
@6
C'JK%*116,SG%"'"!
HTBull Eksp Biol Med.7*8,?6.+6.-BC2%?11@@18#
@6-
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#81#
@66
40 'C*)),G&5"
&HJ PhysiolPharmacol.@*-,?---+--.BC2%?)@).@6#
@68
0 ':'C'!';4*),G&5"&
!!HJ PhysiolPharmacol.@*@,?@87+@@BC2%?-68@.#
@6@
0 ''!';:'C4*)),GS%5"
&VT#Pol MerkurLekarski.1*76,?-@+-@6BC2%?1.1.8#
@67
$"J2C;F(";'*))6,G;
&@)J"".HBioelectromagnetics.8*7,?8)@+
88BC2%?8-7@66#
@6.
;F(2"*))-,G)'K-)@)J"
''"HBioelectromagnetics.6*.,?887+8@-BC2%?6@)-678#
@61
;F("$<;'*11@,G;""
HJ Dairy Sci. 71*1,?861I886BC2%?..118)#
@8)
<=:4*11.,G0!!K$
"HInstitute of Pharmacology, Toxicology & Pharmacy, Veterinary Faculty, Universities of Hannover,
Scientific Institute of Electronics and Radar, University of the German Federal Armed Forces;
4#
@8
4F*))7,G4""!&
HInt J Biometeorol.8*6,?--8+-66BC2%?@1.-87.#
@8
4F*))7,G"!!"!&#!
HInt J Radiat Biol..@*,?.1+)BC2%?)6.@18#
@8-
4F*))7,G"!&+?
"HRadiat Environ Biophys.6@*-,?.+1)B
C2%?78-)7#
@86
4F4*))6,G4""HBioelectromagnetics.8*,?
.1+)BC2%?67-888.#
@88
;*)),G2!"*$,?
!HElectromagn Biol. Med.1*+,?-+-8BC2%?)8@)7@1#
@8@
F'0='C<*),G!
'HJ Exp Biol.6*C,?))+)@BC2%?@-8.#
@87
K2CJ:2*))1,G$5""
'HJ Exp Biol.*C#,?-67-+-677BC2%?1.-7..1#
@8.
C<'2'2F'0=*)).,G
!' J Exp Biol.*C-,?-@.+-@1)BC2%?1))7#
@81
K2CJ'*)).,G!"!
'""HNeuorsci Lett.6-8*,?)-+)7BC2%
.--7))6#
@@)
2"2:(J!2F2*),G='2"(
;HJ Membr Biol.BC2%?61-6@#
@@
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#-@#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
).
@@
'KK%2('*)).,G'+5""
""*4,"HBioelectromagnetics.1*8,?-.7+-1-B
C2%?...@.#
@@-
4=2J'<2X!2<'::$0'<2*111,SG
!HTBiofizika.66*,?-7+6)BC2%?)--)81#
@@6
<24*117,G0"
!!HBioelectromagnetics..*-,?88+@-BC2%?1)1@.66#
@@8
0%<===XX2*11-,G"?
!"HJ Cell Biochem.8*6,?67+68BC2%?.61@66#
@@@
XX2==0%<*11),G%@)+J"
HBioelectromagnetics.*,?-7+68BC2%?-6@8)@#
@@7
(:F$F*))8,G"!"
"?HJ Toxicol Environ Health B Crit Rev..*,?7+6)#
@@.
(:F;2*)),G&'&"H
Environ Res..@*,?1.+)7BC2%?6-76@@#
@@1
(:F;2C*111,G""
'HEnviron Health Perspect.)7*,?1)+1)6BC2%?)8668.#
@7)
;!"/*))7,G!*C,?!'
"HElectromagn Biol Med.@*,?6+8BC2%?7@-)6#
@7
F;*))7,G!"!!
!!"*C,HElectromagn Biol Med.@*,?@-+7BC2%?7686).-#
@7
;*))8,GC!"(C2C='
(Ciconia ciconia)HElectromagn Biol Med.6?)1+1B/%?)#).)A8-@.-7)8)))867#
@7-
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#886#
@76
;$C*))1,G"""!?!
""!"!HPLoS One.6*7,?@6@BC2%?1@)@6#
@78
(*),G2!+!'"HApidologie./%?)#))7A-81+)+))@+&#
@7@
:$";C*),G&!"
'!HToxicol Int..*,?7)+7BC2%?6-)17#
@77
KC:$*)),G0"!!!"
HCurrent Science.1.*),?-7@+-7.#
@7.
0N:(N<0=(:<F*))7,G2"!*,HPLoS One.
*6,?-18BC2%?76@)7@#
@71
=:F*))@,G0"&"!i"
!++!I'H
Acta Syst. Int. J.@*,?I@#
@.)
:F*)),G'"5'+"(;'*G
"5"!H,Deutsches Bienen-journal.)*6,?1I#
@.
:F*)),GJ;+"H*GC!!
H,Schweizerische Bienen-Zeitung.6*1,?-I7#
@.
"="=F*11@,G02?"
)J5+HBioelectromagnetics.7*,?))+)BC2%?1-1@-#
@.-
;'KC4"F$4!";*1.1,G<!"
!&HBioelectromagnetics.)*,?+BC2%?7.-8#
@.6
='22;2*1.1,G0""!HBioelectromagnetics.
)*-,?@+78BC2%?@@878#
@.8
;'KC4"F$4!";*1..,G2!"!!*
<#,&+"+"?!&
'HBioelectromagnetics.1*-,?.8+-)BC2%?-7.1)-#
@.@
4!";;'KC4"F$*1.,G;"7@8'K?&
!HBioelectromagnetics.*6,?-8I-.BC2%?7-@)86#
@.7
=4*17-,G"!HZ.Ange.Entomol.7*6,?.@I16#
@..
='9*17@,G"!HBee World87*,?8)I8@#
@.1
='9*178,G;"H*G;""H,Umschau.-?6@#
@1)
4!2*)),G""+""!*<#,HVet Res.
6*@,?86BC2%?)6-@16#
@1
"$<<$ 40/"K"<'=%0=<0&+
(<*)),G$KC?%+&KC
C%+HPLoS One.8*,?6-87BC2%?)-8)6#
@1
=$"$KJ5JC<;4J2*))1,G+!V
"!HEcology.1)*.,?)@.+)7@BC2%?17-1-@1#
@1-
4!";;'KC4"F$*1.,G;"7@8'K?&
!HBioelectromagnetics.*6,?-8I-.BC2%?7-@)86#
@16
:'FC!;0/"!F*117,G2!
'&+5"HJ Exp Biol.))*C#1,?-@-+-@.BC2%?1-18@#
@18
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#6@#
@1@
4"$F(<0$2*)),G"!
HNature.6@-*7.,?.)6+.)7BC2%?))1.66#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)1
@17
N2+(0*))1,G0"+"
V'HPLoS Biol.7*6,)))).@BC2%?1-8871)#
@1.
4"$F0=$2*)).,G0"+
"HNature.686*7)7,?)6+).BC2%?.@6@-)#
@11
C"F0J%C2"<*))7,G0!421))+2J0
.))+2J!HMutat Res.@@*+,?@1+7.BC2%?7)688@#
7))
C"F02"<*)),G;!
H Int J Radiat Biol...*8,?-68+-87BC2%?)-17.-1#
7)
C"F2"<*)),GVV!!
HInt J Radiat Biol...*8,?-8.+-@@BC2%?)-17.6)#
7)
C"F2"<*)),G&!"!
HMutat Res.@11*+,?7+BC2%?)-11..7#
7)-
$J2"F<4+42"F2*1.-,G/
!"HBiolectromagnetics.6*6,?-8+-@BC2%?@6.71#
7)6
0K;K2*17.,G!"2"HBiol
Bull Acad Sci USSR.8*8,?877+8.6BC2%?-)-1#
7)8
C"F*),G&"H
Cell Biochem Biophys.@-*,?I-BC2%?-@77-6#
7)@
0C"F2"<*)),G0!"!
&42+1))+2J!?+HMutat Res.
7))*+,?8+@BC2%?)67)18#
7)7
!:*)),G2+%<!$"?$<11)I
))@H2010 IEEE International Symposium on Technology and Society. --7+-61.
7).
;'*))6,G;"'"HAdv Space Res.-6*7,?8@@+
876BC2%?8..).1-#
7)1
;*18,G"HYale J Biol Med.8*,?@7+78BC2%?-))@6)8#
7)
;*16-,G0C!0HProc Natl Acad Sci U S A.1*@,?
@-+@@BC2%?@87.)@8#
7
<0FX"2*)).,G"!&(
! HPLoS One.-*.,?1@-BC2%?.@1.68#
7
;*167,GHYale J Biol Med.1*-,?-+-.BC2%?).6.-#
7-
;*168,GHYale J Biol Med.7?77+7-6#
76
:J'<=J"K*))),G"
'"HC R Acad Sci III.--*@,?881+8@-BC2%?)1-#
78
(+0*17.,G9<(""HNature.7*8@6@,?@6I@6#
7@
;C*),GC?5!"HNature.676?7+76BC2%?@777-#
77
0="0N=':0C2;C4*)),G0"+"
"!GNature.6@-*7.,?@66+@67BC2%?)-)@67#
7.
C"'4(:0F$=F;'$"4*)),G<"+
5&"HProc Natl Acad Sci U S A.
)7*1,?7@@+77)BC2%?)@81.8#
71
C"'4KK!0F$<2'"4*),G
5"+"&HProc Natl Acad Sci U S A.).*8,?
)1).+)1BC2%?@771.#
7)
"40$$<:20"N0;'$("4$*))7,G
'""5HNature.66@*7-7,?7.+7.@BC2%?
761-17#
7
"4*),G`&!"+
"&*<,HProc Natl Acad Sci U S A.)1*-,?7)@+7BC2%?88.8#
7
<0"N+0("4$*))7,G0?&
HScience. -@*8.-),?6@I6@8BC2%?788@8.)#
7-
('F*1-,c/"#%cPhys Rev. -7?7B?
)#)-AC$#-7#7#
76
22$!C<+4J'*)).,G+5'
"HJ Chem Phys.1*7,?76)@BC2%?1)68--#
78
4CCJ*))8,G2"HJ Plant Res..*@,?-7+-.1BC2%?@.-)@1#
7@
KC*))-,G%J+5""!!H
Photochem Photobiol Sci.*@,?@-7+@6.BC2%?.8167#
77
N 0 2 :" (" 24 0 C< *)), G!
"!+""?HJ Neuroeng Rehabil.7?BC2%?)7)8-.#
7.
;'*)),G9!&&
"HAdv Space Res..*6,?@68+@8)BC2%?.)-1@7#
71
" KCF:C'C0; F*),GC+
""J*X<#,HIndian J Biochem Biophys.61*,?@-+
7)BC2%?6-86@#
7-)
; F" *),G;!"""
""!HPlant Physiol Biochem.87?@7+7-BC2%?@.-6@8#
7-
JFN5X%5!22$2%$*),G"
"'*!,"+""HIndian J Biochem
Biophys.61*-,?+6BC2%?.)---7#
7-
2;4:*),G""8)))
&"!HBioelectromagnetics.--*8,?6.+6-7BC2%?8--#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
)
7--
2;4:*),G""!
!+"HBioelectromagnetics.-*@,?676+6.6BC2%?-.)67#
7-6
;' *))6, G;" ' " H Adv Space Res. -6*7,? 8@@+
876BC2%?8..).1-#
7-8
'N%'4K:':!'2K'N*),G0"
"+"'"HDokl Biochem
Biophys.66?6.+8BC2%?.16@#
7-@
$;%$$C"=CFK*11.,G%&5"
K!<#!!HBioelectromagnetics.1*-,?8+@BC2%?
1886@1-#
7-7
V':$%*)),S%"""'
""TIzv Akad Nauk Ser Biol.*,?@)+@7BC2%?)-86-)#
7-.
K" *)),G0J!J"
""+&J*X<,HIndian J Biochem Biophys.67*8,?-+-.BC2%?
.)8@1#
7-1
$=X;"0:0*))1,G"!"
!"!!"HInt J Mol Sci.)*),?688+688.BC2%?))8718.#
76)
K" *))1,G0J!"""&
J*X<#,5!HIndian J Biochem
Biophys.6@*,?.6+1BC2%?187117#
76
K" *))@,G&"""
'*0<#,HBioelectromagnetics.1*7,?87+87.BC2%?.8@17#
76
;2;2JJ"%2*))@,G2"
Zea maysHPlant Biosystems.6)*,?.7+1-B/%?)#).)A@-8))8))8-6#
76-
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#1+-)-6#
766
$F2J4</0CFF"2(*11-,G7@J"
2"?"HInt J Biometeorology.-7*6,?1+-6B/%?
)#))7A;()-.781#
768
;";"*))@,G%<("!
"HElctromagn Biol Med.8*,?7+77BC2%?@818--@#
76@
;(00*178,G+5!''"?
iHBiol Bull.6.*-,?-7)+-71#
767
2'CK;;*))@,G&""
HPlant Physiol.6*,?6)+66BC2%?@187--#
76.
2'CK*11.,G<?+HAnn
Bot Lond..?--I6)#
761
;*1.7,GHMath Model..?7-)I7--#
78)
<;J':F*))@,G+'""!H
Science.-*8781,?-7+-76BC2%?@66--.#
78
<;452(2*11),G2"&HSci Prog.76*18C#-,?-67+-81BC2%?
)867#
78
;'$*178,G2"!HScience.1)*6,?-77+-71BC2%?7)@71#
78-
K'4(F0!='$:FF2'K*)),G2?
HPlant Cell Environ.--*,?@-+7-BC2%?1.18-1@#
786
K'4(F0;':2'K*)),G22H
Plant Signal Behav.8*),?C2%?).88178#
788
K'4(F02'K*)),G22HPlant Signal Behav.
8*7,?.@+.-BC2%?)66.67@#
78@
K'4(F02'K*)),G"2?!"
HPlant Cell Environ.--*8,?.@+.7BC2%?))6))@-#
787
K'=F=F2'K*),G0!"
HPlant Signal Behav.7*,?.+.6BC2%?-8-.76#
78.
(0;F('2((2'F;*))1,G0Z
!!K!HPlant Cell.*7,?.+-BC2%?
1@)@6#
781
(F<*))7,G"""HPlant Cell Environ.
-)*-,?61+87BC2%?7@-77#
7@)
!"$$0$KK'!"*))@,G+%C
<#/"CHPlant Signal Behav.*,?8+BC2%?1867#
7@
;!(("<4='2FJ!'KJF$ X*))8,G%
&0'"HBiophys J.
..*,?@1)+@17BC2%?88@8@#
7@
='24*)),G""++0*,Z+!""
"0HJ Gen Physiol..*,?+BC2%?6166#
7@-
;22(F4F*111,G0+!"+
!HFEBS Lett.68.*,?6+66BC2%?)8.1-)#
7@6
4<(2'$(F*))1,G+"
"""JHPlant Cell Environ.-*6,?-1+
-@BC2%?1)86-6@#
7@8
<42'$(F*))8,G0"
HPlant Physiol.-.*6,?))+)1BC2%?@)6)@6.#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
7@@
C9K0$;<*)),GC?HArabidopsis Book..?)8B
C2%?-)-8#
7@7
K'4'02"$;N<<!F*))6,G;"""
!HBioelectrochemistry. @-*+,?1+16BC2%?8)86#
7@.
<+<*))),GC?cc"!
"+HPhotochem Photobiol.7*-,?7-+.BC2%?)1.1818#
7@1
!"$0"F*117,GC"=CCHPlant Physiol.-*,?
)1+7BC2%?-@)#
77)
!"$0"F*11@,G%!"C
<HPlanta.))*6,?6@+68BC2%?866#
77
<!FK'4*)),GC!?000C
""!HBioelectrochemistry.87*,?67+8-BC2%?)6178@#
77
2"F0FK'4*))),G"""?6+
!HBioelectrochemistry.8*,?)+)8BC2%?)1)7)#
77-
X2$2'2;=(*))1,G"+
"!"HPlant Physiol.61*-,?81-+@))BC2%?116@#
776
2'X2$(;=2h*)),G+"
""HPlant Signal Behav.8*.,?1..+11)BC2%?)76.-1#
778
<(F*)),G0+"HPlant Biol (Stuttg).*,?@.+
76BC2%?)-1.-6#
77@
C0*)),G"""HPlant Signal Behav.
8*6,?-71+-.8BC2%?)-17-#
777
2J+4"F4<='C4*))1,GC+
HPlanta.-)*8,?)7+)71BC2%?176-@)#
77.
2':<<'2"*))1,GC+0Z&
!"""HPlant Signal Behav.6*1,?1+
1-BC2%?11-.-7.#
771
2''0*))1,GC""?ccHJ Lipid Res.#@)+@8BC2%?
1)1.-)8#
7.)
!C"FX2!<0'C="<*))1,G""'
""'HPlant Cell Environ.-*,?16+)7BC2%?
1)..6#
7.
>=0>=N*))1,G("""HBiochem J.6*,?
68+8@BC2%?188@6#
7.
0><=="N<>=*)).,G8+
C//$/C%""!!"0ZHPlant Cell.)*,?-8-+-@@BC2%?.8.66#
7.-
J':*))7,GC!"+"""H
Photochem Photobiol..-*,?)+BC2%?@1)@71-#
7.6
2 *))7,G0""'?HPlant Signal Behav.*,?71+.8B
C2%?18@17#
7.8
2J+4"F" K='C*))@,G0
!HPlanta.8*,?.-+1BC2%?@.-87@#
7.@
XY!"(F2=J=4F$*117,G$+
0Z+!"HProc Natl Acad Sci U S A.16*@,?
78+788BC2%?)-.@)1#
7.7
FK4X"X02:XCF<F$FC;2*)).,
G"!!J!
;!!$/HPlant Cell Physiol.61*),?618+8)7BC2%?
.787.@#
7..
;2XC22J2X"X0/:";($FC*))6,
GC!J!!!
"!0ZHPlant Physiol.-8*,?-+6-B
C2%?86)@1#
7.1
/'"0*111,G2!Z+C
"HPlant Cell.*,?@-+7BC2%?117@6-#
71)
$&K4;CC(<"4*))@,G"*1))2J,
'HPhysiologia Plantarum..*,?.-+..B
/%?)#A #-11+-)86#))@#))76)#&#
71
K*))@,G="'K$02;C
HPlant Signal Behav.*8,?@+@6BC2%?18@1.7#
71
/C0='0=J<(F*111,G"""&
!"!!+
HPlant Physiol.1*,?-+.BC2%?1..)-@-#
71-
';*11@,G;!"
&HFEBS Lett.-1)*-,?78+71BC2%?.7)@.7@#
716
/C4<*),G"
H J Plant Physiol.@.*,?)-+).BC2%?)@-)@@#
718
/C4<*)),G"?"!
HPlant Signal Behav.8*,?-6+6BC2%?)81.)8#
71@
4C24<;4%"$*))1,G"";
&HPlant Signal Behav.6*,?))+).BC2%?1@61.#
717
4<C*))1,G"""+
'HJ Plant Physiol.@@*-,?1)+-))BC2%?.7@)8)#
ELECTROMAGNETIC SENSITIVITY
AND
ELECTROMAGNETIC HYPERSENSITIVITY
71.
4C24<;"F$%"$*)).,G$""
"HJ Plant Physiol.@8*),?)7)+)7.BC2%?71-@6).#
711
K'40;2'K*))1,GKHBioelectrochemistry.
78*,?6+67BC2%?1-8@111#
.))
K'402'KF*)).,GCHPlant Signal Behav.-*7,?
61)+61BC2%?17)661@#
.)
K'4F*))7,G0"!HPlant
Signa, Behav.*-,?-1+68BC2%?18@1.#
.)
2K20K=4F0222$0*))6,GC
)84J"HBioelectromagnetics.8*@,?6)-+6)7BC2%?8-))78#
.)-
K(04(;C<"4C(*))6,GC$42+<'
$HPlant Signal Behav.*@,?8+86BC2%?17)6867#
.)6
!('K4(2(!'*),G;"'"
*0,HScientificWorldJournal.)?7@11B
C2%?@61--#
.)8
$& K 4 ; C C ( <" 4 *))., G" 5 *1)) 2J,
*8 K +, "? "
""HPlanta.7*6,?..-+.1BC2%?.)@1.7#
.)@
CJ$KFXF*))@,G4!'8)J
"HBiomagn Res Technol.6?IBC2%?@68771#
.)7
"":*)),G%$(5;'"!""?C
/!HInt J Forestry Res..-@7.B?)#88A))A.-@7.#
.).
='=X"'+2';*))7,G%'0HAnn
Bot.))*6,?71+71@BC2%?7@.@7@#
.)1
2244*11,GJ!!0
Z
HJ Exp Bot.6-*6,?
661I686#
.)
0J4<;"(4;<$(2"2!!4J*))-,G='&
"5+!""'?"+
HJ Altern Complement Med.1*,?7+.BC2%?.)6)78#
.
X'F4"F$C*11@,ELF Communications System Ecological Monitoring Program: Final
Summary Report*%$%0"%!0C /
=0="0,$)@6+@,#6-#
.
K22*),G%'HS%"TWohnung+Gesundheit.
*;";"%!,6*",6-+68#
.-
2" 0(!!""0J2C2;;;2CJJ4CCK2*)),
G$'"""&?+
%HEnviron Health.1?@BC2%?)-8-8.@#
.6
("2!*11-,G2"""+"
HAm J Epidemiol.-.*7,?6@7+6.BC2%?.-78#
.8
00*),GC<?"2(!&"?0
CH
.@
(*),Dirty Electricityand Electromagnetic Radiation: Understanding Electromagnetic Energy *F
;';`B%;17.)1.).76618#
.7
:NF/*),G$F?5
HPathophysiology.C2%?68.111#
..
4F<0*),G"?((iHSci Total Environ.66?)-+B
C2%?8-@)6#
.1
F/*))@,G?+++HElectromagn Biol Med.
8*6,?68+8.BC2%?77.8.6#
.)
;";""2;2+)).*7
,)).#
.
%;"*))8,IEQ Indoor Environmental Quality* %
;"*%;,";0;
*;,,B?;%?"(?##
.
!"F"*)).,GJ"&
HHealth Hazard Evaluation Report.?0
0C%/%/#))7+))18+
-)@-B&?/&<*/<,#.#
.-
00FF<J=40<(*))@,G0
02HHealth Hazard Evaluation Report.?0
0WC%/W%/#))+)8-+116B#8#
.6
"0C*),G=/"J""?"H
Pathophysiology.1*,?+-BC2%?77.)#
.8
C"F*),G4"!C+!
"2$4&H+;
2*,Drosophila Melanogaster: Life Cycle, Genetics and Development.C!N'*%;?
17.+@67)718,#
.@
2+;<!;>CK"F|J$*))6,G&421))+
2J""!!HNeurobiol Dis.7*-,?
668+686BC2%?8871.)#
.7
=!<N<;'24$*))-,G!
"HJ Cell Biochem..1*,?6.+88BC2%?@.1)7#
..
(C=C$<F2:J$*)),G2!'H
Differentiation.@7*6+8,?1-+17BC2%?@.-611#
